Filed Pursuant to 424(b)(5)
File No. 333-236463
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 24, 2020)
Up to $150,000,000
7.375% Senior
Notes due 2023
6.875% Senior
Notes due 2023
6.75% Senior Notes
due 2024
6.375% Senior
Notes due 2025
6.50% Senior Notes
due 2026
7.25% Senior Notes
due 2027
7.50% Senior Notes
due 2027
Depositary Shares,
each representing 1/1000th of a Share of 6.875% Series A Cumulative Perpetual Preferred
Stock (Liquidation Preference
Equivalent to $25.00 Per Depositary Share)
Depositary Shares,
each representing 1/1000th of a Share of 7.375% Series B Cumulative Perpetual Preferred
Stock (Liquidation Preference
Equivalent to $25.00 Per Depositary Share)
We have entered into
an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley FBR, Inc. (which has subsequently
been renamed B. Riley Securities, Inc.) (“B. Riley Securities” or the “Agent”), on February
14, 2020, under which we may offer and sell, from time to time through or to B. Riley Securities, as agent or principal, up to
$150,000,000 aggregate amount of our:
|
●
|
7.375%
Senior Notes due 2023 (the “7.375% 2023 Notes”);
|
|
●
|
6.875%
Senior Notes due 2023 (the “6.875% 2023 Notes”);
|
|
●
|
6.75%
Senior Notes due 2024 (the “2024 Notes”);
|
|
●
|
6.375%
Senior Notes due 2025 (the “2025 Notes”);
|
|
●
|
6.50%
Senior Notes due 2026 (the “2026 Notes”);
|
|
●
|
7.25%
Senior Notes due 2027 (the “7.25% 2027 Notes”);
|
|
●
|
7.50%
Senior Notes due 2027 (the “7.50% 2027 Notes” and together with the 7.375% 2023 Notes, the 6.875% 2023 Notes,
the 2024 Notes, the 2025 Notes, the 2026 Notes and the 7.25% 2027 Notes, the “Notes”);
|
|
●
|
Depositary
Shares, each representing 1/1000th of a share of 6.875% Series A Cumulative Perpetual Preferred Stock (Liquidation
Preference Equivalent to $25.00 per Depositary Share) (the “Series A Depositary Shares”); and
|
|
●
|
Depositary
Shares, each representing 1/1000th of a share of 7.375% Series B Cumulative Perpetual Preferred Stock (Liquidation
Preference Equivalent to $25.00 per Depositary Share) (the “Series B Depositary Shares” and, together with
the Notes and the Series A Depositary Shares, the “Offered Securities”);
|
through this prospectus supplement and the accompanying prospectus.
This prospectus supplement and the accompanying prospectus update and replace the prior sales agreement prospectus dated February
24, 2020 (the “prior prospectus”) that relates to our “at the market offering” of our 7.375% 2023 Notes,
our 6.875% 2023 Notes, our 2024 Notes, our 2025 Notes, our 2026 Notes, our 7.25% 2027 Notes and our Series A Depositary Shares.
This prospectus supplement and the accompanying prospectus should be read in conjunction with the base prospectus dated February
24, 2020, which will be delivered with this prospectus supplement. As of the date of this prospectus supplement, we have sold Notes
(excluding the 7.50% 2027 Notes and excluding any repurchase of Notes) pursuant to the prior prospectus having an aggregate offering
price of approximately $3.5 million and no Series A Depositary Shares under the prior prospectus, leaving up to $146.5
of Notes and Depositary Shares available for offer and sale pursuant to this prospectus supplement and the accompanying prospectus.
Sales of the Offered
Securities, if any, under this prospectus supplement and the accompanying prospectus may be made in transactions that are deemed
to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities
Act”). The Agent is not required to sell any specific number of the Offered Securities, but the Agent will make all
sales using commercially reasonable efforts consistent with its normal trading and sales practices on mutually agreed terms between
the Agent and us. See “Plan of Distribution.”
The Offered Securities
to which this prospectus supplement and the accompanying prospectus relate will be offered and sold through the Agent over a period
of time and from time to time. Under the Sales Agreement, the Agent will be entitled to compensation of up to 2.0% of the gross
proceeds of all Offered Securities sold through it as our Agent. In connection with the sale of the Offered Securities, the Agent
will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the Agent
will be deemed to be underwriting commissions or discounts. There is no arrangement to place proceeds of the offering in escrow,
trust or similar arrangement. See “Plan of Distribution.”
The 7.375% 2023 Notes,
6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes will mature on May 31, 2023, September
30, 2023, May 31, 2024, February 28, 2025, September 30, 2026, December 31, 2027 and May 31, 2027, respectively. Interest will
be paid quarterly in arrears on January 31, April 30, July 31 and October 31 of each year. Interest on the Notes will accrue from
the most recent interest payment date immediately preceding the respective dates of issuance of the Notes, except that Notes purchased
after the record dates noted below, but prior to the interest payment date immediately following such record date (or if settlement
of a purchase of Notes otherwise occurs after such record date but prior to the interest payment date immediately following such
record date), will not begin to accrue interest until the interest payment date immediately following such record date. The interest
payable on each interest payment date will be paid only to holders of record of the Notes at the close of business on January
15, April 15, July 15 and October 15 of each year, as the case may be, immediately preceding the applicable interest payment date.
As a general matter, holders of the Notes will not be entitled to receive any payments of principal on the Notes prior to the
stated maturity date.
We may redeem the 7.375%
2023 Notes in whole or in part at our option (i) prior to May 31, 2021, at a price equal to $25.75 per note, plus accrued and unpaid
interest to, but excluding, the date of redemption, (ii) on or after May 31, 2021 and prior to May 31, 2022, at a price equal to
$25.375 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or after May 31, 2022
and prior to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding the
date of redemption, as described under “Description of the Notes—Optional Redemption.”
We may redeem the 6.875%
2023 Notes in whole or in part at our option (i) prior to September 30, 2021, at a price equal to $25.50 per note, plus accrued
and unpaid interest to, but excluding, the date of redemption, (ii) on or after September 30, 2021 and prior to September 30, 2022,
at a price equal to $25.25 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or
after September 30, 2022 and prior to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest
to, but excluding the date of redemption, as described under “Description of the Notes—Optional Redemption.”
The Notes will be issued in denominations of $25 and in integral multiples thereof.
We may redeem the
2024 Notes for cash in whole or in part at any time at our option (i) on or after May 31, 2021 and prior to May 31, 2022, at a
price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on or after May
31, 2022 and prior to May 31, 2023, at a price equal to $25.25 per note, plus accrued and unpaid interest to, but excluding, the
date of redemption, and (iii) on or after May 31, 2023 and prior to maturity, at a price equal to 100% of their principal amount,
plus accrued and unpaid interest to, but excluding, the date of redemption.
We may redeem the
2025 Notes for cash in whole or in part at any time at our option (i) on or after February 28, 2021 and prior to February 28,
2022, at a price equal to $25.75 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on
or after February 28, 2022 and prior to February 28, 2023, at a price equal to $25.50 per note, plus accrued and unpaid interest
to, but excluding, the date of redemption, (iii) on or after February 28, 2023 and prior to February 29, 2024, at a price equal
to $25.25 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, and (iv) on or after February
29, 2024 and prior to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding,
the date of redemption.
We may redeem the
2026 Notes for cash in whole or in part at any time at our option (i) on or after September 30, 2022 and prior to September 30,
2023, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on
or after September 30, 2023 and prior to September 30, 2024, at a price equal to $25.25 per note, plus accrued and unpaid interest
to, but excluding, the date of redemption, and (iii) on or after September 30, 2024 and prior to maturity, at a price equal to
100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption.
We may redeem the
7.25% 2027 Notes in whole or in part on or after December 31, 2020, respectively, at our option, at a redemption price equal to
100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption, as described under
“Description of the Notes—Optional Redemption.”
We may redeem the 7.50% 2027 Notes in whole or in part, at our
option, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the
date of redemption, as described under “Description of the Notes—Optional Redemption.”
We will pay cumulative
distributions on the Series A Preferred Stock underlying the Series A Depositary Shares, from, and including, the date of original
issuance, in the amount of $1.71875 per depositary share each year, which is equivalent to 6.875% of the $25.00 liquidation preference
per depositary share. Dividends on the Series A Preferred Stock will be payable quarterly in arrears, on or about the last day
of January, April, July and October of each year (or, if not on a business day, on the next succeeding business day).
Generally,
we may not redeem the Series A Preferred Stock underlying the Series A Depositary Shares until October 7, 2024, and except as
described below upon the occurrence of a Delisting Event or Change of Control (each as defined herein), as applicable. On or after
October 7, 2024, we may, at our option, redeem the shares of the Series A Preferred Stock underlying the Series A Depositary Shares,
in whole or from time to time in part, by paying $25,000.00 per share ($25.00 per depositary share), plus any accumulated and
unpaid dividends to, but not including, the redemption date. In addition, upon the occurrence of a Delisting Event or a Change
of Control (each as defined herein), we may, subject to certain conditions, at our option, redeem the Series A Preferred Stock
underlying the Series A Depositary Shares, in whole or in part within 90 days after the first date on which such Delisting Event
occurred or within 120 days after the first date on which such Change of Control occurred, as applicable, by paying $25,000.00
per share ($25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the redemption date.
If we exercise any of our redemption rights relating to the Series A Preferred Stock underlying the Series A Depositary Shares,
the holders of the Series A Depositary Shares representing the Series A Preferred Stock will not have the conversion right described
below.
Upon
the occurrence of a Delisting Event or a Change of Control, as applicable, each holder of a depositary share of the underlying
Series A Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Date or Change of Control Conversion
Date (each as defined herein), we have provided or provide notice of our election to redeem the Series A Preferred Stock) to direct
the depositary, on such holder’s behalf, to convert some or all of the shares of Series A Preferred Stock underlying the
Series A Depositary Shares held by such holder on the Delisting Event Conversion Date or Change of Control Conversion Date, as
applicable, into a number of shares of our common stock per depositary share equal to the lesser of:
|
●
|
the
quotient obtained by dividing (i) the sum of the $25.00 liquidation preference plus the amount of any accumulated and unpaid
dividends thereon to, but not including, the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable
(unless the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, is after a record date for
a Series A Preferred Stock dividend payment and prior to the corresponding Series A Preferred Stock dividend payment date,
in which case no additional amount for such accumulated and unpaid dividend will be included in this sum) by (ii) the Common
Stock Price (as defined herein); and
|
|
●
|
2.176
(i.e., the “Share Cap”), subject to certain adjustments;
|
subject, in each case, to the conditions
described in this prospectus supplement and the accompanying prospectus, including, under specified circumstances, an aggregate
cap on the total number of shares of common stock issuable upon conversion and to provisions for the receipt of alternative consideration.
The Series A Preferred
Stock underlying the Series A Depositary Shares has no maturity date and will remain outstanding indefinitely unless redeemed
by us or converted into shares of common stock in connection with a Delisting Event or Change of Control by the holders of the
Series A Depositary Shares representing the Series A Preferred Stock. Investors in the Series A Depositary Shares generally will
have no voting rights, but will have limited voting rights if we fail to pay dividends for six or more quarters (whether or not
declared or consecutive) and in certain other events.
We will pay cumulative
distributions on the Series B Preferred Stock underlying the Series B Depositary Shares, from, and including, the date of original
issuance, in the amount of $1.84375 per depositary share each year, which is equivalent to 7.375% of the $25.00 liquidation preference
per depositary share. Dividends on the Series B Preferred Stock will be payable quarterly in arrears, on or about the last day
of January, April, July and October of each year (or, if not on a business day, on the next succeeding business day).
Generally,
we may not redeem the Series B Preferred Stock underlying the Series B Depositary Shares until September 4, 2025, and except as
described below upon the occurrence of a Delisting Event or Change of Control (each as defined herein), as applicable. On or after
September 4, 2025, we may, at our option, redeem the shares of the Series B Preferred Stock underlying the Series B Depositary
Shares, in whole or from time to time in part, by paying $25,000.00 per share ($25.00 per depositary share), plus any accumulated
and unpaid dividends to, but not including, the redemption date. In addition, upon the occurrence of a Delisting Event or a Change
of Control (each as defined herein), we may, subject to certain conditions, at our option, redeem the Series B Preferred Stock
underlying the Series B Depositary Shares, in whole or in part within 90 days after the first date on which such Delisting Event
occurred or within 120 days after the first date on which such Change of Control occurred, as applicable, by paying $25,000.00
per share ($25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the redemption date.
If we exercise any of our redemption rights relating to the Series B Preferred Stock underlying the Series B Depositary Shares,
the holders of the Series B Depositary Shares representing the Series B Preferred Stock will not have the conversion right described
below.
Upon
the occurrence of a Delisting Event or a Change of Control, as applicable, each holder of a depositary share of the underlying
Series B Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Date or Change of Control Conversion
Date (each as defined herein), we have provided or provide notice of our election to redeem the Series B Preferred Stock) to direct
the depositary, on such holder’s behalf, to convert some or all of the shares of Series B Preferred Stock underlying the
Series B Depositary Shares held by such holder on the Delisting Event Conversion Date or Change of Control Conversion Date, as
applicable, into a number of shares of our common stock per depositary share equal to the lesser of:
|
●
|
the
quotient obtained by dividing (i) the sum of the $25.00 liquidation preference plus the amount of any accumulated and unpaid dividends
thereon to, but not including, the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable (unless
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, is after a record date for a Series B
Preferred Stock dividend payment and prior to the corresponding Series B Preferred Stock dividend payment date, in which case
no additional amount for such accumulated and unpaid dividend will be included in this sum) by (ii) the Common Stock Price (as
defined herein); and
|
|
●
|
1.8671
(i.e., the “Share Cap”), subject to certain adjustments;
|
subject, in each case, to the conditions
described in this prospectus supplement and the accompanying prospectus, including, under specified circumstances, an aggregate
cap on the total number of shares of common stock issuable upon conversion and to provisions for the receipt of alternative consideration.
The Series B Preferred
Stock underlying the Series B Depositary Shares has no maturity date and will remain outstanding indefinitely unless redeemed
by us or converted into shares of common stock in connection with a Delisting Event or Change of Control by the holders of the
Series B Depositary Shares representing the Series B Preferred Stock. Investors in the Series B Depositary Shares generally will
have no voting rights, but will have limited voting rights if we fail to pay dividends for six or more quarters (whether or not
declared or consecutive) and in certain other events.
The up to $150,000,000
in total aggregate principal amount (inclusive of any Depositary Shares sold hereunder) of 7.375% 2023 Notes, 6.875% 2023 Notes,
2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes that we may offer and sell under this prospectus constitutes
a further issuance of and are fungible with the $129,907,275 in aggregate principal amount of 7.375% Senior Notes due 2023 that
we have issued to date (the “Initial 7.375% 2023 Notes”), the $113,109,025 in aggregate principal amount of
6.875% Senior Notes due 2023 that we have issued to date (the “Initial 6.875% 2023 Notes”), the $111,494,175
in aggregate principal amount of 6.75% Senior Notes due 2024 that we have issued to date (the “Initial 2024 Notes”),
the $132,250,000 in aggregate principal amount of 6.375% Senior Notes due 2025 that we have issued to date (the “Initial
2025 Notes”), the $135,085,600 in aggregate principal amount of 6.50% Senior Notes due 2026 that we have issued to date
(the “Initial 2026 Notes”), the $122,976,275 in aggregate principal amount of 7.25% Senior Notes due 2027 that
we have issued to date (the “Initial 7.25% 2027 Notes”) and the $125,766,150 in aggregate principal amount of 7.50%
Senior Notes due 2027 (the “Initial 7.50% 2027 Notes” and, together with the Initial 7.375% 2023 Notes, the
Initial 6.875% 2023 Notes, the Initial 2024 Notes, the Initial 2025 Notes, the Initial 2026 Notes and the Initial 7.25% 2027 Notes,
the “Initial Notes”), respectively, and form a single series of debt securities with the Initial 7.375% 2023
Notes, Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial
7.50% 2027 Notes, respectively. Unless the context requires otherwise, references to the “Notes,” “7.375% 2023
Notes,” “6.875% 2023 Notes,” “2024 Notes,” “2025 Notes,” “2026 Notes,” “7.25%
2027 Notes,” or “7.50% 2027 Notes” will not include the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes,
Initial 2024 Notes, Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes or Initial 7.50% 2027 Notes. The 7.375% 2023
Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes will have terms identical
to the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial 2025 Notes, Initial 2026 Notes, Initial
7.25% 2027 Notes and Initial 7.50% 2027 Notes, respectively, and will have the same CUSIP number as, and will be fungible and
vote together with, the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial 2025 Notes, Initial
2026 Notes, Initial 7.25% 2027 Notes or Initial 7.50% 2027 Notes, respectively, immediately upon issuance.
The Notes will be
our senior unsecured obligations and will rank equal in right of payment with all of our existing and future senior unsecured
and unsubordinated indebtedness. The Notes will be effectively subordinated in right of payment to all of our existing and future
secured indebtedness, and the Notes will be structurally subordinated to all existing and future indebtedness (including trade
payables) of our subsidiaries.
The 7.375% 2023 Notes
are quoted on Nasdaq Global Market (“NASDAQ”) under the symbol “RILYH,” the 6.875% 2023 Notes are
quoted on NASDAQ under the symbol “RILYI,” the 2024 Notes are quoted on NASDAQ under the symbol “RILYO,”
the 2025 Notes are quoted on NASDAQ under the symbol “RILYM,” the 2026 Notes will be quoted on NASDAQ under the symbol
“RILYN,” the 7.25% 2027 Notes are quoted on NASDAQ under the symbol “RILYG,” and the 7.50% 2027 Notes
are quoted on NASDAQ under the symbol “RILYZ.” Our Series A Depositary Shares are quoted on NASDAQ under the symbol
“RILYP” and our Series B Depositary Shares are quoted on NASDAQ under the symbol “RILYL.”
On October 8, 2020, the last reported sale price per $25 principal
amount of 7.375% 2023 Note was $25.15, the last reported sale price per $25 principal amount of 6.875% 2023 Note was $24.82, the
last reported sale price per $25 principal amount of 2024 Note was $24.85, the last reported sale price per $25 principal amount
of 6.375% 2025 Note was $24.16, the last reported sales price per $25 principal amount of 2026 Notes was $23.92, the last reported
sale price per $25 principal amount of 7.25% 2027 Note was $24.92 and the last reported sale price per $25 principal amount of
7.50% 2027 Note was $25.05. On October 8, 2020, there were 2,000,000 Series A Depositary Shares outstanding and the last reported
sales price of our Series A Depositary Shares was $24.00 per share and 1,300,000 Series B Depositary Shares outstanding and the
last reported sale price of our Series B Depositary Shares was $25.29 per share.
Delivery of the Offered
Securities in book-entry form only through The Depository Trust Company will be made on or about the second trading date following
the date of purchase.
Investing in the Offered Securities
involves a high degree of risk. You should carefully consider the risks described under “Risk Factors” beginning on
page S-15 of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement and the
accompanying prospectus.
Neither the U.S. Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
B. Riley Securities
The date of this prospectus supplement is October
9, 2020.
TABLE OF CONTENTS
Prospectus Supplement
Prospectus
ABOUT THIS PROSPECTUS SUPPLEMENT
This prospectus supplement
and the accompanying prospectus are part of a registration statement that we filed with the Securities and Exchange Commission
(“SEC”) utilizing a “shelf” registration process. By using a shelf registration statement, we may
offer our Offered Securities having an aggregate offering price of up to $150,000,000 from time to time under this prospectus
supplement at prices and on terms to be determined by market conditions at the time of offering.
This document is in
two parts. The first part is this prospectus supplement, including the documents incorporated by reference, which describes the
specific terms of this offering. The second part, the accompanying base prospectus, including the documents incorporated by reference,
provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document
combined. We urge you to carefully read this prospectus supplement and the accompanying prospectus, and the documents incorporated
by reference herein and therein, before buying any of the securities being offered under this prospectus supplement. This prospectus
supplement may add or update information contained in the accompanying prospectus and the documents incorporated by reference
therein. To the extent that any statement we make in this prospectus supplement is inconsistent with statements made in the accompanying
prospectus or any documents incorporated by reference therein that were filed before the date of this prospectus supplement, the
statements made in this prospectus supplement will be deemed to modify or supersede those made in the accompanying prospectus
and such documents incorporated by reference therein.
You should rely only
on the information contained in this prospectus supplement and the accompanying prospectus, or incorporated by reference herein
or therein. Neither we nor the Agent have authorized anyone to provide you with different information. No dealer, salesperson
or other person is authorized to give any information or to represent anything not contained in this prospectus supplement and
the accompanying prospectus. You should not rely on any unauthorized information or representation. This prospectus supplement
is an offer to sell only the securities offered hereby, and only under circumstances and in jurisdictions where it is lawful to
do so. You should assume that the information in this prospectus supplement and accompanying prospectus is accurate only as of
the date on the front of the applicable document and that any information we have incorporated by reference is accurate only as
of the date of the document incorporated by reference, regardless of the date of delivery of this prospectus supplement or the
accompanying prospectus, or any sale of a security.
As used in this prospectus,
unless the context indicates or otherwise requires, “the Company,” “B. Riley,” “we,” “us”
or “our” refer to the combined business of B. Riley Financial, Inc. and its consolidated subsidiaries.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS
This prospectus supplement
and the accompanying prospectus, including the documents incorporated by reference herein and therein contain forward-looking
statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”). These statements involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or achievements to be materially different from any future results, performances
or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited
to, statements relating to our future financial performance, the growth of the market for our services, expansion plans and opportunities
and statements regarding our intended uses of the proceeds of the securities offered hereby. In some cases, you can identify forward-looking
statements by terminology such as “anticipates,” “believes,” “can,” “continue,”
“could,” “estimates,” “expects,” “intends,” “may,” “plans,”
“potential,” “predicts,” “should,” “will,” “would,” the negative of
such terms or other comparable terminology. The statements we make regarding the following subject matters are forward-looking
by their nature:
|
●
|
plans, objectives,
expectations and intentions and other factors discussed in “Risk Factors” contained in this prospectus.
|
The forward-looking
statements contained in this prospectus supplement reflect our current views about future events, are based on assumptions, and
are subject to known and unknown risks and uncertainties. Many important factors could cause actual results or achievements to
differ materially from any future results or achievements expressed in or implied by our forward-looking statements, including
the factors listed below. Many of the factors that will determine future events or achievements are beyond our ability to control
or predict. Certain of these are important factors that could cause actual results or achievements to differ materially from the
results or achievements reflected in our forward-looking statements, including, but not limited to:
|
●
|
volatility in our
revenues and results of operations;
|
|
●
|
changing conditions
in the financial markets;
|
|
●
|
our ability to generate
sufficient revenues to achieve and maintain profitability;
|
|
●
|
the short term nature
of our engagements;
|
|
●
|
the accuracy of
our estimates and valuations of inventory or assets in “guarantee” based engagements;
|
|
●
|
competition in the
asset management business;
|
|
●
|
potential losses
related to our auction or liquidation engagements;
|
|
●
|
our dependence on
communications, information and other systems and third parties;
|
|
●
|
potential losses
related to purchase transactions in our auction and liquidations business;
|
|
●
|
the potential loss
of financial institution clients;
|
|
●
|
potential losses
from or illiquidity of our proprietary investments;
|
|
●
|
changing economic
and market conditions;
|
|
●
|
potential liability
and harm to our reputation if we were to provide an inaccurate appraisal or valuation;
|
|
●
|
failure to successfully
compete in any of our segments;
|
|
●
|
our ability to borrow
under our credit facilities as necessary;
|
|
●
|
failure to comply
with the terms of our credit agreements;
|
|
●
|
our ability to meet
future capital requirements;
|
|
●
|
our ability to realize
the benefits of our completed acquisitions, including our ability to achieve anticipated opportunities and operating cost
savings, and accretion to reported earnings estimated to result from completed acquisitions in the time frame expected by
management or at all;
|
|
●
|
our ability to realize
the expected benefits of our acquisition of magicJack; and
|
|
●
|
the diversion of
management time on acquisition-related issues.
|
The forward-looking
statements contained in this prospectus supplement reflect our views and assumptions only as of the date of this prospectus supplement.
You should not place undue reliance on forward-looking statements. Except as required by law, we assume no responsibility for
updating any forward-looking statements nor do we intend to do so. Our actual results, performance or achievements could differ
materially from the results expressed in, or implied by, these forward-looking statements. The risks included in this section
are not exhaustive. Additional factors that could cause actual results to differ materially from those described in the forward-looking
statements are set forth in the section entitled “Risk Factors” beginning on page S-15.
PROSPECTUS SUMMARY
This summary is not complete and does
not contain all of the information that you should consider before investing in the securities offered by this prospectus supplement
and accompanying prospectus. You should read this summary together with the entire prospectus supplement and accompanying prospectus,
including our financial statements, the notes to those financial statements and the other documents that are incorporated by reference
in this prospectus, before making an investment decision. See “Risk Factors” beginning on page S-15 of this prospectus
supplement for a discussion of the risks involved in investing in our securities.
Our Business
B. Riley Financial,
Inc. (NASDAQ: RILY) and its subsidiaries provide collaborative financial services and solutions through several operating subsidiaries
including:
|
●
|
B. Riley Securities, Inc. (“B. Riley Securities”) is a leading, full service investment bank providing financial advisory, corporate finance, research, securities lending and sales and trading services to corporate, institutional and high net worth individual clients.
|
|
●
|
B. Riley Wealth
Management, Inc. provides comprehensive wealth management and brokerage services to individuals and families, corporations
and non-profit organizations, including qualified retirement plans, trusts, foundations and endowments.
|
|
●
|
B. Riley Capital
Management, LLC, a Securities and Exchange Commission (“SEC”) registered investment advisor, which includes:
|
|
●
|
B.
Riley Asset Management, an advisor to certain private funds and to institutional and high net worth investors.
|
|
●
|
Great
American Capital Partners, LLC (“GACP”), the general partner of two private funds, GACP I, L.P. and GACP II,
L.P., both direct lending funds that provide senior secured loans and second lien secured loan facilities to middle market public
and private U.S. companies.
|
|
●
|
B. Riley Advisory
Services (“BR Advisory”), a specialty financial advisory service that provides consulting services related
to bankruptcy, restructuring, crisis management, forensic accounting, and litigation matters, in addition to appraisal and
valuation services.
|
|
●
|
B. Riley Retail
Solutions, a leading provider of asset disposition and retail liquidation services.
|
|
●
|
B. Riley Real Estate
Solutions, a real estate services firm established as B. Riley Real Estate, LLC in February 2020.
|
We also pursue a strategy
of investing in or acquiring companies through B. Riley Principal Investments which we believe have attractive investment return
characteristics. As part of this strategy, we have completed the following acquisitions or investments.
|
●
|
UOL is a communications
company that offers consumer subscription services and products, consisting of Internet access services and devices under
the NetZero and Juno brands primarily sold in the United States.
|
|
●
|
magicJack is a Voice
over IP (“VoIP”) cloud-based technology and services communications provider.
|
|
●
|
BR Brand Holdings
LLC, in which we acquired a majority investment interest on October 28, 2019, is a brand investment portfolio.
|
We are headquartered
in Los Angeles with offices in major cities throughout the United States including New York, Chicago, Boston, Dallas, Memphis,
Metro Washington D.C. and West Palm Beach.
For financial reporting
purposes we classify our businesses into five operating segments: (i) Capital Markets, (ii) Auction and Liquidation, (iii)
Valuation and Appraisal, (iv) Principal Investments – United Online and magicJack and (v) Brands segment as a result of
acquiring a majority investment interest in BR Brands Holdings LLC on October 28, 2019.
Capital Markets
Segment. Our Capital Markets segment provides a full array of investment banking, corporate finance,
consulting, financial advisory, research, securities lending, wealth management and sales and trading services to corporate, institutional
and high net worth clients. Our corporate finance and investment banking services include merger and acquisitions as well as restructuring
advisory services to public and private companies, initial and secondary public offerings, and institutional private placements.
In addition, we trade equity securities as a principal for our account, including investments in funds managed by our subsidiaries.
Our Capital Markets segment also includes our asset management businesses that manage various private and public funds for institutional
and individual investors.
Auction and Liquidation
Segment. Our Auction and Liquidation segment utilizes our significant industry experience, a scalable
network of independent contractors and industry-specific advisors to tailor our services to the specific needs of a multitude
of clients, logistical challenges and distressed circumstances. Furthermore, our scale and pool of resources allow us to offer
our services across North American as well as parts of Europe, Asia and Australia. Our Auction and Liquidation segment operates
through two main divisions, retail store liquidations and wholesale and industrial assets dispositions. Our wholesale and industrial
assets dispositions division operates through limited liability companies that are controlled by us.
Valuation and Appraisal
Segment. Our Valuation and Appraisal segment provides valuation and appraisal services to financial
institutions, lenders, private equity firms and other providers of capital. These services primarily include the valuation of
assets (i) for purposes of determining and monitoring the value of collateral securing financial transactions and loan arrangements
and (ii) in connection with potential business combinations. Our Valuation and Appraisal segment operates through limited liability
companies that are majority owned by us.
Principal Investments
– United Online and magicJack Segment. Our Principal Investments – United Online and magicJack
segment consists of businesses which have been acquired primarily for attractive investment return characteristics. Currently,
this segment includes UOL, through which we provide consumer Internet access, magicJack, through which we provide VoIP communication
and related product and subscription services.
Brands Segment.
Our Brands segment consists of a brand investment portfolio that is focused on generating revenue through the licensing of
trademarks held by BR Brand Holdings LLC, which we own a majority of the equity interests. We license intellectual property of
six brands: Catherine Malandrino, English Laundry, Joan Vass, Kensie Girl, Limited Too and Nanette Lepore.
Our Corporate Information
We are a Delaware
corporation. Our executive offices are located at 11100 Santa Monica Blvd., Suite 800, Los Angeles, California 90025, and the
telephone number at our principal executive office is (818) 884-3737. Our website addresses are http://www.brileyfin.com, http://www.unitedonline.net,
http://www.magicjack.com and http://www.vocaltec.com. We have not incorporated by reference into this prospectus the
information on our website, and you should not consider it to be a part of this document.
THE OFFERING
The following is a brief summary of
some of the terms of the offering and is qualified in its entirety by reference to the more detailed information appearing elsewhere
in this prospectus supplement and the accompanying prospectus. For a more complete description of the terms of the Notes and Depositary
Shares, see the “Description of the Notes,” “Description of the Series A Preferred Stock and the Series A Depositary
Shares,” and “Description of Series B Preferred Stock and the Series B Depositary Shares” section in this prospectus
supplement.
Issuer
|
|
B.
Riley Financial, Inc.
|
|
|
|
Offered Securities
|
|
Up
to $150,000,000 aggregate amount of our:
|
|
|
|
|
|
●
7.375% 2023 Notes;
|
|
|
|
|
|
●
6.875% 2023 Notes;
|
|
|
|
|
|
●
2024 Notes;
|
|
|
|
|
|
●
2025 Notes;
|
|
|
|
|
|
●
2026 Notes;
|
|
|
|
|
|
●
7.25% 2027 Notes;
|
|
|
|
|
|
●
7.50% 2027 Notes;
|
|
|
|
|
|
●
Series A Depositary Shares; and
|
|
|
|
|
|
●
Series B Depositary Shares.
|
|
|
|
|
|
The
7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes offered hereby
are a further issuance of, form of a single series with and will have the same terms as the Initial 7.375% 2023 Notes, Initial
6.875% 2023 Notes, Initial 2024 Notes, Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50%
2027 Notes, respectively.
|
|
|
|
Manner of offering
|
|
“At
the market offering” that may be made from time to time through the Agent, as sales agent, subject to our instruction
as to amount and timing. The Agent is not required to sell any specific principal amount of the Notes, but the Agent will
make all sales using commercially reasonable efforts consistent with its normal trading and sales practices on mutually agreed
terms between the Agent and us. See “Plan of Distribution” on page S-69.
|
|
|
|
Notes
|
|
|
|
|
|
Maturity
|
|
The
7.375% 2023 Notes will mature on May 31, 2023, the 6.875% 2023 Notes will mature on September 30, 2023, the 2024 Notes will
mature on May 31, 2024, the 2025 Notes will mature on February 28, 2025, the 2026 Notes will mature on September 30, 2026,
the 7.25% 2027 Notes will mature on December 31, 2027 and the 7.50% 2027 Notes will mature on May 31, 2027, each unless redeemed
prior to maturity.
|
|
|
|
Interest
Rate and Payment Dates
|
|
7.375%
interest per annum on the principal amount of the 7.375% 2023 Notes, 6.875% interest per annum on the principal amount of
the 6.875% 2023 Notes, 6.75% interest per annum on the principal amount of the 2024 Notes, 6.375% interest per annum on the
principal amount of the 2025 Notes, 6.50% interest per annum on the principal amount of the 2026 Notes, 7.25% interest per
annum on the principal amount of the 7.25% 2027 Notes and 7.50% interest per annum on the principal amount of the 7.50% 2027
Notes, will accrue from the most recent interest payment date immediately preceding the date of issuance of the 7.375% 2023
Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, respectively, except
that Notes purchased after the record dates noted below, but prior to the interest payment date immediately following such
record date (or if settlement of a purchase of Notes otherwise occurs after such record date but prior to the interest payment
date immediately following such record date), such Notes will not begin to accrue interest until the interest payment date
immediately following such record date. Interest will be paid quarterly in arrears on January 31, April 30, July 31 and October
31 of each year. The interest payable on each interest payment date will be paid only to holders of record of the Notes at
the close of business on January 15, April 15, July 15 and October 15 of each year, as the case may be, immediately preceding
the applicable interest payment date. As a general matter, holders of the Notes will not be entitled to receive any payments
of principal on the Notes prior to the stated maturity date.
|
Guarantors
|
|
None.
|
|
|
|
Ranking
|
|
The
Notes will be our senior unsecured obligations and will rank equal in right of payment with all of our existing and future
senior unsecured and unsubordinated indebtedness. The Notes will be effectively subordinated to all of our existing and future
secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes will be structurally subordinated
to all existing and future indebtedness (including trade payables) of our subsidiaries.
|
|
|
|
|
|
The
indentures governing the Notes do not limit the amount of indebtedness that we or our subsidiaries may incur or whether any
such indebtedness can be secured by our assets.
|
|
|
|
Optional
Redemption
|
|
We may redeem the 7.375% 2023 Notes in whole or in part at our
option (i) prior to May 31, 2021, at a price equal to $25.75 per note, plus accrued and unpaid interest to, but excluding, the
date of redemption, (ii) on or after May 31, 2021 and prior to May 31, 2022, at a price equal to $25.375 per note, plus accrued
and unpaid interest to, but excluding, the date of redemption, and (iii) on or after May 31, 2022 and prior to maturity, at a price
equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding the date of redemption
|
|
|
|
|
|
We may redeem the 6.875% 2023 Notes in whole or in part at our
option (i) prior to September 30, 2021, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding,
the date of redemption, (ii) on or after September 30, 2021 and prior to September 30, 2022, at a price equal to $25.25 per note,
plus accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or after September 30, 2022 and prior
to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding the date of
redemption, as described under “Description of the Notes—Optional Redemption.”
|
|
|
|
|
|
We
may redeem the 2024 Notes for cash in whole or in part at any time at our option (i) on or after May 31, 2021 and prior to
May 31, 2022, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption,
(ii) on or after May 31, 2022 and prior to May 31, 2023, at a price equal to $25.25 per note, plus accrued and unpaid interest
to, but excluding, the date of redemption, and (iii) on or after May 31, 2023 and prior to maturity, at a price equal to 100%
of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption. We may redeem the 2026
Notes for cash in whole or in part at any time at our option (i) on or after September 30, 2022 and prior to September 30,
2023, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii)
on or after September 30, 2023 and prior to September 30, 2024, at a price equal to $25.25 per note, plus accrued and unpaid
interest to, but excluding, the date of redemption, and (iii) on or after September 30, 2024 and prior to maturity, at a price
equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption.
|
|
|
|
|
|
We
may redeem the 2025 Notes for cash in whole or in part at any time at our option (i) on or after February 28, 2021 and prior
to February 28, 2022, at a price equal to $25.75 per note, plus accrued and unpaid interest to, but excluding, the date of
redemption, (ii) on or after February 28, 2022 and prior to February 28, 2023, at a price equal to $25.50 per note, plus accrued
and unpaid interest to, but excluding, the date of redemption, (iii) on or after February 28, 2023 and prior to February 29,
2024, at a price equal to $25.25 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, and
(iv) on or after February 29, 2024 and prior to maturity, at a price equal to 100% of their principal amount, plus accrued
and unpaid interest to, but excluding, the date of redemption.
|
|
|
We
may redeem the 2026 Notes for cash in whole or in part at any time at our option (i) on or after September 30, 2022 and prior
to September 30, 2023, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of
redemption, (ii) on or after September 30, 2023 and prior to September 30, 2024, at a price equal to $25.25 per note, plus
accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or after September 30, 2024 and prior
to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date
of redemption.
|
|
|
|
|
|
We
may redeem the 7.25% 2027 Notes in whole or in part on or after December 31, 2020, at our option, at a redemption price equal
to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption, as described
under “Description of the Notes—Optional Redemption.”
|
|
|
|
|
|
We may redeem the 7.50% 2027 Notes in whole or in part, at our
option, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the
date of redemption, as described under “Description of the Notes—Optional Redemption.”
|
|
|
|
|
|
See
“Description of the Notes — Optional Redemption” for additional details.
|
|
|
|
Sinking
Fund
|
|
The
Notes will not be subject to any sinking fund (i.e., no amounts will be set aside by us to ensure repayment of the Notes at
maturity).
|
|
|
|
Use of Proceeds
|
|
We
expect to use the net proceeds of this offering for general corporate purposes, which may include funding future acquisitions
and investments, repaying indebtedness, making capital expenditures and funding working capital. See “Use of Proceeds.”
|
|
|
|
Events of Default
|
|
Events
of default generally will include failure to pay principal, failure to pay interest, failure to observe or perform any other
covenant or warranty in the Notes or in the indentures, and certain events of bankruptcy, insolvency or reorganization. See
“Description of the Notes — Events of Default.”
|
|
|
|
Certain Covenants
|
|
The
indentures that govern the Notes contains certain covenants, including, but not limited to, restrictions on our ability to
merge or consolidate with or into any other entity. See “Description of the Notes — Covenants.”
|
|
|
|
No Financial Covenants
|
|
The
indentures relating to the Notes do not contain financial covenants.
|
|
|
|
Additional Notes
|
|
We
may create and issue additional notes ranking equally and ratably with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes,
2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, in all respects, so that such additional notes will constitute
and form a single series with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes
and 7.50% 2027 Notes, as applicable, and will have the same terms as to status, redemption or otherwise (except the price
to public, the issue date and, if applicable, the initial interest payment date) as such Notes. We will not issue any such
additional notes unless such issuance would constitute a “qualified reopening” for U.S. federal income tax purposes.
|
Defeasance
|
|
The
Notes are subject to legal and covenant defeasance by us. See “Description of the Notes — Defeasance” for
more information.
|
|
|
|
Listing
|
|
The
7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, when issued,
are or will be quoted on NASDAQ under the symbols “RILYH,” “RILYI,” “RILYO,” “RILYM,”
“RILYN,” “RILYG,” and “RILYZ” respectively.
|
|
|
|
Form and Denomination
|
|
The
Notes will be issued in book-entry form in minimum denominations of $25 and integral multiples in excess thereof. The Notes
will be represented by a permanent global certificate deposited with the trustee as custodian for The Depository Trust Company
(“DTC”) and registered in the name of a nominee of DTC. Beneficial interests in any of the Notes will be
shown on, and transfers will be effected only through, records maintained by DTC and its direct and indirect participants
and any such interest may not be exchanged for certificated securities, except in limited circumstances.
|
|
|
|
Trustee
|
|
U.S.
Bank National Association under the 2016 Indenture relating to the 7.375% 2023 Notes, 6.875% 2023 Notes, 7.25% 2027 Notes
and 7.50% 2027 Notes.
|
|
|
|
|
|
The
Bank of New York Mellon Trust Company, N.A. under the 2019 Indenture relating to the 2024 Notes, 2025 Notes and 2026 Notes.
|
|
|
|
Governing Law
|
|
The
Notes will be and the indentures governing the Notes are governed by the laws of the State of New York.
|
Series A Depositary Shares and Series A Preferred Stock
|
|
|
|
Ranking
|
|
The
Series A Preferred Stock underlying the Series A Depositary Shares will rank, as to dividend rights and rights upon our liquidation,
dissolution or winding up:
|
|
|
|
|
|
(1) Senior
to all classes or series of our common stock and to all other equity securities issued by us other than any equity securities
issued by us with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Stock;
|
|
|
|
|
|
(2) Junior
to all equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series
A Preferred Stock with respect to the payment of dividends and the distribution of assets upon our liquidation, dissolution
or winding up; and
|
|
|
|
|
|
(3) Effectively
junior to all our existing and future indebtedness (including indebtedness convertible into our common stock or preferred
stock) and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our
existing or future subsidiaries.
|
|
|
|
Dividends
|
|
We
will pay cumulative cash dividends on the Series A Preferred Stock, when and as declared by our Board of Directors, at the
rate of 6.875% of the $25,000.00 liquidation preference ($25.00 per depositary share) per year (equivalent to $1,718.75 or
$1.71875 per depositary share).
|
|
|
|
|
|
Dividends
will be payable quarterly in arrears, on or about the last day of January, April, July and October; provided that if any dividend
payment date is not a business day, then the dividend which would otherwise have been payable on that dividend payment date
may be paid on the next succeeding business day, and no interest, additional dividends or other sums will accumulate. Dividends
will accumulate and be cumulative from, and including, the date of original issuance. Dividends on the Series A Preferred
Stock underlying the Series A Depositary Shares will continue to accumulate whether or not (i) any of our agreements prohibit
the current payment of dividends, (ii) we have earnings or funds legally available to pay the dividends, or (iii) our
Board of Directors does not declare the payment of the dividends.
|
|
|
|
Liquidation Preference
|
|
The
liquidation preference of each share of Series A Preferred Stock is $25,000.00 ($25.00 per depositary share). Upon liquidation,
Series A preferred shareholders will be entitled to receive the liquidation preference with respect to their shares of Series
A Preferred Stock plus an amount equal to accumulated but unpaid dividends with respect to such shares. See “Description
of Series A Preferred Stock and the Depositary Shares — Liquidation Preference” on page S-41 of this prospectus
supplement.
|
|
|
|
Optional Redemption
|
|
We
may not redeem the Series A Preferred Stock underlying the Series A Depositary Shares prior to October 7, 2024, except as
described below under “Special Optional Redemption.” At any time on or after October 7, 2024, we may, at our option,
redeem the Series A Preferred Stock, in whole or from time to time in part, by paying $25,000.00 per share (equivalent to
$25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date of redemption, and
the depositary will redeem a proportional number of Series A Depositary Shares representing the shares redeemed. We refer
to this redemption as an “optional redemption.”
|
Special Optional
Redemption
|
|
Upon
the occurrence of a Delisting Event (as defined below), we may, at our option, redeem the Series A preferred stock, in whole
or in part, within 90 days after the first date on which such Delisting Event occurred, for cash, at a redemption price
of $25,000.00 per share (equivalent to $25.00 per depositary share), plus any accrued and unpaid dividends to, but not including,
the date of redemption, and the depositary will redeem a proportional number of Series A Depositary Shares representing the
shares redeemed.
|
|
|
|
|
|
A
“Delisting Event” occurs when, after the original issuance of Series A Preferred Stock, both (i) the shares of
Series A Preferred Stock (or the Series A Depositary Shares) are no longer listed on the New York Stock Exchange (the “NYSE”),
the NYSE American LLC (“NYSE AMER”) or the Nasdaq Stock Market LLC (“NASDAQ”), or listed
or quoted on an exchange or quotation system that is a successor to the NYSE, the NYSE AMER or NASDAQ, and (ii) we are not
subject to the reporting requirements of the Exchange Act, but any Series A Preferred Stock is still outstanding.
|
|
|
Upon
the occurrence of a Change of Control (as defined below), we may, at our option, redeem the Series A Preferred Stock underlying
the Series A Depositary Shares, in whole or in part within 120 days after the first date on which such Change of Control occurred,
for cash, at a redemption price of $25,000.00 per share (equivalent to $25.00 per depositary share), plus any accrued and
unpaid dividends to, but not including, the date of redemption, and the depositary will redeem a proportional number of Series
A Depositary Shares representing the shares redeemed.
|
|
|
|
|
|
A
“Change of Control” occurs when, after the original issuance of the Series A Preferred Stock, the following have
occurred and are continuing:
|
|
|
|
|
|
● the
acquisition by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of
the Exchange Act, of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction
or series of purchases, mergers or other acquisition transactions of shares of our company entitling that person to exercise
more than 50% of the total voting power of all shares of our company entitled to vote generally in elections of directors
(except that such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire,
whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
|
|
|
|
|
|
● following
the closing of any transaction referred to in the bullet point above, neither we nor any acquiring or surviving entity (or
if, in connection with such transaction shares of our common stock are converted into or exchanged for (in whole or in part)
common equity securities of another entity), has a class of common securities (or ADRs representing such securities) listed
on the NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor to the NYSE,
the NYSE AMER or NASDAQ.
|
|
|
We
refer to redemption following a Delisting Event or Change of Control as a “special optional redemption.” If, prior
to the Delisting Event Conversion Date or the Change of Control Conversion Date, as applicable, we have provided or provide
notice of exercise of any of our redemption rights relating to the Series A Preferred Stock (whether our optional redemption
right or our special optional redemption right), the holders of Series A Depositary Shares representing interests in the Series
A Preferred Stock will not have the conversion right described below.
|
|
|
|
Conversion Rights
|
|
Upon
the occurrence of a Delisting Event or a Change of Control, as applicable, each holder of Series A Depositary Shares representing
interests in the Series A Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Date or Change
of Control Conversion Date, as applicable, we have provided or provide notice of our election to redeem the Series A Preferred
Stock) to direct the depositary, on such holder’s behalf, to convert some or all of the Series A Preferred Stock underlying
the Series A Depositary Shares held by such holder on the Delisting Event Conversion Date or Change of Control Conversion
Date, as applicable into a number of shares of our common stock (or equivalent value of alternative consideration) per depositary
share equal to the lesser of:
|
|
|
|
|
|
● the
quotient obtained by dividing (1) the sum of the $25.00 per depositary share liquidation preference plus the amount of any
accumulated and unpaid dividends to, but not including, the Delisting Event Conversion Date or Change of Control Conversion
Date, as applicable (unless the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable is after
a record date for a Series A Preferred Stock dividend payment and prior to the corresponding Series A Preferred Stock dividend
payment date, in which case no additional amount for such accumulated and unpaid dividend will be included in this sum) by
(2) the Common Stock Price (as defined herein); and
|
|
|
|
|
|
● 2.176
(i.e., the Share Cap), subject to certain adjustments;
|
|
|
|
|
|
and
subject, in each case, to the conditions described in this prospectus supplement and the accompanying prospectus, including,
under specified circumstances, an aggregate cap on the total number of shares of our common stock issuable upon conversion
and to provisions for the receipt of alternative consideration.
|
|
|
|
|
|
If,
prior to the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, we have provided or provide
a redemption notice, whether pursuant to our special optional redemption right or our optional redemption right, holders of
Series A Depositary Shares representing interests in the Series A Preferred Stock will not have any right to direct the depositary
to convert the Series A Preferred Stock, and any Series A Preferred Stock subsequently selected for redemption that has been
tendered for conversion will be redeemed on the related date of redemption instead of converted on the Delisting Event Conversion
Date or Change of Control Conversion Date, as applicable.
|
|
|
Because
each depositary share represents a 1/1000th interest in a share of the Series A Preferred Stock, the number of shares of common
stock ultimately received for each depositary share will be equal to the number of shares of common stock received upon conversion
of each share of Series A Preferred Stock divided by 1000. In the event that the conversion would result in the issuance of
fractional shares of common stock, we will pay the holder of Series A Depositary Shares cash in lieu of such fractional shares.
|
|
|
|
|
|
For
a definition of “Change of Control Conversion Right”, “Change of Control Conversion Date,” “Common
Stock Price,” “Delisting Event Conversion Right,” and “Delisting Event Conversion Date” and
for a description of the adjustments and provisions for the receipt of alternative consideration that may be applicable to
the Delisting Event Conversion Right or Change of Control Conversion Right described above, see “Description of Series
A Preferred Stock and the Depositary Shares — Conversion Rights.”
|
|
|
|
|
|
Except
as provided above in connection with a Delisting Event or Change of Control, shares of the Series A Preferred Stock are not
convertible into or exchangeable for any other securities or property.
|
|
|
|
No Maturity, Sinking
Fund or Mandatory Redemption
|
|
The
Series A Preferred Stock underlying the Series A Depositary Shares does not have any stated maturity date and is not subject
to mandatory redemption at the option of the holder or any sinking fund. We are not required to set aside funds to redeem
the Series A Preferred Stock. Accordingly, the Series A Preferred Stock and Series A Depositary Shares will remain outstanding
indefinitely unless we decide to redeem them pursuant to our optional redemption or special optional redemption rights, or
they are converted in connection with a Delisting Event or Change of Control.
|
|
|
|
Limited Voting Rights
|
|
Holders
of the Series A Depositary Shares representing interests in the Series A Preferred Stock generally will have no voting rights.
However, if we do not pay dividends on any outstanding shares of Series A Preferred Stock for six or more quarterly dividend
periods (whether or not declared or consecutive), holders of Series A Depositary Shares representing interests in the Series
A Preferred Stock (voting separately as a class with all other outstanding series of preferred stock upon which like voting
rights have been conferred and are exercisable) will be entitled to elect two additional directors to our Board of Directors
to serve until all unpaid dividends have been fully paid or declared and set apart for payment. In addition, certain material
and adverse changes to the terms of the Series A Preferred Stock cannot be made without the affirmative vote of holders of
at least 66 2/3% of the outstanding shares of Series A Preferred Stock, voting as a separate class.
See “Description of Series A Preferred Stock and the Depositary Shares — Limited Voting Rights” beginning
on page S-48 of this prospectus supplement. In any matter in which the Series A Preferred Stock may vote, each share of
Series A Preferred Stock shall be entitled to one vote. As a result, each depositary share will be entitled to 1/1000th of
a vote.
|
|
|
|
Listing
|
|
The Series A Depositary Shares are listed on NASDAQ under the
symbol “RILYP.”
|
|
|
|
Form
|
|
The
Series A Depositary Shares will be issued and maintained in book-entry form registered in the name of the nominee of The Depository
Trust Company, except under limited circumstances.
|
|
|
|
Depositary
|
|
Continental
Stock Transfer and Trust Company.
|
Series B Depositary Shares and Series B Preferred Stock
|
|
|
|
Ranking
|
|
The
Series B Preferred Stock underlying the Series B Depositary Shares will rank, as to dividend rights and rights upon our liquidation,
dissolution or winding up:
|
|
|
|
|
|
(1)
Senior to all classes or series of our common stock and to all other equity securities issued by us expressly designated as
ranking junior to the Series B Preferred Stock;
|
|
|
|
|
|
(2)
On parity with our Series A Preferred Stock;
|
|
|
|
|
|
(2) Junior
to all equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series
B Preferred Stock with respect to the payment of dividends and the distribution of assets upon our liquidation, dissolution
or winding up; and
|
|
|
|
|
|
(3) Effectively
junior to all our existing and future indebtedness (including indebtedness convertible into our common stock or preferred
stock) and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our
existing or future subsidiaries.
|
|
|
|
Dividends
|
|
We
will pay cumulative cash dividends on the Series B Preferred Stock, when and as declared by our Board of Directors, at the
rate of 7.375% of the $25,000.00 liquidation preference ($25.00 per depositary share) per year (equivalent to $1,843.75 or
$1.84375 per depositary share).
|
|
|
|
|
|
Dividends
will be payable quarterly in arrears, on or about the last day of January, April, July and October; provided that if any dividend
payment date is not a business day, then the dividend which would otherwise have been payable on that dividend payment date
may be paid on the next succeeding business day, and no interest, additional dividends or other sums will accumulate. Dividends
will accumulate and be cumulative from, and including, the date of original issuance. Dividends on the Series B Preferred
Stock underlying the Series B Depositary Shares will continue to accumulate whether or not (i) any of our agreements prohibit
the current payment of dividends, (ii) we have earnings or funds legally available to pay the dividends, or (iii) our
Board of Directors does not declare the payment of the dividends.
|
|
|
|
Liquidation Preference
|
|
The
liquidation preference of each share of Series B Preferred Stock is $25,000.00 ($25.00 per depositary share). Upon liquidation,
Series B preferred shareholders will be entitled to receive the liquidation preference with respect to their shares of Series
B Preferred Stock plus an amount equal to accumulated but unpaid dividends with respect to such shares. See “Description
of Series B Preferred Stock and the Depositary Shares — Liquidation Preference” on page S-52 of this prospectus
supplement.
|
|
|
|
Optional Redemption
|
|
We
may not redeem the Series B Preferred Stock underlying the Series B Depositary Shares prior to September 4, 2025, except as
described below under “Special Optional Redemption.” At any time on or after September 4, 2025, we may, at our
option, redeem the Series B Preferred Stock, in whole or from time to time in part, by paying $25,000.00 per share (equivalent
to $25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date of redemption,
and the depositary will redeem a proportional number of Series B Depositary Shares representing the shares redeemed. We refer
to this redemption as an “optional redemption.”
|
Special Optional
Redemption
|
|
Upon
the occurrence of a Delisting Event (as defined below), we may, at our option, redeem the Series B preferred stock, in whole
or in part, within 90 days after the first date on which such Delisting Event occurred, for cash, at a redemption price
of $25,000.00 per share (equivalent to $25.00 per depositary share), plus any accrued and unpaid dividends to, but not including,
the date of redemption, and the depositary will redeem a proportional number of Series B Depositary Shares representing the
shares redeemed.
|
|
|
|
|
|
A
“Delisting Event” occurs when, after the original issuance of Series B Preferred Stock, both (i) the shares of
Series B Preferred Stock (or the Series B Depositary Shares) are no longer listed on the NYSE, the NYSE AMER or the NASDAQ,
or listed or quoted on an exchange or quotation system that is a successor to the NYSE, the NYSE AMER or NASDAQ, and (ii)
we are not subject to the reporting requirements of the Exchange Act, but any Series B Preferred Stock is still outstanding.
|
|
|
|
|
|
Upon
the occurrence of a Change of Control (as defined below), we may, at our option, redeem the Series B Preferred Stock underlying
the Series B Depositary Shares, in whole or in part within 120 days after the first date on which such Change of Control occurred,
for cash, at a redemption price of $25,000.00 per share (equivalent to $25.00 per depositary share), plus any accrued and
unpaid dividends to, but not including, the date of redemption, and the depositary will redeem a proportional number of Series
B Depositary Shares representing the shares redeemed.
|
|
|
|
|
|
A
“Change of Control” occurs when, after the original issuance of the Series B Preferred Stock, the following have
occurred and are continuing:
|
|
|
|
|
|
● the
acquisition by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of
the Exchange Act, of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction
or series of purchases, mergers or other acquisition transactions of shares of our company entitling that person to exercise
more than 50% of the total voting power of all shares of our company entitled to vote generally in elections of directors
(except that such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire,
whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
|
|
|
|
|
|
● following
the closing of any transaction referred to in the bullet point above, neither we nor any acquiring or surviving entity (or
if, in connection with such transaction shares of our common stock are converted into or exchanged for (in whole or in part)
common equity securities of another entity), has a class of common securities (or ADRs representing such securities) listed
on the NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor to the NYSE,
the NYSE AMER or NASDAQ.
|
|
|
|
|
|
We
refer to redemption following a Delisting Event or Change of Control as a “special optional redemption.” If, prior
to the Delisting Event Conversion Date or the Change of Control Conversion Date, as applicable, we have provided or provide
notice of exercise of any of our redemption rights relating to the Series B Preferred Stock (whether our optional redemption
right or our special optional redemption right), the holders of Series B Depositary Shares representing interests in the Series
B Preferred Stock will not have the conversion right described below.
|
Conversion Rights
|
|
Upon
the occurrence of a Delisting Event or a Change of Control, as applicable, each holder of Series B Depositary Shares representing
interests in the Series B Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Date or Change
of Control Conversion Date, as applicable, we have provided or provide notice of our election to redeem the Series B Preferred
Stock) to direct the depositary, on such holder’s behalf, to convert some or all of the Series B Preferred Stock underlying
the Series B Depositary Shares held by such holder on the Delisting Event Conversion Date or Change of Control Conversion
Date, as applicable into a number of shares of our common stock (or equivalent value of alternative consideration) per depositary
share equal to the lesser of:
|
|
|
|
|
|
● the
quotient obtained by dividing (1) the sum of the $25.00 per depositary share liquidation preference plus the amount of any
accumulated and unpaid dividends to, but not including, the Delisting Event Conversion Date or Change of Control Conversion
Date, as applicable (unless the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable is after
a record date for a Series B Preferred Stock dividend payment and prior to the corresponding Series B Preferred Stock dividend
payment date, in which case no additional amount for such accumulated and unpaid dividend will be included in this sum) by
(2) the Common Stock Price (as defined herein); and
|
|
|
|
|
|
● 1.8671
(i.e., the Share Cap), subject to certain adjustments;
|
|
|
|
|
|
and
subject, in each case, to the conditions described in this prospectus supplement and the accompanying prospectus, including,
under specified circumstances, an aggregate cap on the total number of shares of our common stock issuable upon conversion
and to provisions for the receipt of alternative consideration.
|
|
|
|
|
|
If,
prior to the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, we have provided or provide
a redemption notice, whether pursuant to our special optional redemption right or our optional redemption right, holders of
Series B Depositary Shares representing interests in the Series B Preferred Stock will not have any right to direct the depositary
to convert the Series B Preferred Stock, and any Series B Preferred Stock subsequently selected for redemption that has been
tendered for conversion will be redeemed on the related date of redemption instead of converted on the Delisting Event Conversion
Date or Change of Control Conversion Date, as applicable.
|
|
|
|
|
|
Because
each depositary share represents a 1/1000th interest in a share of the Series B Preferred Stock, the number of shares of common
stock ultimately received for each depositary share will be equal to the number of shares of common stock received upon conversion
of each share of Series B Preferred Stock divided by 1000. In the event that the conversion would result in the issuance of
fractional shares of common stock, we will pay the holder of Series B Depositary Shares cash in lieu of such fractional shares.
|
|
|
For
a definition of “Change of Control Conversion Right”, “Change of Control Conversion Date,” “Common
Stock Price,” “Delisting Event Conversion Right,” and “Delisting Event Conversion Date” and
for a description of the adjustments and provisions for the receipt of alternative consideration that may be applicable to
the Delisting Event Conversion Right or Change of Control Conversion Right described above, see “Description of Series
B Preferred Stock and the Depositary Shares — Conversion Rights.”
|
|
|
|
|
|
Except
as provided above in connection with a Delisting Event or Change of Control, shares of the Series B Preferred Stock are not
convertible into or exchangeable for any other securities or property.
|
|
|
|
No Maturity, Sinking
Fund or Mandatory Redemption
|
|
The
Series B Preferred Stock underlying the Series B Depositary Shares does not have any stated maturity date and is not subject
to mandatory redemption at the option of the holder or any sinking fund. We are not required to set aside funds to redeem
the Series B Preferred Stock. Accordingly, the Series B Preferred Stock and Series B Depositary Shares will remain outstanding
indefinitely unless we decide to redeem them pursuant to our optional redemption or special optional redemption rights, or
they are converted in connection with a Delisting Event or Change of Control.
|
|
|
|
Limited Voting Rights
|
|
Holders
of the Series B Depositary Shares representing interests in the Series B Preferred Stock generally will have no voting rights.
However, if we do not pay dividends on any outstanding shares of Series B Preferred Stock for six or more quarterly dividend
periods (whether or not declared or consecutive), holders of shares of the Series B Preferred Stock and the holders of preferred
stock of all other classes and series ranking on parity with the Series B Preferred Stock with respect to payment of dividends
and the distribution of assets upon liquidation, dissolution or winding up, and upon which like voting rights have been conferred,
including our Series A Preferred Stock, and are exercisable, which we refer to as our parity preferred stock, and with which
the holders of Series B Preferred Stock and all classes and series of parity preferred stock are entitled to vote together
as a single class, voting together as a single class will be entitled to elect two additional directors to our Board of Directors
to serve until all unpaid dividends have been fully paid or declared and set apart for payment. In addition, the affirmative
vote of the holders of at least two-thirds of the outstanding shares of the Series B Preferred Stock and any other class
or series of parity preferred stock with which the holders of Series B Preferred Stock are entitled to vote together as a
single class, including our Series A Preferred Stock, is required for us to create, authorize or issue any class or series
of stock ranking senior to the Series B Preferred Stock or to amend any provision of our charter so as to materially and adversely
affect the terms of the Series B Preferred Stock. If the proposed charter amendments would materially and adversely affect
the rights, preferences, privileges or voting powers of the Series B Preferred Stock disproportionately relative to any other
class or series of parity preferred stock, the affirmative vote of the holders of at least two-thirds of the outstanding shares
of the Series B Preferred Stock, voting as a separate class, is also required. See “Description of Series B Preferred
Stock and the Series B Depositary Shares — Limited Voting Rights” beginning on page S-58 of this prospectus
supplement. In any matter in which the Series B Preferred Stock may vote, each share of Series B Preferred Stock shall be
entitled to one vote. As a result, each depositary share will be entitled to 1/1000th of a vote.
|
Listing
|
|
The Series B Depositary Shares are listed on NASDAQ under the
symbol “RILYL.”
|
|
|
|
Form
|
|
The
Series B Depositary Shares will be issued and maintained in book-entry form registered in the name of the nominee of The Depository
Trust Company, except under limited circumstances.
|
|
|
|
Depositary
|
|
Continental
Stock Transfer and Trust Company.
|
|
|
|
Risk Factors
|
|
An
investment in the Offered Securities involves significant risks. Please refer to “Risk Factors” beginning on page
S-15 and other information included or incorporated by reference in this prospectus supplement for a discussion of factors
you should carefully consider before investing in the Offered Securities.
|
|
|
|
Conflicts
of Interest
|
|
B. Riley Securities is an affiliate of B. Riley Financial, Inc.
and, as such, may be deemed to have a “conflict of interest” in this offering of Offered Securities within the meaning
of Financial Industry Regulatory Authority, Inc. (“FINRA”) Rule 5121. Consequently, this offering of Offered
Securities will be conducted in compliance with the provisions of FINRA Rule 5121. B. Riley Securities may not make sales of Offered
Securities in this offering to any of its discretionary accounts without the prior written approval of the account holder.
|
RISK FACTORS
An investment in the Offered Securities
involves significant risks, including the risks described below. Before purchasing the Offered Securities, you should carefully
consider each of the following risk factors as well as the other information and risk factors contained in this prospectus supplement
and the accompanying prospectus and the documents incorporated by reference, including our consolidated financial statements and
the related notes. Each of these risk factors, either alone or taken together, could adversely affect our business, operating
results and financial condition, as well as adversely affect the value of an investment in the Offered Securities. The risks described
below are not the only ones we face. This prospectus supplement and the documents incorporated herein by reference also contain
forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated
in these forward-looking statements as a result of certain factors, including the risks referenced below and described in the
documents incorporated herein by reference, including (i) our annual report on Form 10-K for the fiscal year ended December 31,
2019, which is on file with the SEC and is incorporated herein by reference, (ii) our quarterly reports on Form 10-Q for the quarters
ended March 31, 2020 and June 30, 2020, which is incorporated by reference into this prospectus supplement, and (iii) other documents
we file from time to time with the SEC that are deemed incorporated by reference into this prospectus supplement. Additional risks
of which we are not presently aware or that we currently believe are immaterial which may also impair our business operations
and financial position. Our business, financial condition, results of operations and/or our future growth prospects could be materially
and adversely affected by the materialization of any of these risks. As a result, you could lose some or all of any investment
you may have made or may make in our Company.
Risks Related to this Offering
We may be able to incur substantially
more debt, which could have important consequences to you.
We may be able to
incur substantial additional indebtedness in the future. The terms of the indentures governing the Notes will not prohibit us
from doing so. If we incur any additional indebtedness that ranks equally with the Notes, the holders of that debt will be entitled
to share ratably with you in any proceeds distributed in connection with any insolvency, liquidation, reorganization or dissolution.
This may have the effect of reducing the amount of proceeds paid to you. Incurrence of additional debt would also further reduce
the cash available to invest in operations, as a result of increased debt service obligations. If new debt is added to our current
debt levels, the related risks that we now face could intensify.
In November 2016 we
completed an initial offering of 7.50% Senior Notes due 2021 (the “2021 Notes”) with an aggregate principal
amount of $28,750,000. In May 2017, we completed an initial offering of 7.50% Senior Notes due 2027 with an aggregate principal
amount of $60,375,000. In December 2017, we completed an initial offering of 7.25% Senior Notes due 2027 with an aggregate principal
amount of $80,500,000. In May 2018, we completed an initial offering of 7.375% Senior Notes due 2023 with an aggregate principal
amount of $100,050,000. In September 2018, we completed an initial offering of 6.875% Senior Notes due 2023 with an aggregate
principal amount of $100,050,000. In May 2019, we completed an initial offering of 6.75% Senior Notes due 2024 with an aggregate
principal amount of $100,050,000. In September 2019, we completed an initial offering of 6.50% Senior Notes due 2026 with an aggregate
principal amount of $115,000,000. In February 2020, we completed an initial offering of 6.375% Senior Notes due 2025 with an aggregate
principal amount of $132,250,000.
In June 2017, December 2017, June 2018, December 2018, September
2019, December 2019 and February 2020, we entered into At Market Issuance Sales Agreement with B. Riley Securities to sell, pursuant
to one or more of such agreements, additional 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.50% 2027
Notes, 7.25% 2027 Notes, and 2021 Notes, under which such agreements, we sold an additional $29,857,275 in aggregate principal
amount of 7.375% 2023 Notes, $13,059,025 in aggregate principal amount of 6.875% 2023 Notes, $11,444,175 in aggregate principal
amount of 2024 Notes, $20,085,600 in aggregate principal amount of 2026
Notes, $65,391,150 in aggregate principal amount of 7.50% 2027 Notes and $42,476,275 in aggregate principal amount of 7.25%
2027 Notes as of the date of this prospectus supplement. On December 30, 2019, we redeemed all of the issued and outstanding 7.50%
2021 Notes having an aggregate principal amount of $52,154,350.
Our level of indebtedness
could have important consequences to you, because:
|
●
|
it could affect
our ability to satisfy our financial obligations, including those relating to the Notes;
|
|
●
|
a substantial portion
of our cash flows from operations would have to be dedicated to interest and principal payments and may not be available for
operations, capital expenditures, expansion, acquisitions or general corporate or other purposes;
|
|
●
|
it may impair our
ability to obtain additional debt or equity financing in the future;
|
|
●
|
it may limit our
ability to refinance all or a portion of our indebtedness on or before maturity;
|
|
●
|
it may limit our
flexibility in planning for, or reacting to, changes in our business and industry; and
|
|
●
|
it may make us more
vulnerable to downturns in our business, our industry or the economy in general.
|
Our operations may
not generate sufficient cash to enable us to service our debt. If we fail to make a payment on the Notes, we could be in default
on the Notes, and this default could cause us to be in default on other indebtedness, to the extent outstanding. Conversely, a
default under any other indebtedness, if not waived, could result in acceleration of the debt outstanding under the related agreement
and entitle the holders thereof to bring suit for the enforcement thereof or exercise other remedies provided thereunder. In addition,
such default or acceleration may result in an event of default and acceleration of other indebtedness of the Company, entitling
the holders thereof to bring suit for the enforcement thereof or exercise other remedies provided thereunder. If a judgment is
obtained by any such holders, such holders could seek to collect on such judgment from the assets of the Company. If that should
occur, we may not be able to pay all such debt or to borrow sufficient funds to refinance it. Even if new financing were then
available, it may not be on terms that are acceptable to us.
However, no event
of default under the Notes would result from a default or acceleration of, or suit, other exercise of remedies or collection proceeding
by holders of, our other outstanding debt, if any. As a result, all or substantially all of our assets may be used to satisfy
claims of holders of our other outstanding debt, if any, without the holders of the Notes having any rights to such assets. The
indentures governing the Notes will not restrict our ability to incur additional indebtedness.
The Notes will be unsecured and
therefore will be effectively subordinated to any secured indebtedness that we currently have or that we may incur in the future.
The Notes will not
be secured by any of our assets or any of the assets of our subsidiaries. As a result, the Notes will be effectively subordinated
to any secured indebtedness that we or our subsidiaries have currently outstanding or may incur in the future (or any indebtedness
that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness.
The indentures governing the Notes do not prohibit us or our subsidiaries from incurring additional secured (or unsecured) indebtedness
in the future. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or
future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure
that indebtedness and may consequently receive payment from these assets before they may be used to pay other creditors, including
the holders of the Notes.
The Notes will be structurally subordinated
to the indebtedness and other liabilities of our subsidiaries.
The Notes are obligations
exclusively of B. Riley and not of any of our subsidiaries. None of our subsidiaries is a guarantor of the Notes, and the Notes
are not required to be guaranteed by any subsidiaries we may acquire or create in the future. Therefore, in any bankruptcy, liquidation
or similar proceeding, all claims of creditors (including trade creditors) of our subsidiaries will have priority over our equity
interests in such subsidiaries (and therefore the claims of our creditors, including holders of the Notes) with respect to the
assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still
be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities
of any such subsidiary senior to our claims. Consequently, the Notes will be structurally subordinated to all indebtedness and
other liabilities (including trade payables) of any of our subsidiaries and any subsidiaries that we may in the future acquire
or establish as financing vehicles or otherwise. The indentures governing the Notes do not prohibit us or our subsidiaries from
incurring additional indebtedness in the future. In addition, future debt and security agreements entered into by our subsidiaries
may contain various restrictions, including restrictions on payments by our subsidiaries to us and the transfer by our subsidiaries
of assets pledged as collateral.
The Series A Preferred Stock, Series
B Preferred Stock and the Depositary Shares rank junior to all of our indebtedness and other liabilities and are effectively junior
to all indebtedness and other liabilities of our subsidiaries.
In the event of our
bankruptcy, liquidation, dissolution or winding-up of our affairs, our assets will be available to pay obligations on the Series
A Preferred Stock and Series B Preferred Stock only after all of our indebtedness and other liabilities have been paid. The rights
of holders of the Series A Preferred Stock and Series B Preferred Stock to participate in the distribution of our assets will
rank junior to the prior claims of our current and future creditors and any future series or class of preferred stock we may issue
that ranks senior to the Series A Preferred Stock and Series B Preferred Stock. In addition, the Series A Preferred Stock and
Series B Preferred Stock effectively ranks junior to all existing and future indebtedness and other liabilities of (as well as
any preferred equity interests held by others in) our existing subsidiaries and any future subsidiaries. Our existing subsidiaries
are and any future subsidiaries would be separate legal entities and have no legal obligation to pay any amounts to us in respect
of dividends due on the Series A Preferred Stock and Series B Preferred Stock. If we are forced to liquidate our assets to pay
our creditors, we may not have sufficient assets to pay amounts due on any or all of the Series A Preferred Stock and Series B
Preferred Stock then outstanding. We and our subsidiaries have incurred and may in the future incur substantial amounts of debt
and other obligations that will rank senior to the Series A Preferred Stock and Series B Preferred Stock. We may incur additional
indebtedness and become more highly leveraged in the future, which could harm our financial position and potentially limit our
cash available to pay dividends. As a result, we may not have sufficient funds remaining to satisfy our dividend obligations relating
to our Series A Preferred Stock and Series B Preferred Stock if we incur additional indebtedness.
Future offerings of
debt or senior equity securities may adversely affect the market price of the depositary shares. If we decide to issue debt or
senior equity securities in the future, it is possible that these securities will be governed by an indenture or other instrument
containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we issue
in the future may have rights, preferences and privileges more favorable than those of the Series A Preferred Stock and Series
B Preferred Stock and may result in dilution to owners of the depositary shares. We and, indirectly, our shareholders, will bear
the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any future offering
will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature
of our future offerings. Thus holders of the depositary shares will bear the risk of our future offerings reducing the market
price of the depositary shares and diluting the value of their holdings in us.
The indentures under which the Notes
will be issued contains limited protection for holders of the Notes.
The indentures under
which the Notes will be issued offers limited protection to holders of the Notes. The terms of the indentures and the Notes do
not restrict our or any of our subsidiaries’ ability to engage in, or otherwise be a party to, a variety of corporate transactions,
circumstances or events that could have an adverse impact on your investment in the Notes. In particular, the terms of the indentures
and the Notes will not place any restrictions on our or our subsidiaries’ ability to:
|
●
|
issue debt securities
or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that
would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore
rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3)
indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the
Notes and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity
interests in our subsidiaries and therefore rank structurally senior to the Notes with respect to the assets of our subsidiaries;
|
|
●
|
pay dividends on,
or purchase or redeem or make any payments in respect of, capital stock or other securities subordinated in right of payment
to the Notes;
|
|
●
|
sell assets (other
than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);
|
|
●
|
enter into transactions
with affiliates;
|
|
●
|
create liens (including
liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;
|
|
●
|
create restrictions
on the payment of dividends or other amounts to us from our subsidiaries.
|
In addition, the indentures
do not include any protection against certain events, such as a change of control, a leveraged recapitalization or “going
private” transaction (which may result in a significant increase of our indebtedness levels), restructuring or similar transactions.
Furthermore, the terms of the indentures and the Notes do not protect holders of the Notes in the event that we experience changes
(including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require
that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow,
or liquidity. Also, an event of default or acceleration under our other indebtedness would not necessarily result in an Event
of Default under the Notes.
Our ability to recapitalize,
incur additional debt and take a number of other actions that are not limited by the terms of the Notes may have important consequences
for you as a holder of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes
or negatively affecting the trading value of the Notes.
Other debt we issue
or incur in the future could contain more protections for its holders than the indentures and the Notes, including additional
covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market
for and trading levels and prices of the Notes.
As a holder of depositary shares representing interests
in the Series A Preferred Stock or Series B Preferred Stock, you will have extremely limited voting rights.
Your voting rights
as a holder of depositary shares will be limited. Our common stock is the only class of our securities that carries full voting
rights. Voting rights for holders of depositary shares will exist primarily with respect to the ability to elect (together with
the holders of other outstanding series of our preferred stock, or depositary shares representing interests in our preferred stock,
or additional series of preferred stock we may issue in the future and upon which similar voting rights have been or are in the
future conferred and are exercisable) two additional directors to our Board of Directors in the event that six quarterly dividends
(whether or not declared or consecutive) payable on the Series B Preferred Stock are in arrears, and with respect to voting on
amendments to our articles of incorporation or certificate of designation (in some cases voting together with the holders of other
outstanding series of our preferred stock as a single class) that materially and adversely affect the rights of the holders of
depositary shares representing interests in the Series A Preferred Stock or Series B Preferred Stock (and other series of preferred
stock, as applicable) or create additional classes or series of our stock that are senior to the Series A Preferred Stock and
Series B Preferred Stock, provided that in any event adequate provision for redemption has not been made. Other than the limited
circumstances described in this prospectus supplement, holders of depositary shares will not have any voting rights.
An increase in market interest rates
could result in a decrease in the value of the Notes.
In general, as market
interest rates rise, notes bearing interest at a fixed rate decline in value. Consequently, if you purchase the Notes, and the
market interest rates subsequently increase, the market value of your Notes may decline. We cannot predict the future level of
market interest rates.
An active trading market for the
Notes and Depositary Shares may not develop, which could limit the market price of the Notes or the Depositary Shares or your
ability to sell them.
The 7.375% 2023 Notes
(when issued) and Initial 7.375% 2023 Notes are quoted on NASDAQ under the symbol “RILYH,” the 6.875% 2023 Notes (when
issued) and Initial 6.875% 2023 Notes are quoted on NASDAQ under the symbol “RILYI,” the 2024 Notes (when issued)
and Initial 2024 Notes are quoted on NASDAQ under the symbol “RILYO,” the 2025 Notes (when issued) and Initial 2025
Notes are quoted on NASDAQ under the symbol “RILYM,” the 2026 Notes (when issued) and Initial 2026 Notes will be quoted
on NASDAQ under the symbol “RILYN,” the 7.25% 2027 Notes (when issued) and Initial 7.25% 2027 Notes are quoted on
NASDAQ under the symbol “RILYG,” the 7.50% 2027 Notes (when issued) and Initial 7.50% 2027 Notes are quoted on NASDAQ
under the symbol “RILYZ,” the Series A Depositary Shares are quoted on NASDAQ under the symbol “RILYP,”
and the Series B Depositary Shares are quoted on NASDAQ under the symbol “RILYL.” We cannot provide any assurances
that an active trading market will develop for our senior notes or depositary shares or that our senior note holders or depositary
share holders will be able to sell their senior notes or depositary shares. If the senior notes and depositary sahres are traded
after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest
rates, the market for similar securities, our credit ratings, general economic conditions, our financial condition, performance
and prospects and other factors. Accordingly, we cannot assure our senior note holders or depositary share holders that a liquid
trading market will develop for our senior notes or depositary shares, that our senior note holders or depositary share holders
will be able to sell our senior notes or depositary shares at a particular time or that the price our holders receive when they
sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for our senior
notes or depositary shares may be harmed. Accordingly, our senior note holders or depositary share holders may be required to
bear the financial risk of their investment for an indefinite period of time.
We may issue additional Notes.
Under the terms of
the indentures governing the Notes, we may from time to time without notice to, or the consent of, the holders of the Notes, create
and issue additional notes which will be equal in rank to the Notes. We will not issue any such additional notes unless such issuance
would constitute a “qualified reopening” for U.S. federal income tax purposes.
We may issue additional shares of
the Series A Preferred Stock and Series B Preferred Stock and additional series of preferred stock that rank on a parity with
the Series A Preferred Stock and Series B Preferred Stock as to dividend rights, rights upon liquidation or voting rights.
We are allowed to
issue additional shares of Series A Preferred Stock and Series B Preferred Stock and additional series of preferred stock that
would rank on a parity with the Series A Preferred Stock and Series B Preferred Stock as to dividend payments and rights upon
our liquidation, dissolution or winding up of our affairs pursuant to our articles of incorporation and the certificate of designations
for the Series A Preferred Stock and Series B Preferred Stock without any vote of the holders of the Series A Preferred Stock
and Series B Preferred Stock. Our articles of incorporation authorize us to issue up to 1,000,000 shares of preferred stock in
one or more series on terms determined by our Board of Directors. Further, the use of depositary shares enables us to issue significant
amounts of preferred stock, notwithstanding the number of shares authorized by our articles of incorporation. The issuance of
additional shares of Series A Preferred Stock and Series B Preferred Stock and additional series of parity preferred stock could
have the effect of reducing the amounts available to the Series A Preferred Stock and Series B Preferred Stock upon our liquidation
or dissolution or the winding up of our affairs. It also may reduce dividend payments on the Series A Preferred Stock and Series
B Preferred Stock issued if we do not have sufficient funds to pay dividends on all Series A Preferred Stock and Series B Preferred
Stock outstanding and other classes of stock with equal priority with respect to dividends.
In addition, although
holders of the depositary shares are entitled to limited voting rights, as described in “Description of Series A Preferred
Stock and the Depositary Shares – Voting Rights” and “Description of Series B Preferred Stock and the Depositary
Shares — Voting Rights,” with respect to such matters, the holders of the depositary shares will vote separately
as a class along with all other outstanding series of our preferred stock that we may issue upon which like voting rights
have been conferred and are exercisable. As a result, the voting rights of holders of the depositary shares may be significantly
diluted, and the holders of such other series of preferred stock that we may issue may be able to control or significantly influence
the outcome of any vote.
Future issuances and
sales of parity preferred stock, or the perception that such issuances and sales could occur, may cause prevailing market prices
for the depositary shares and our common stock to decline and may adversely affect our ability to raise additional capital in
the financial markets at times and prices favorable to us. Such issuances may also reduce or eliminate our ability to pay dividends
on our common stock.
The rating for the 7.375% 2023 Notes,
6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes and 7.25% 2027 Notes, could at any time be revised downward or withdrawn
entirely at the discretion of the issuing rating agency.
We have obtained a
rating for the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes and 7.25% 2027 Notes. Ratings only reflect
the views of the issuing rating agency or agencies and such ratings could at any time be revised downward or withdrawn entirely
at the discretion of the issuing rating agency. A rating is not a recommendation to purchase, sell or hold the 7.375% 2023 Notes,
6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes and 7.25% 2027 Notes. Ratings do not reflect market prices or suitability
of a security for a particular investor and the rating of the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026
Notes and 7.25% 2027 Notes may not reflect all risks related to us and our business, or the structure or market value of the 7.375%
2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes and 7.25% 2027 Notes. We may elect to issue other securities
for which we may seek to obtain a rating in the future. If we issue other securities with a rating, such ratings, if they are
lower than market expectations or are subsequently lowered or withdrawn, could adversely affect the market for or the market value
of the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes and 7.25% 2027 Notes.
The Depositary Shares have not been
rated.
The Series A Preferred
Stock and Series B Preferred Stock and the depositary shares have not been rated and may never be rated. It is possible, however,
that one or more rating agencies might independently decide to assign a rating to the depositary shares or that we may elect to
obtain a rating of the depositary shares in the future. Furthermore, we may elect to issue other securities for which we may seek
to obtain a rating. If any ratings are assigned to the depositary shares in the future or if we issue other securities with a
rating, such ratings, if they are lower than market expectations or are subsequently lowered or withdrawn, could adversely affect
the market for, or the market value of, the depositary shares.
Ratings reflect the
views of the issuing rating agency or agencies, and such ratings could at any time be revised downward, placed on negative outlook
or withdrawn entirely at the discretion of the issuing rating agency or agencies. Furthermore, a rating is not a recommendation
to purchase, sell or hold any particular security, including the depositary shares. Ratings do not reflect market prices or the
suitability of a security for a particular investor, and any future rating of the depositary shares may not reflect all risks
related to us and our business, or the structure or market value of the depositary shares.
Our management team may invest or spend the proceeds
of this offering in ways with which you may not agree or in ways which may not yield a significant return.
Our management will
have broad discretion over the use of proceeds from this offering. We intend to use the net proceeds, if any, from this offering
for general corporate purposes, which may include funding future acquisitions and investments, repaying indebtedness, making capital
expenditures and funding working capital. However, we have not determined the specific allocation of the net proceeds among these
potential uses. Our management will have considerable discretion in the application of the net proceeds, and you will not have
the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. The net proceeds
may be used for corporate purposes that do not increase our operating results or enhance the value of our common stock.
You may experience future dilution as a result of future
equity offerings.
In order to raise
additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable
for our common stock. We cannot assure you that we will be able to sell shares or other securities in any other offering at a
price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing
shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we
sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future
transactions may be higher or lower than the price per share in this offering.
USE OF PROCEEDS
We expect to use the
net proceeds of this offering for general corporate purposes, which may include funding future acquisitions and investments, repaying
indebtedness, making capital expenditures and funding working capital. Pending any specific application, we may initially invest
the net proceeds in short-term marketable securities.
We have not determined
the amounts we plan to spend on the areas listed above or the timing of these expenditures. As a result, our management will have
broad discretion to allocate the net proceeds.
DESCRIPTION OF THE NOTES
The 7.375% 2023 Notes, 6.875% 2023
Notes, 7.25% 2027 Notes and 7.50% 2027 Notes are being issued under an Indenture dated as of November 2, 2016, as supplemented
by the First Supplemental Indenture dated November 2, 2016, the Second Supplemental Indenture dated as of May 31, 2017, the Third
Supplemental Indenture dated as of December 13, 2017, the Fourth Supplemental Indenture dated as of May 17, 2018 and the Fifth
Supplemental Indenture dated as of September 11, 2018, which we refer to collectively as the “2016 Indenture,” between
the Company and U.S. Bank National Association, trustee.
The 2024 Notes, 2025 Notes and the
2026 Notes are being issued under an Indenture dated as of May 7, 2019, as supplemented by the First Supplemental Indenture dated
May 7, 2019, the Second Supplemental Indenture dated as of September 23, 2019 and the Third Supplemental Indenture dated as of
February 12, 2020, which we refer to collectively as the “2019 Indenture,” between the Company and The Bank of New
York Mellon Trust Company, N.A., trustee.
We use the term “indentures”
to refer collectively to the 2016 Indenture and the 2019 Indenture. We use the term “trustee” to refer to U.S. Bank
National Association, as trustee, under the 2016 Indenture, and The Bank of New York Mellon Trust Company, N.A., as trustee, under
the 2019 Indenture, as applicable. Set forth below is a description of the specific terms of the Notes and the indentures. This
description supplements (and to the extent inconsistent with, replaces) the description of the general terms and provisions of
our debt securities set forth in the prospectus under the caption “Description of Debt Securities.” The following
description does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the indentures
filed as an exhibit to the Current Reports on Form 8-K filed on February 12, 2020, September 23, 2019, May 7, 2019, September
11, 2018, May 17, 2018, December 13, 2017 and November 2, 2016.
General
The 7.375% 2023 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026
Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, but excluding the Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial 2025
Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes), with an initial outstanding aggregate principal
amount of $0;
|
|
●
|
will mature on May
31, 2023, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest from the most recent interest payment date immediately preceding the date of issuance of the 2023 Notes at an annual rate of 7.375%, payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 7.375% 2023 Notes purchased after the record dates noted below, but prior to the interest payment date immediately following such record date (or if settlement of a purchase of 7.375% 2023 Notes otherwise occurs after such record date but prior to the interest payment date immediately following such record date), such 7.375% 2023 Notes will not begin to accrue interest until the interest payment date immediately following such record date, and the interest payable on each interest payment date will be paid only to holders of record of the 7.375% 2023 Notes at the close of business on January 15, April 15, July 15 and October 15 of each year, as the case may be, immediately preceding the applicable interest payment date;
|
|
|
|
|
●
|
will be redeemable at our option, in whole or in part, at any time on and after May 31, 2020, at the price and on the terms described under “—Optional Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
are listed on NASDAQ
under the symbol “RILYH”; and
|
|
●
|
will be represented
by one or more registered 7.375% 2023 Notes in global form, but in certain limited circumstances may be represented by 7.375%
2023 Notes in definitive form.
|
The 6.875% 2023 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 2024 Notes, 2025 Notes, 2026
Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 2024 Notes, Initial 2025
Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes), with an initial outstanding aggregate principal
amount of $0;
|
|
●
|
will mature on September
30, 2023, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest
from the most recent interest payment date immediately preceding the date of issuance of the 6.875% 2023 Notes at an annual
rate of 6.875%, payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 6.875%
2023 Notes purchased after the record dates noted below, but prior to the interest payment date immediately following such
record date (or if settlement of a purchase of 6.875% 2023 Notes otherwise occurs after such record date but prior to the
interest payment date immediately following such record date), such 6.875% 2023 Notes will not begin to accrue interest until
the interest payment date immediately following such record date, and the interest payable on each interest payment date will
be paid only to holders of record of the 6.875% 2023 Notes at the close of business on January 15, April 15, July 15 and October
15 of each year, as the case may be, immediately preceding the applicable interest payment date;
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after September 30, 2020, at the price and on the terms described under
“—Optional Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
are listed on NASDAQ
under the symbol “RILYI”; and
|
|
●
|
will be represented
by one or more registered 6.875% 2023 Notes in global form, but in certain limited circumstances may be represented by 6.875%
2023 Notes in definitive form.
|
The 2024 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2025 Notes,
2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes,
Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes), with an initial outstanding
aggregate principal amount of $0;
|
|
●
|
will mature on May
31, 2024, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest
from the most recent interest payment date immediately preceding the date of issuance of the 2024 Notes at an annual rate
of 6.75%, payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 2024 Notes
purchased after the record dates noted below, but prior to the interest payment date immediately following such record date
(or if settlement of a purchase of 2024 Notes otherwise occurs after such record date but prior to the interest payment date
immediately following such record date), such 2024 Notes will not begin to accrue interest until the interest payment date
immediately following such record date, and the interest payable on each interest payment date will be paid only to holders
of record of the 2024 Notes at the close of business on January 15, April 15, July 15 and October 15 of each year, as the
case may be, immediately preceding the applicable interest payment date;
|
|
|
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after May 31, 2021, at the price and on the terms described under “—Optional
Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
are listed on NASDAQ
under the symbol “RILYO”; and
|
|
●
|
will be represented
by one or more registered 2024 Notes in global form, but in certain limited circumstances may be represented by 2024 Notes
in definitive form.
|
The 2025 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes,
2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes,
Initial 2024 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes), with an initial outstanding
aggregate principal amount of $0;
|
|
●
|
will mature on February
28, 2025, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest from the
most recent interest payment date immediately preceding the date of issuance of the 2025 Notes at an annual rate of 6.375%,
payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 2025 Notes purchased
after the record dates noted below, but prior to the interest payment date immediately following such record date (or
if settlement of a purchase of 2025 Notes otherwise occurs after such record date but prior to the interest payment date
immediately following such record date), such 2025 Notes will not begin to accrue interest until the interest payment
date immediately following such record date, and the interest payable on each interest payment date will be paid only
to holders of record of the 2025 Notes at the close of business on January 15, April 15, July 15 and October 15 of each
year, as the case may be, immediately preceding the applicable interest payment date;
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after February 28, 2021, at the price and on the terms described under
“—Optional Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
will be listed on
NASDAQ under the symbol “RILYM”; and
|
|
●
|
will be represented
by one or more registered 2025 Notes in global form, but in certain limited circumstances may be represented by 2025 Notes
in definitive form.
|
The 2026 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes,
2025 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes,
Initial 2024 Notes, Initial 2025 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes), with an initial outstanding
aggregate principal amount of $0;
|
|
●
|
will mature on September
30, 2026, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest from the
most recent interest payment date immediately preceding the date of issuance of the 2026 Notes at an annual rate of 6.50%,
payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 2026 Notes purchased
after the record dates noted below, but prior to the interest payment date immediately following such record date (or
if settlement of a purchase of 2026 Notes otherwise occurs after such record date but prior to the interest payment date
immediately following such record date), such 2026 Notes will not begin to accrue interest until the interest payment
date immediately following such record date, and the interest payable on each interest payment date will be paid only
to holders of record of the 2026 Notes at the close of business on January 15, April 15, July 15 and October 15 of each
year, as the case may be, immediately preceding the applicable interest payment date;
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after September 30, 2022, at the price and on the terms described under
“—Optional Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
will be listed on
NASDAQ under the symbol “RILYN”; and
|
|
●
|
will be represented
by one or more registered 2026 Notes in global form, but in certain limited circumstances may be represented by 2026 Notes
in definitive form.
|
The 7.25% 2027 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes,
2025 Notes, 2026 Notes and 7.50% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial
2024 Notes, Initial 2026 Notes and Initial 7.50% 2027 Notes), with an initial outstanding aggregate principal amount of $0;
|
|
●
|
will mature on December
31, 2027, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest
from the most recent interest payment date immediately preceding the date of issuance of the 7.25% 2027 Notes at an annual
rate of 7.25%, payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 7.25%
2027 Notes purchased after the record dates noted below, but prior to the interest payment date immediately following such
record date (or if settlement of a purchase of 7.25% 2027 Notes otherwise occurs after such record date but prior to the interest
payment date immediately following such record date), such 7.25% 2027 Notes will not begin to accrue interest until the interest
payment date immediately following such record date, and the interest payable on each interest payment date will be paid only
to holders of record of the 7.25% 2027 Notes at the close of business on January 15, April 15, July 15 and October 15 of each
year, as the case may be, immediately preceding the applicable interest payment date;
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after December 31, 2020, at the price and on the terms described under
“—Optional Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
are listed on NASDAQ
under the symbol “RILYG”; and
|
|
●
|
will be represented
by one or more registered 7.25% 2027 Notes in global form, but in certain limited circumstances may be represented by 7.25%
2027 Notes in definitive form.
|
The 7.50% 2027 Notes:
|
●
|
will be our general
unsecured, senior obligations;
|
|
●
|
will be initially
limited to an aggregate principal amount of $150,000,000 (together with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes,
2025 Notes, 2026 Notes and 7.25% 2027 Notes, but excluding the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial
2024 Notes, Initial 2026 Notes and Initial 7.50% 2027 Notes), with an initial outstanding aggregate principal amount of $0;
|
|
●
|
will mature on May
31, 2027, unless earlier redeemed or repurchased, and 100% of the aggregate principal amount will be paid at maturity;
|
|
●
|
will bear cash interest
from the most recent interest payment date immediately preceding the date of issuance of the 7.50% 2027 Notes at an annual
rate of 7.50%, payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, except that 7.50%
2027 Notes purchased after the record dates noted below, but prior to the interest payment date immediately following such
record date (or if settlement of a purchase of 7.50% 2027 Notes otherwise occurs after such record date but prior to the interest
payment date immediately following such record date), such 7.50% 2027 Notes will not begin to accrue interest until the interest
payment date immediately following such record date, and the interest payable on each interest payment date will be paid only
to holders of record of the 7.50% 2027 Notes at the close of business on January 15, April 15, July 15 and October 15 of each
year, as the case may be, immediately preceding the applicable interest payment date;
|
|
●
|
will be redeemable
at our option, in whole or in part, at any time on and after May 31, 2020, at the price and on the terms described under “—Optional
Redemption” below;
|
|
●
|
will be issued in
denominations of $25 and integral multiples of $25 in excess thereof;
|
|
●
|
will not have a
sinking fund;
|
|
●
|
are listed on NASDAQ
under the symbol “RILYG”; and
|
|
●
|
will be represented
by one or more registered 7.50% 2027 Notes in global form, but in certain limited circumstances may be represented by 7.50%
2027 Notes in definitive form.
|
The indentures do
not limit the amount of indebtedness that we or our subsidiaries may issue. The indentures do not contain any financial covenants
and do not restrict us from paying dividends or issuing or repurchasing our other securities. Other than restrictions described
under “— Covenants — Merger, Consolidation or Sale of Assets” below, the indentures do not contain any
covenants or other provisions designed to afford holders of the Notes protection in the event of a highly leveraged transaction
involving us or in the event of a decline in our credit rating as the result of a takeover, recapitalization, highly leveraged
transaction or similar restructuring involving us that could adversely affect such holders.
We may from time to
time, without the consent of the existing holders, issue additional 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes,
2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes having the same terms as to status, redemption or otherwise (except the price
to public, the issue date and, if applicable, the initial interest payment date) that may constitute a single fungible series
with the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, respectively,
offered by this prospectus; provided that if any such additional notes are not fungible with the Notes initially offered hereby
for U.S. federal income tax purposes, such additional notes will have one or more separate CUSIP numbers.
Ranking
The Notes are senior
unsecured obligations of the Company, and, upon our liquidation, dissolution or winding up, will rank (i) senior to the outstanding
shares of our common stock, (ii) senior to any of our future subordinated debt, (iii) pari passu (or equally) with our
future unsecured and unsubordinated indebtedness, (iv) effectively subordinated to any existing or future secured indebtedness
(including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the
assets securing such indebtedness and (v) structurally subordinated to all existing and future indebtedness of our subsidiaries,
financing vehicles or similar facilities.
Any borrowings under the Wells Fargo Credit Agreement are secured
by the proceeds we receive for services rendered in connection with liquidation service contracts pursuant to which any outstanding
loan or letters of credit are issued and the assets that are sold at liquidation related to such contracts and will be effectively
senior to the Notes to the extent of the value of such proceeds and assets. As of September 30, 2020, we have no letters of credit
outstanding under the Wells Fargo Credit Agreement.
Interest
Interest on the 7.375%
2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes will accrue from the
most recent interest payment date immediately preceding the date of issuance of the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024
Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes, respectively, to, but excluding, the maturity date or earlier
acceleration or redemption, except that Notes purchased after the record dates noted below, but prior to the interest payment
date immediately following such record date (or if settlement of a purchase of Notes otherwise occurs after such record date but
prior to the interest payment date immediately following such record date), such Notes will not begin to accrue interest until
the interest payment date immediately following such record date. Interest will be paid quarterly in arrears on January 31, April
30, July 31 and October 31 of each year. The interest payable on each interest payment date will be paid only to holders of record
of the Notes at the close of business on January 15, April 15, July 15 and October 15 of each year, as the case may be, immediately
preceding the applicable interest payment date. As a general matter, holders of the Notes will not be entitled to receive any
payments of principal on the Notes prior to the stated maturity date.
The amount of interest
payable for any interest period, including interest payable for any partial interest period, will be computed on the basis of
a 360-day year comprised of twelve 30-day months. If an interest payment date falls on a non-business day, the applicable interest
payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment.
“Business day”
means, for any place where the principal and interest on the Notes is payable, each Monday, Tuesday, Wednesday, Thursday and Friday
which is not a day in which banking institutions in New York are authorized or obligated by law or executive order to close.
Optional Redemption
The 7.375% 2023 Notes may be redeemed in whole or in part at
any time at our option (i) prior to May 31, 2021, at a price equal to $25.75 per note, plus accrued and unpaid interest to, but
excluding, the date of redemption, (ii) on or after May 31, 2021 and prior to May 31, 2022, at a price equal to $25.375 per note,
plus accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or after May 31, 2022 and prior to maturity,
at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption.
In each case, redemption shall be upon notice not fewer than 30 days and not more than 60 days prior to the date fixed for redemption.
We may redeem the 6.875% 2023 Notes in whole or in part at our
option (i) prior to September 30, 2021, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding,
the date of redemption, (ii) on or after September 30, 2021 and prior to September 30, 2022, at a price equal to $25.25 per note,
plus accrued and unpaid interest to, but excluding, the date of redemption, and (iii) on or after September 30, 2022 and prior
to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding the date of
redemption. In each case, redemption shall be upon notice not fewer than 30 days and not more than 60 days prior to the date fixed
for redemption.
We may redeem the
2024 Notes for cash in whole or in part at any time at our option (i) on or after May 31, 2021 and prior to May 31, 2022, at a
price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on or after May
31, 2022 and prior to May 31, 2023, at a price equal to $25.25 per note, plus accrued and unpaid interest to, but excluding, the
date of redemption, and (iii) on or after May 31, 2023 and prior to maturity, at a price equal to 100% of their principal amount,
plus accrued and unpaid interest to, but excluding, the date of redemption.
We may redeem the
2025 Notes for cash in whole or in part at any time at our option (i) on or after February 28, 2021 and prior to February 28,
2022, at a price equal to $25.75 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on
or after February 28, 2022 and prior to February 28, 2023, at a price equal to $25.50 per note, plus accrued and unpaid interest
to, but excluding, the date of redemption, (iii) on or after February 28, 2023 and prior to February 29, 2024, at a price equal
to $25.25 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, and (iv) on or after February
29, 2024 and prior to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding,
the date of redemption.
We may redeem the
2026 Notes for cash in whole or in part at any time at our option (i) on or after September 30, 2022 and prior to September 30,
2023, at a price equal to $25.50 per note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on
or after September 30, 2023 and prior to September 30, 2024, at a price equal to $25.25 per note, plus accrued and unpaid interest
to, but excluding, the date of redemption, and (iii) on or after September 30, 2024 and prior to maturity, at a price equal to
100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption.
The 7.25% 2027 Notes
may be redeemed in whole or in part at any time or from time to time on or after December 31, 2020, at our option, upon notice
not fewer than 30 days and not more than 60 days prior to the date fixed for redemption, at a redemption price equal to the principal
amount plus any unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.
The 7.50% 2027 Notes may be redeemed in whole or in part at
any time or from time to time, at our option, upon notice not fewer than 30 days and not more than 60 days prior to the date fixed
for redemption, at a redemption price equal to the principal amount plus any unpaid interest payable thereon accrued to, but excluding,
the date fixed for redemption.
If less than all of
the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or 7.50% 2027 Notes are to be redeemed,
the particular 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes,
respectively, to be redeemed will be selected not more than 45 days prior to the redemption date by the trustee from the outstanding
7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or 7.50% 2027 Notes, respectively,
not previously called for redemption, by lot, or in the trustee’s discretion, on a pro-rata basis, provided that the unredeemed
portion of the principal amount of any 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes
or 7.50% 2027 Notes, respectively, will be in an authorized denomination (which will not be less than the minimum authorized denomination)
for such 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or 7.50% 2027 Notes, respectively.
The trustee will promptly notify us in writing of the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes,
7.25% 2027 Notes or 7.50% 2027 Notes, respectively, selected for redemption and, in the case of any 7.375% 2023 Notes, 6.875%
2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or 7.50% 2027 Notes, respectively, selected for partial redemption,
the principal amount thereof to be redeemed.
Unless we default
on the payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the Notes called
for redemption.
Events of Default
Holders of a particular
series of Notes will have rights if an Event of Default occurs in respect of such series of Notes and is not cured, as described
later in this subsection. The term “Event of Default” in respect of a series of Notes means any of the following:
|
●
|
we do not pay interest
on any Note within the same series when due, and such default is not cured within 30 days;
|
|
●
|
we do not pay the
principal of the Notes within the same series when due and payable;
|
|
●
|
we breach any covenant
or warranty in the indenture with respect to such series of Notes and such breach continues for 60 days after we receive a
written notice of such breach from the trustee or the holders of at least 25% of the principal amount of the Notes within
the same series; and
|
|
●
|
certain specified
events of bankruptcy, insolvency or reorganization occur and remain undischarged or unstayed for a period of 90 days.
|
The trustee may withhold
notice to the holders of either series of the Notes of any default, except in the payment of principal or interest, if the trustee
in good faith determines the withholding of notice to be in the interest of the holders of such series of the Notes.
Each year, we will
furnish to the trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance
with the indentures and the Notes, or else specifying any default.
Remedies if an Event of Default
Occurs
If an Event of Default
has occurred and is continuing, the trustee or the holders of not less than 25% of the outstanding principal amount of the Notes
within the same series may declare the entire principal amount of the Notes within the same series, together with accrued and
unpaid interest, if any, to be due and payable immediately by a notice in writing to us and, if notice is given by the holders
of the Notes within the same series, the trustee. This is called an “acceleration of maturity.” If the Event of Default
occurs in relation to our filing for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur, the
principal amount of the Notes, together with accrued and unpaid interest, if any, will automatically, and without any declaration
or other action on the part of the trustee or the holders, become immediately due and payable.
At any time after
a declaration of acceleration of a particular series of Notes has been made by the trustee or the holders of such Notes and before
any judgment or decree for payment of money due has been obtained by the trustee, the holders of a majority of the outstanding
principal of such Notes, by written notice to us and the trustee, may rescind and annul such declaration and its consequences
if (i) we have paid or deposited with the trustee all amounts due and owed with respect to such Notes (other than principal that
has become due solely by reason of such acceleration) and certain other amounts, and (ii) any other Events of Default have been
cured or waived.
At our election, the
sole remedy with respect to an Event of Default due to our failure to comply with certain reporting requirements under the Trust
Indenture Act or under “— Covenants — Reporting” below, for the first 180 calendar days after the occurrence
of such Event of Default, consists exclusively of the right to receive additional interest on the Notes at an annual rate equal
to (1) 0.25% for the first 90 calendar days after such default and (2) 0.50% for calendar days 91 through 180 after such default.
On the 181st day after such Event of Default, if such violation is not cured or waived, the trustee or the holders
of not less than 25% of the outstanding principal amount of the Notes may declare the principal, together with accrued and unpaid
interest, if any, on the Notes to be due and payable immediately. If we choose to pay such additional interest, we must notify
the trustee and the holders of the Notes by certificate of our election at any time on or before the close of business on the
first business day following the Event of Default.
Before a holder of
the Notes is allowed to bypass the trustee and bring a lawsuit or other formal legal action or take other steps to enforce such
holder’s rights relating to the Notes, the following must occur:
|
●
|
such holder must
give the trustee written notice that the Event of Default has occurred and remains uncured;
|
|
●
|
the holders of at
least 25% of the outstanding principal of the same series of Notes must have made a written request to the trustee to institute
proceedings in respect of such Event of Default in its own name as trustee;
|
|
●
|
such holder or holders
must have offered to the trustee indemnity satisfactory to the trustee against the costs, expenses and liabilities to be incurred
in compliance with such request;
|
|
●
|
the trustee for
60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding; and
|
|
●
|
no direction inconsistent
with such written request has been given to the trustee during such 60-day period by holders of a majority of the outstanding
principal of the same series of Notes.
|
No delay or omission
in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.
Book-entry and other indirect holders
of the Notes should consult their banks or brokers for information on how to give notice or direction to or make a request of
the trustee and how to declare or cancel an acceleration of maturity.
Waiver of Defaults
The holders of not
less than a majority of the outstanding principal amount of the 7.375% 2023 Notes and the Initial 7.375% 2023 Notes, voting together,
the 6.875% 2023 Notes and the Initial 6.875% 2023 Notes, voting together, the 2024 Notes and the Initial 2024 Notes, voting together,
the 2025 Notes and the Initial 2025 Notes, voting together, the 2026 Notes and the Initial 2026 Notes, voting together, the 7.25%
2027 Notes and the Initial 7.25% 2027 Notes, and the 7.50% 2027 Notes and the Initial 7.50% 2027 Notes, voting together, may on
behalf of the holders of all 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or 7.50%
2027 Notes, respectively, waive any past default with respect to such 7.375% 2023 Notes and Initial 7.375% 2023 Notes, 6.875%
2023 Notes and Initial 6.875% 2023 Notes, 2024 Notes and Initial 2024 Notes, 2025 Notes and Initial 2025 Notes, 2026 Notes and
Initial 2026 Notes or 7.25% 2027 Notes or Initial 7.25% 2027 Notes, other than (i) a default in the payment of principal or interest
on such series of Notes, when such payments are due and payable (other than by acceleration as described above), or (ii) in respect
of a covenant that cannot be modified or amended without the consent of each holder of such series of Notes.
Covenants
In addition to any
other covenants described in the prospectus supplement, as well as standard covenants relating to payment of principal and interest,
maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related
matters, the following covenants will apply to the Notes. To the extent of any conflict or inconsistency between a base indenture
and the following covenants, the following covenants will govern.
Merger, Consolidation or Sale of
Assets
The indenture provides
that we will not merge or consolidate with or into any other person (other than a merger of a wholly owned subsidiary into us),
or sell, transfer, lease, convey or otherwise dispose of all or substantially all our property in any one transaction or series
of related transactions unless:
|
●
|
we are the surviving
entity or the entity (if other than us) formed by such merger or consolidation or to which such sale, transfer, lease, conveyance
or disposition is made will be a corporation or limited liability company organized and existing under the laws of the United
States of America, any state thereof or the District of Columbia;
|
|
●
|
the surviving entity
(if other than us) expressly assumes, by supplemental indenture in form reasonably satisfactory to the trustee, executed and
delivered to the trustee by such surviving entity, the due and punctual payment of the principal of, and premium, if any,
and interest on, all the Notes outstanding, and the due and punctual performance and observance of all the covenants and conditions
of the indenture to be performed by us;
|
|
●
|
immediately before
and immediately after giving effect to such transaction or series of related transactions, no default or Event of Default
has occurred and is continuing; and
|
|
●
|
in the case of a
merger where the surviving entity is other than us, we or such surviving entity will deliver, or cause to be delivered, to
the trustee, an officers’ certificate and an opinion of counsel, each stating that such transaction and the supplemental
indenture, if any, in respect thereto, comply with this covenant and that all conditions precedent in the indenture relating
to such transaction have been complied with.
|
Reporting
If, at any time, we
are not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports with the
SEC, we agree to furnish to holders of the Notes and the trustee, for the period of time during which the Notes are outstanding,
our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated
financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements
will be prepared, in all material respects, in accordance with GAAP, as applicable.
Modification or Waiver
There are three types
of changes we can make to the indentures and the Notes (in each case below, all references to the Notes shall include the Initial
Notes as well as the Notes offered hereby):
Changes Not Requiring Approval
First, there are changes
that we can make to the Notes without the specific approval of the holders of the Notes. This type is limited to clarifications
and certain other changes that would not adversely affect holders of the Notes in any material respect and include changes:
|
●
|
to evidence the
succession of another corporation, and the assumption by the successor corporation of our covenants, agreements and obligations
under the indentures and the Notes;
|
|
●
|
to add to our covenants
such new covenants, restrictions, conditions or provisions for the protection of the holders of the Notes, and to make the
occurrence, or the occurrence and continuance, of a default in any of such additional covenants, restrictions, conditions
or provisions an Event of Default;
|
|
●
|
to modify, eliminate
or add to any of the provisions of the indentures to such extent as necessary to effect the qualification of the indentures
under the Trust Indenture Act, and to add to the indentures such other provisions as may be expressly permitted by the trust
indenture act, excluding however, the provisions referred to in Section 316(a)(2) of the Trust Indenture Act;
|
|
●
|
to cure any ambiguity
or to correct or supplement any provision contained in the indentures or in any supplemental indenture which may be defective
or inconsistent with other provisions;
|
|
●
|
to evidence and
provide for the acceptance and appointment of a successor trustee and to add or change any provisions of the indentures as
necessary to provide for or facilitate the administration of the trust by more than one trustee; and
|
|
●
|
to make provisions
in regard to matters or questions arising under the indentures, so long such other provisions to do not materially affect
the interest of any other holder of the Notes.
|
Changes Requiring Approval of Each
Holder
We cannot make certain
changes to the Notes without the specific approval of each holder of the same series of Notes. The following is a list of those
types of changes:
|
●
|
changing the stated
maturity of the principal of, or any installment of interest on, any Note;
|
|
●
|
reducing the principal
amount or rate of interest of any Note;
|
|
●
|
changing the place
of payment where any Note or any interest is payable;
|
|
●
|
impairing the right
to institute suit for the enforcement of any payment on or after the date on which it is due and payable;
|
|
●
|
reducing the percentage
in principal amount of holders of the Notes whose consent is needed to modify or amend the indentures; and
|
|
●
|
reducing the percentage
in principal amount of holders of the Notes whose consent is needed to waive compliance with certain provisions of the indentures
or to waive certain defaults.
|
Changes Requiring Majority Approval
Any other change to
the indentures and the Notes would require the following approval:
|
●
|
if the change only
affects a particular series of Notes, it must be approved by holders of not less than a majority in aggregate principal amount
of the applicable series of outstanding Notes; and
|
|
●
|
if the change affects
more than one series of debt securities issued under the applicable indenture, it must be approved by the holders of not less
than a majority in aggregate principal amount of each of the series of debt securities affected by the change.
|
Consent from holders to any change to
the indentures or the Notes must be given in writing.
Further Details Concerning Voting
The amount of Notes
in a particular series deemed to be outstanding for the purpose of voting will include all such Notes in such series authenticated
and delivered under the indenture applicable to such series of Notes as of the date of determination except:
|
●
|
Notes cancelled
by the trustee or delivered to the trustee for cancellation;
|
|
●
|
Notes for which
we have deposited with the trustee or paying agent or set aside in trust money for their payment or redemption and, if money
has been set aside for the redemption of the Notes, notice of such redemption has been duly given pursuant to the indenture
to the satisfaction of the trustee;
|
|
●
|
Notes held by the
Company, its subsidiaries or any other entity which is an obligor under the Notes, unless such Notes have been pledged in
good faith and the pledgee is not the Company, an affiliate of the Company or an obligor under the Notes;
|
|
●
|
Notes for which
have undergone full defeasance, as described below; and
|
|
●
|
Notes which have
been paid or exchanged for other Notes due to such Notes loss, destruction or mutilation, with the exception of any such Notes
held by bona fide purchasers who have presented proof to the trustee that such Notes are valid obligations of the Company.
|
We will generally
be entitled to set any day as a record date for the purpose of determining the holders of a particular series of Notes that are
entitled to vote or take other action under the indenture, and the trustee will generally be entitled to set any day as a record
date for the purpose of determining the holders of such series of Notes that are entitled to join in the giving or making of any
Notice of Default, any declaration of acceleration of maturity of such Notes, any request to institute proceedings or the reversal
of such declaration. If we or the trustee set a record date for a vote or other action to be taken by the holders of such Notes,
that vote or action can only be taken by persons who are holders of such Notes on the record date and, unless otherwise specified,
such vote or action must take place on or prior to the 180th day after the record date. We may change the record date
at our option, and we will provide written notice to the trustee and to each holder of a particular series of Notes of any such
change of record date.
Defeasance
The following defeasance
provisions will be applicable to the Notes. “Defeasance” means that, by irrevocably depositing with the trustee an
amount of cash denominated in U.S. dollars and/or U.S. government obligations sufficient to pay all principal and interest, if
any, on all or any series of the Notes when due and satisfying any additional conditions noted below, we will be deemed to have
been discharged from our obligations under such Notes. In the event of a “covenant defeasance,” upon depositing such
funds and satisfying similar conditions discussed below we would be released from certain covenants under the indenture relating
to the specific Notes. The consequences to the holders of the Notes would be that, while they would no longer benefit from certain
covenants under the indenture, and while the Notes could not be accelerated for any reason, the holders of the Notes nonetheless
would be guaranteed to receive the principal and interest owed to them.
Covenant Defeasance
Under the indentures,
we have the option to take the actions described below and be released from some of the restrictive covenants under the indentures
under which any series of the Notes were issued. This is called “covenant defeasance.” In that event, holders of such
Notes would lose the protection of those restrictive covenants but would gain the protection of having money and government securities
set aside in trust to repay the Notes. In order to achieve covenant defeasance, the following must occur:
|
●
|
we must irrevocably
deposit or cause to be deposited with the trustee as trust funds for the benefit of the all holders of the applicable series
of the Notes cash, U.S. government obligations or a combination of cash and U.S. government obligations sufficient to generate
enough cash to make interest, principal and any other applicable payments on such Notes on their various due dates;
|
|
●
|
we must deliver
to the trustee a legal opinion of our counsel stating that under U.S. federal income tax law, we may make the above deposit
and covenant defeasance without causing holders to be taxed on the applicable series of the Notes differently than if those
actions were not taken;
|
|
●
|
we must deliver
to the trustee an officers’ certificate stating that the applicable series of the Notes, if then listed on any securities
exchange, will not be delisted as a result of the deposit;
|
|
●
|
no default or Event
of Default with respect to the applicable series of the Notes has occurred and is continuing, and no defaults or Events of
Defaults related to bankruptcy, insolvency or organization occurs during the 90 days following the deposit;
|
|
●
|
the covenant defeasance
must not cause the trustee to have a conflicting interest within the meaning of the Trust Indenture Act;
|
|
●
|
the covenant defeasance
must not result in a breach or violation of, or constitute a default under, the indenture or any other material agreements
or instruments to which we are a party;
|
|
●
|
the covenant defeasance
must not result in the trust arising from the deposit constituting an investment company within the meaning of the Investment
Company Act unless such trust will be registered under the Investment Company Act or exempt from registration thereunder;
and
|
|
●
|
we must deliver
to the trustee an officers’ certificate and a legal opinion from our counsel stating that all conditions precedent with
respect to the covenant defeasance have been complied with.
|
Full Defeasance
If there is a change
in U.S. federal income tax law, we can legally release ourselves from all payment and other obligations on any applicable series
of the Notes if we take the following actions below:
|
●
|
we must irrevocably
deposit or cause to be deposited with the trustee as trust funds for the benefit of the all holders of the applicable series
of the Notes cash, U.S. government obligations or a combination of cash and U.S. government obligations sufficient to generate
enough cash to make interest, principal and any other applicable payments on the Notes on their various due dates;
|
|
●
|
we must deliver
to the trustee a legal opinion confirming that there has been a change to the current U.S. federal income tax law or an Internal
Revenue Service ruling that allows us to make the above deposit without causing holders to be taxed on the applicable series
of the Notes any differently than if we did not make the deposit;
|
|
●
|
we must deliver
to the trustee an officers’ certificate stating that the applicable series of the Notes, if then listed on any securities
exchange, will not be delisted as a result of the deposit;
|
|
●
|
no default or Event
of Default with respect to the applicable series of the Notes has occurred and is continuing and no defaults or Events of
Defaults related to bankruptcy, insolvency or organization occurs during the 90 days following the deposit;
|
|
●
|
the full defeasance
must not cause the trustee to have a conflicting interest within the meaning of the Trust Indenture Act;
|
|
●
|
the full defeasance
must not result in a breach or violation of, or constitute a default under, the indenture or any other material agreements
or instruments to which we are a party;
|
|
●
|
the full defeasance
must not result in the trust arising from the deposit constituting an investment company within the meaning of the Investment
Company Act unless such trust will be registered under the Investment Company Act or exempt from registration thereunder;
and
|
|
●
|
we must deliver
to the trustee an officers’ certificate and a legal opinion from our counsel stating that all conditions precedent with
respect to the full defeasance have been complied with.
|
In the event that
the trustee is unable to apply the funds held in trust to the payment of obligations under the applicable series of the Notes
by reason of a court order or governmental injunction or prohibition, then those of our obligations discharged under the full
defeasance or covenant defeasance will be revived and reinstated as though no deposit of funds had occurred, until such time as
the trustee is permitted to apply all funds held in trust under the procedure described above may be applied to the payment of
obligations under such Notes. However, if we make any payment of principal or interest on the applicable series of the Notes to
the holders, we will have the right to receive such payments from the trust in the place of the holders.
Listing
The 7.375% 2023 Notes,
6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes are listed on NASDAQ under the symbols
“RILYH,” “RILYI,” “RILYO,” “RILYM,” “RILYN,” and “RILYG”
and “RILYZ,” respectively. The Notes trade “flat,” meaning that purchasers will not pay and sellers will
not receive any accrued and unpaid interest on the Notes that is not included in the trading price.
Governing Law
The indentures and
the Notes will be governed by and construed in accordance with the laws of the State of New York.
Global Notes; Book-Entry Issuance
The Notes will be
issued in the form of one or more global certificates, or “Global Notes,” registered in the name of The Depository
Trust Company, or “DTC”. DTC has informed us that its nominee will be Cede & Co. Accordingly, we expect Cede &Co.
to be the initial registered holder of the Notes. No person that acquires a beneficial interest in the Notes will be entitled
to receive a certificate representing that person’s interest in the Notes except as described herein. Unless and until definitive
securities are issued under the limited circumstances described below, all references to actions by holders of the Notes will
refer to actions taken by DTC upon instructions from its participants, and all references to payments and notices to holders will
refer to payments and notices to DTC or Cede & Co., as the registered holder of these securities.
DTC has informed us
that it is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within
the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the
meaning of the New York Uniform Commercial Code, and a “clearing agency” registered pursuant to the provisions of
Section 17A of the Exchange Act. DTC holds and provides asset servicing for over 3.5 million issues of U.S. and non-U.S. equity
issues, corporate and municipal debt issues, and money market instruments from over 100 countries that DTC’s participants,
or “Direct Participants,” deposit with DTC. DTC also facilitates the post-trade settlement among Direct Participants
of sales and other securities transactions in deposited securities through electronic computerized book-entry transfers and pledges
between Direct Participants’ accounts. This eliminates the need for physical movement of securities certificates. Direct
Participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, clearing corporations and
certain other organizations. DTC is a wholly owned subsidiary of The Depository Trust & Clearing Corporation, or “DTCC.”
DTCC is the holding
company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing
agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others such
as both U.S. and non-U.S. securities brokers and dealers, banks, trust companies and clearing corporations that clear through
or maintain a custodial relationship with a Direct Participant, either directly or indirectly, or “Indirect Participants.”
DTC has an S&P rating of AA+. The DTC Rules applicable to its participants are on file with the SEC. More information about
DTC can be found at www.dtcc.com.
Purchases of the Notes
under the DTC system must be made by or through Direct Participants, which will receive a credit for the Notes on DTC’s
records. The ownership interest of each actual purchaser of each Note, or the “Beneficial Owner,” is in turn to be
recorded on the Direct and Indirect Participants’ records. Beneficial Owners will not receive written confirmation from
DTC of their purchase. Beneficial Owners are, however, expected to receive written confirmations providing details of the transaction,
as well as periodic statements of their holdings, from the Direct or Indirect Participant through which the Beneficial Owner entered
into the transaction. Transfers of ownership interests in the Notes are to be accomplished by entries made on the books of Direct
and Indirect Participants acting on behalf of Beneficial Owners. Beneficial Owners will not receive certificates representing
their ownership interests in the Notes, except in the event that use of the book-entry system for the Notes is discontinued.
To facilitate subsequent
transfers, all Notes deposited by Direct Participants with DTC are registered in the name of DTC’s partnership nominee,
Cede & Co., or such other name as may be requested by an authorized representative of DTC. The deposit of the Notes with DTC
and their registration in the name of Cede & Co. or such other DTC nominee do not effect any change in beneficial ownership.
DTC has no knowledge of the actual Beneficial Owners of the Notes; DTC’s records reflect only the identity of the Direct
Participants to whose accounts the Notes are credited, which may or may not be the Beneficial Owners. The Direct and Indirect
Participants will remain responsible for keeping account of their holdings on behalf of their customers.
Conveyance of notices
and other communications by DTC to Direct Participants, by Direct Participants to Indirect Participants, and by Direct Participants
and Indirect Participants to Beneficial Owners will be governed by arrangements among them, subject to any statutory or regulatory
requirements as may be in effect from time to time.
Redemption notices
will be sent to DTC. If less than all of the Notes are being redeemed, DTC’s practice is to determine by lot the amount
of the interest of each Direct Participant in the Notes to be redeemed.
Neither DTC nor Cede
& Co. (nor any other DTC nominee) will consent or vote with respect to the Notes unless authorized by a Direct Participant
in accordance with DTC’s Procedures. Under its usual procedures, DTC mails an Omnibus Proxy to us as soon as possible after
the record date. The Omnibus Proxy assigns Cede & Co.’s consenting or voting rights to those Direct Participants to
whose accounts the Notes are credited on the record date (identified in a listing attached to the Omnibus Proxy).
Redemption proceeds,
distributions and interest payments on the Notes will be made to Cede & Co., or such other nominee as may be requested by
an authorized representative of DTC. DTC’s practice is to credit Direct Participants’ accounts upon DTC’s receipt
of funds and corresponding detail information from us or the applicable trustee or depositary on the payment date in accordance
with their respective holdings shown on DTC’s records. Payments by Participants to Beneficial Owners will be governed by
standing instructions and customary practices, as is the case with the Notes held for the accounts of customers in bearer form
or registered in “street name,” and will be the responsibility of such Participant and not of DTC nor its nominee,
the applicable trustee or depositary, or us, subject to any statutory or regulatory requirements as may be in effect from time
to time. Payment of redemption proceeds, distributions and interest payments to Cede & Co. (or such other nominee as may be
requested by an authorized representative of DTC) is the responsibility of us or the applicable trustee or depositary. Disbursement
of such payments to Direct Participants will be the responsibility of DTC, and disbursement of such payments to the Beneficial
Owners will be the responsibility of Direct and Indirect Participants.
The information in
this section concerning DTC and DTC’s book-entry system has been obtained from sources that we believe to be reliable, but
we take no responsibility for the accuracy thereof.
None of the Company,
the trustee, any depositary, or any agent of any of them will have any responsibility or liability for any aspect of DTC’s
or any participant’s records relating to, or for payments made on account of, beneficial interests in a Global Note, or
for maintaining, supervising or reviewing any records relating to such beneficial interests.
Termination of a Global Note
If a Global Note is
terminated for any reason, interest in it will be exchanged for certificates in non-book-entry form as certificated securities.
After such exchange, the choice of whether to hold the certificated Notes directly or in street name will be up to the investor.
Investors must consult their own banks or brokers to find out how to have their interests in a Global Note transferred on termination
to their own names, so that they will be holders of the Notes. See “— Form, Exchange and Transfer of Certificated
Registered Securities.”
Payment and Paying Agents
We will pay interest
to the person listed in the trustee’s records as the owner of the Notes at the close of business on the record date for
the applicable interest payment date, even if that person no longer owns the Note on the interest payment date. Because we pay
all the interest for an interest period to the holders on the record date, holders buying and selling the Notes must work out
between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the Notes to prorate
interest fairly between buyer and seller based on their respective ownership periods within the particular interest period.
Payments on Global Notes
We will make payments
on the Notes so long as they are represented by Global Notes in accordance with the applicable policies of the depositary in effect
from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect
holders who own beneficial interest in the Global Notes. An indirect holder’s right to those payments will be governed by
the rules and practices of the depositary and its participants.
Payments on Certificated Securities
In the event the Notes
become represented by certificates, we will make payments on the Notes as follows. We will pay interest that is due on an interest
payment date by check mailed on the interest payment date to the holder of the Note at his or her address shown on the trustee’s
records as of the close of business on the record date. We will make all payments of principal by check at the office of the trustee
in the contiguous United States and/or at other offices that may be specified in the indenture or a notice to holders against
surrender of the Note.
Payment When Offices Are Closed
If any payment is
due on the Notes on a day that is not a business day, we will make the payment on the next day that is a business day. Payments
made on the next business day in this situation will be treated under the indenture as if they were made on the original due date.
Such payment will not result in a default under the Notes or the indenture, and no interest will accrue on the payment amount
from the original due date to the next day that is a business day.
Book-entry and other
indirect holders should consult their banks or brokers for information on how they will receive payments on the Notes.
Form, Exchange and Transfer of Certificated Registered Securities
Notes in physical,
certificated form will be issued and delivered to each person that DTC identifies as a beneficial owner of the related Notes only
if:
|
●
|
DTC notified us
at any time that it is unwilling or unable to continue as depositary for the Global Notes;
|
|
●
|
DTC ceases to be
registered as a clearing agency under the Exchange Act; or
|
|
●
|
an Event of Default
with respect to such Global Note has occurred and is continuing.
|
Holders may exchange
their certificated securities for Notes of smaller denominations or combined into fewer Notes of larger denominations, as long
as the total principal amount is not changed and as long as the denomination is equal to or greater than $25.
Holders may exchange
or transfer their certificated securities at the office of the trustee. We have appointed the trustee to act as our agent for
registering the Notes in the name of holders transferring Notes. We may at any time designate additional transfer agents or rescind
the designation of any transfer agent or approve a change in the office through which any transfer agent acts.
Holders will not be
required to pay a service charge for any registration of transfer or exchange of their certificated securities, but they may be
required to pay any tax or other governmental charge associated with the registration of transfer or exchange. The transfer or
exchange will be made only if our transfer agent is satisfied with the holder’s proof of legal ownership.
If we redeem any of
the Notes, we may block the transfer or exchange of those Notes selected for redemption during the period beginning 15 days before
the day we mail the notice of redemption and ending on the day of that mailing, in order to determine or fix the list of holders
to prepare the mailing. We may also refuse to register transfer or exchanges of any certificated Notes selected for redemption,
except that we will continue to permit transfers and exchanges of the unredeemed portion of any Note that will be partially redeemed.
About the Trustees
U.S. Bank National
Association is the trustee under the 2016 Indenture governing the 7.375% 2023 Notes, 6.875% 2023 Notes, 7.25% 2027 Notes and 7.50%
2027 Notes and will be the principal paying agent and registrar for the 7.375% 2023 Notes, 6.875% 2023 Notes, 7.25% 2027 Notes
and 7.50% 2027 Notes. U.S. Bank National Association may resign or be removed with respect to the 7.375% 2023 Notes, 6.875% 2023
Notes, 7.25% 2027 Notes and 7.50% 2027 Notes provided that a successor trustee is appointed to act with respect to the 7.375%
2023 Notes, 6.875% 2023 Notes, 7.25% 2027 Notes and 7.50% 2027 Notes.
The Bank of New York
Mellon Trust Company, N.A., is the trustee under the 2019 Indenture governing the 2024 Notes, 2025 Notes and the 2026 Notes and
will be the principal paying agent and registrar for the 2024 Notes, 2025 Notes and the 2026 Notes. The Bank of New York Mellon
Trust Company, N.A., may resign or be removed with respect to the 2024 Notes, 2025 Notes and the 2026 Notes provided that a successor
trustee is appointed to act with respect to the 2024 Notes, 2025 Notes and the 2026 Notes.
DESCRIPTION OF SERIES A PREFERRED STOCK
AND THE SERIES A DEPOSITARY SHARES
The following is a summary of the material
terms and provisions of the Series A Preferred Stock and the Depositary Shares. The statements below describing our Series A Preferred
Stock are in all respects subject to and qualified in their entirety by reference to the applicable provisions of our articles
of incorporation, including the certificate of designation establishing the Series A Preferred Stock, and our bylaws, each of
which is available from us as described in the “Where You Can Find More Information” section of this prospectus supplement
and is incorporated by reference in this prospectus supplement. See also “Description of Series A Depositary Shares”
in the accompanying prospectus. This description of the particular terms of the Series A Preferred Stock and the Series A Depositary
Shares supplements the description of the general terms and provisions of our preferred stock set forth in the accompanying prospectus
under “Description of Preferred Stock” and under “Description of Series A Depositary Shares.” For a description
of the common stock into which the Series A Preferred Stock is convertible, see “Description of Capital Stock — Common
Stock” in the accompanying prospectus.
General
Our Amended and Restated
Certificate of Incorporation, provides that we are authorized to issue 101,000,000 shares of capital stock. Our authorized capital
stock is comprised of 100,000,000 shares of common stock, $0.0001 par value per share, and 1,000,000 shares of preferred stock,
par value $0.0001 per share.
Shares of preferred
stock and related depositary shares may be offered and sold from time to time, in one or more series, as authorized by our Board
of Directors. Our Board of Directors is authorized to set for each series of preferred stock and related depositary shares the
terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to distributions, qualifications and
terms or conditions of redemption. The Series A Preferred Stock is being issued pursuant to the certificate of designation that
sets forth the terms of a series of preferred stock consisting of up to 10,000 shares, designated 6.875% Series A Cumulative Perpetual
Preferred Stock.
The depositary for
the Series A Preferred Stock is Continental Stock Transfer & Trust Company.
Each depositary share
represents a 1/1000th fractional interest in a share of Series A Preferred Stock. The Series A Preferred Stock underlying
the Series A Depositary Shares will be deposited with Continental Stock Transfer & Trust Company, as depositary, under a deposit
agreement among us, the depositary and the holders from time to time of the depositary receipts issued by the depositary under
the deposit agreement. The Series A Depositary Shares will be evidenced by depositary receipts issued pursuant to the deposit
agreement. Subject to the terms of the deposit agreement, each record holder of depositary receipts evidencing Series A Depositary
Shares will be entitled, proportionately, to all the rights and preferences of, and subject to all of the limitations of, the
interest in the Series A Preferred Stock underlying the Series A Depositary Shares (including dividend, voting, redemption and
liquidation rights and preferences).
Ranking
The Series A Preferred
Stock represented by the Series A Depositary Shares will, as to dividend rights and rights upon our liquidation, dissolution or
winding-up, rank:
|
(1)
|
Senior to all classes
or series of our common stock and to all other equity securities issued by us other than any equity securities issued by us
with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Stock;
|
|
(2)
|
Junior to all equity
securities issued by us with terms specifically providing that those equity securities rank senior to the Series A Preferred
Stock with respect to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding
up; and
|
|
(3)
|
Effectively junior
to all our existing and future indebtedness (including indebtedness convertible into our common stock or preferred stock)
and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing
or future subsidiaries.
|
Dividends
Holders of Series
A Depositary Shares representing interests in the Series A Preferred Stock will be entitled to receive, when and as declared by
our Board of Directors, out of funds legally available for the payment of dividends, cumulative cash dividends at the rate of
6.875% of the $25,000.00 liquidation preference ($25.00 per depositary share) per year (equivalent to $1,718.75 per year or $1.71875
per year per depositary share). Dividends on the Series A Preferred Stock will accumulate and be cumulative from, and including,
the date of original issue by us of the Series A Preferred Stock. Dividends will be payable quarterly in arrears on or about the
last day of January, April, July and October; provided that if any dividend payment date is not a business day, as defined in
the certificate of designation, then the dividend which would otherwise have been payable on that dividend payment date may be
paid on the next succeeding business day and no interest, additional dividends or other sums will accumulate on the amounts so
payable for the period from and after that dividend payment date to that next succeeding business day. Whenever we pay dividends
on the Series A Preferred Stock held by the depositary, the depositary will pay dividends on the same date on the Series A Depositary
Shares. We refer to each such date as a Dividend Payment Date.
Any dividend, including
any dividend payable on the Series A Preferred Stock for any partial dividend period, will be computed on the basis of a 360-day
year consisting of twelve 30-day months. Dividends are payable to holders of record of Series A Depositary Shares as they appear
in the depositary’s records at the close of business on the applicable record date, which will be the date that our Board
of Directors designates for the payment of a dividend that is not more than 30 nor less than 10 days prior to the Dividend Payment
Date, which we refer to as a Dividend Payment Record Date.
Our Board of Directors
will not authorize, pay or set apart for payment by us any dividend on the Series A Preferred Stock at any time that:
|
●
|
the terms and provisions
of any of our agreements, including any agreement relating to our indebtedness, prohibits such authorization, payment or setting
apart for payment;
|
|
●
|
the terms and provisions
of any of our agreements, including any agreement relating to our indebtedness, provides that such authorization, payment
or setting apart for payment thereof would constitute a breach of, or a default under, such agreement; or
|
|
●
|
the law restricts
or prohibits the authorization or payment.
|
Notwithstanding the
foregoing, dividends on the Series A Preferred Stock will accumulate whether or not:
|
●
|
the terms and provisions
of any of our agreements relating to our indebtedness prohibit such authorization, payment or setting apart for payment;
|
|
●
|
there are funds
legally available for the payment of the dividends; and
|
|
●
|
the dividends are
authorized.
|
No interest, or sums
in lieu of interest, will be payable in respect of any dividend payment or payments on the Series A Preferred Stock, which may
be in arrears, and holders of the Series A Preferred Stock will not be entitled to any dividends in excess of the full cumulative
dividends described above. Any dividend payment made on the Series A Preferred Stock shall first be credited against the earliest
accumulated but unpaid dividends due with respect to those shares.
If, for any taxable
year, we elect to designate as “capital gain dividends” (as defined in Section 857 of the Internal Revenue Code of
1986, as amended, which we refer to as the Code) a portion, which we refer to as the Capital Gains Amount, of the dividends not
in excess of our earning and profits that are paid or made available for the year to the holders of all classes of shares, or
the Total Dividends, then the portion of the Capital Gains Amount that will be allocable to the holders of Series A Depositary
Shares will be the Capital Gains Amount multiplied by a fraction, the numerator of which will be the total dividends (within the
meaning of the Code) paid or made available to the holders of Series A Depositary Shares for the year and the denominator of which
will be the Total Dividends.
We will not pay or
declare and set apart for payment any dividends (other than a dividend paid in common stock or other stock ranking junior to the
Series A Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution
or winding up) or declare or make any distribution of cash or other property on common stock or other stock that ranks junior
to or on parity with the Series A Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary
liquidation, dissolution or winding up or redeem or otherwise acquire common stock or other stock that ranks junior to or on parity
with the Series A Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution
or winding up (except (i) by conversion into or exchange for common stock or other stock ranking junior to the Series A Preferred
Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution or winding up, (ii)
for the redemption of shares of our stock pursuant to the provisions of our charter relating to the restrictions upon ownership
and transfer of our stock and (iii) for a purchase or exchange offer made on the same terms to holders of all outstanding shares
of Series A Preferred Stock and any other stock that ranks on parity with the Series A Preferred Stock with respect to dividend
rights and rights upon our voluntary or involuntary liquidation, dissolution or winding up), unless we also have either paid or
declared and set apart for payment full cumulative dividends on the Series A Preferred Stock for all past dividend periods.
Notwithstanding the
foregoing, if we do not either pay or declare and set apart for payment full cumulative dividends on the Series A Preferred Stock
and all stock that ranks on parity with the Series A Preferred Stock with respect to dividends, the amount which we have declared
will be allocated pro rata to the holders of Series A Preferred Stock and to each equally ranked class or series of stock, so
that the amount declared for each share of Series A Preferred Stock and for each share of each equally ranked class or series
of stock is proportionate to the accrued and unpaid dividends on those shares. Any dividend payment made on the Series A Preferred
Stock will first be credited against the earliest accrued and unpaid dividend.
Liquidation Preference
In the event of any
voluntary or involuntary liquidation, dissolution or winding up of our affairs, the holders of shares of Series A Preferred Stock
are entitled to be paid out of our assets legally available for distribution to our shareholders a liquidation preference of $25,000.00
per share (or $25.00 per depositary share), plus an amount equal to any accumulated and unpaid dividends to the date of payment
(whether or not declared), before any distribution or payment may be made to holders of shares of common stock or any other class
or series of our equity stock ranking, as to liquidation rights, junior to the Series A Preferred Stock.
If, upon our voluntary
or involuntary liquidation, dissolution or winding up, our available assets are insufficient to pay the full amount of the liquidating
distributions on all outstanding shares of Series A Preferred Stock and the corresponding amounts payable on all shares of each
other class or series of capital stock ranking, as to liquidation rights, on a parity with the Series A Preferred Stock, then
the holders of the Series A Preferred Stock and each such other class or series of capital stock ranking, as to liquidation rights,
on a parity with the Series A Preferred Stock will share ratably in any distribution of assets in proportion to the full liquidating
distributions to which they would otherwise be respectively entitled. Holders of Series A Preferred Stock will be entitled to
written notice of any liquidation no fewer than 30 days and no more than 60 days prior to the payment date. After payment of the
full amount of the liquidating distributions to which they are entitled, the holders of Series A Preferred Stock and Series A
Depositary Shares will have no right or claim to any of our remaining assets.
Our consolidation
or merger with or into any other entity or the sale, lease, transfer or conveyance of all or substantially all of our property
or business will not be deemed to constitute our liquidation, dissolution or winding up. The Series A Preferred Stock will
rank senior to the common stock as to priority for receiving liquidating distributions and on a parity with any existing and future
equity securities which, by their terms, rank on a parity with the Series A Preferred Stock.
Optional Redemption
The Series A Preferred
Stock is not redeemable prior to October 7, 2024, except under the circumstances described below. On or after October 7, 2024,
the Series A Preferred Stock may be redeemed at our option, in whole or in part, from time to time, at a redemption price of $25,000.00
per share ($25.00 per depositary share), plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred
Stock up to, but not including, the date of such redemption, upon the giving of notice, as provided below. Whenever we redeem
shares of our Series A Preferred Stock held by the depositary, the depositary will redeem as of the same redemption date a number
of Series A Depositary Shares representing the shares so redeemed and the depositary receipts evidencing such Series A Depositary
Shares.
If fewer than all
of the outstanding shares of Series A Preferred Stock are to be redeemed, the shares to be redeemed will be determined pro rata
or by lot.
We shall give the
depositary not less than 30 nor more than 60 days prior written notice of redemption of the deposited Series A Preferred Stock.
A similar notice of redemption will be mailed by the depositary not less than 30 nor more than 60 days prior to the date fixed
for redemption to each holder of record of Series A Depositary Shares that is to be redeemed. The notice will notify the holder
of the election to redeem the shares and will state at least the following:
|
●
|
the date fixed for
redemption thereof, which we refer to as the Redemption Date;
|
|
●
|
the number of shares
of Series A Preferred Stock and Series A Depositary Shares to be redeemed (and, if fewer than all the shares are to be redeemed,
the number of shares to be redeemed from such holder);
|
|
●
|
the place(s) where
the depositary receipts evidencing the Series A Depositary Shares are to be surrendered for payment; and
|
|
●
|
that dividends on
the Series A Depositary Shares will cease to accumulate on the date prior to the Redemption Date.
|
On or after the Redemption
Date, each holder of Series A Depositary Shares to be redeemed must present and surrender the depositary receipts evidencing the
Series A Depositary Shares to the depositary at the place designated in the notice of redemption. The redemption price of the
shares will then be paid to or on the order of the person whose name appears on such depositary receipts as the owner thereof.
Each surrendered depositary receipt will be canceled. In the event that fewer than all the depositary receipts are to be redeemed,
a new depositary receipt will be issued representing the unredeemed Series A Depositary Shares.
From and after the
Redemption Date (unless we default in payment of the redemption price):
|
●
|
all dividends on
the shares designated for redemption in the notice will cease to accumulate;
|
|
●
|
all rights of the
holders of the shares, except the right to receive the redemption price thereof (including all accumulated and unpaid dividends
up to the date prior to the Redemption Date), will cease and terminate;
|
|
●
|
the shares will
not thereafter be transferred (except with our consent) on the depositary’s books; and
|
|
●
|
the shares will
not be deemed to be outstanding for any purpose whatsoever.
|
Unless full cumulative
dividends on all shares of Series A Preferred Stock shall have been or contemporaneously are declared and paid or declared and
a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods,
no shares of Series A Preferred Stock shall be redeemed unless all outstanding shares of Series A Preferred Stock are simultaneously
redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Series A Preferred Stock (except
by exchanging it for our capital stock ranking junior to the Series A Preferred Stock as to dividends and upon liquidation); provided,
however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Series A Preferred Stock pursuant
to a purchase or exchange offer made on the same terms to holders of all outstanding Series A Depositary Shares representing interests
in the Series A Preferred Stock.
Special Optional Redemption
During any period
of time (whether before or after October 7, 2024) that both (i) the Series A preferred stock (or the Series A Depositary Shares)
are no longer listed on the NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor
to the NYSE, the NYSE AMER or NASDAQ, and (ii) we are not subject to the reporting requirements of the Exchange Act, but any Series
A preferred stock is still outstanding (which we refer to collectively as a “Delisting Event”), we may, at our option,
redeem the Series A preferred stock, in whole or in part and within 90 days after the date of the Delisting Event, by paying $25,000.00
per share (equivalent to $25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date
of redemption.
In addition, upon
the occurrence of a Change of Control (defined below), we may, at our option, redeem the Series A Preferred Stock, in whole or
in part and within 120 days after the first date on which such Change of Control occurred, by paying $25,000.00 per share (equivalent
to $25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date of redemption (other
than any dividend with a record date before the applicable redemption date and a payment date after the applicable redemption
date, which will be paid on the payment date notwithstanding prior redemption of such shares).
If, prior to the Delisting
Event Conversion Date or Change of Control Conversion Date (each as defined below), as applicable, we have provided or provide
notice of redemption with respect to the Series A Preferred Stock (whether pursuant to our optional redemption right described
above or our special optional redemption), the holders of Series A Depositary Shares representing interests in the Series A Preferred
Stock will not be permitted to exercise the conversion right described below under “— Conversion Rights” in
respect of their shares called for redemption.
The depositary will
mail to you, if you are a record holder of the Series A Depositary Shares representing interests in the Series A Preferred Stock,
a notice of redemption, furnished by us, no fewer than 30 days nor more than 60 days before the redemption date. The depositary
will send the notice to your address shown on the records of the depositary. No failure to give the notice or any defect in the
notice or in the mailing of the notice will affect the validity of the proceedings for the redemption of any Series A Depositary
Shares or shares of our Series A Preferred Stock except as to a holder to whom notice was defective or not given. Each notice
will state the following:
|
●
|
the number of Series
A Depositary Shares representing interests in the Series A Preferred Stock to be redeemed;
|
|
●
|
the place(s) where
the depositary receipts (or Series A Preferred Stock certificates, if no longer held in depositary form) are to be surrendered
for payment;
|
|
●
|
that the Series
A Preferred Stock is being redeemed pursuant to our special optional redemption right in connection with the occurrence of
a Delisting Event or Change of Control, as applicable, and a brief description of the transaction or transactions or circumstances
constituting such Delisting Event or Change of Control, as applicable;
|
|
●
|
that the holders
of Series A Depositary Shares representing interests in the Series A Preferred Stock to which the notice relates will not
be able to convert such shares of Series A Preferred Stock in connection with the Delisting Event or Change of Control, as
applicable, and each share of Series A Preferred Stock tendered for conversion that is selected, prior to the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable, for redemption will be redeemed on the related date of
redemption instead of converted on the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable;
and
|
|
●
|
that dividends on
the Series A Preferred Stock to be redeemed will cease to accumulate on the date prior to the redemption date.
|
A “Change of
Control” is when, after the original issuance of the Series A Preferred Stock, the following have occurred and are continuing:
|
●
|
the acquisition
by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange
Act of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series
of purchases, mergers or other acquisition transactions of shares of our company entitling that person to exercise more than
50% of the total voting power of all shares of our company entitled to vote generally in elections of directors (except that
such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire, whether
such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
|
|
●
|
following the closing
of any transaction referred to in the bullet point above, neither we nor any acquiring or surviving entity (or if, in connection
with such transaction shares of our common stock are converted into or exchanged for (in whole or in part) common equity securities
of another entity, such other entity) has a class of common securities (or ADRs representing such securities) listed on the
NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor to the NYSE, the
NYSE AMER or NASDAQ.
|
If we redeem fewer
than all of the outstanding shares of Series A Preferred Stock, the notice of redemption mailed to each record holder of Series
A Depositary Shares will also specify the number of shares of Series A Preferred Stock that we will redeem from such record holder.
In this case, we will determine the number of shares of Series A Preferred Stock to be redeemed on a pro rata basis or by lot.
If we have given a
notice of redemption and have irrevocably set aside sufficient funds for the redemption for the benefit of the holders of the
Series A Depositary Shares representing interests in the Series A Preferred Stock called for redemption, then from and after the
redemption date, those Series A Depositary Shares will be treated as no longer being outstanding, no further dividends will accumulate
on the underlying Series A Preferred Stock and all other rights of the holders of those Series A Depositary Shares will terminate.
If any redemption date is not a business day, then the redemption price and accumulated and unpaid dividends, if any, payable
upon redemption may be paid on the next business day and no interest, additional dividends or other sums will accumulate on the
amount payable for the period from and after that redemption date to that next business day. The holders of those Series A Depositary
Shares will retain their right to receive the redemption price for their underlying shares of Series A Preferred Stock (including
any accumulated and unpaid dividends to but excluding the redemption date).
The holders of Series
A Depositary Shares representing interests in the Series A Preferred Stock at the close of business on a dividend record date
will be entitled to receive the dividend payable with respect to the Series A Preferred Stock on the corresponding payment date
notwithstanding the redemption of the Series A Preferred Stock between such record date and the corresponding payment date or
our default in the payment of the dividend due. Except as provided above, we will make no payment or allowance for unpaid dividends,
whether or not in arrears, on Series A Preferred Stock to be redeemed.
Unless full cumulative
dividends on all shares of Series A Preferred Stock shall have been or contemporaneously are declared and paid or declared and
a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods,
no shares of Series A Preferred Stock shall be redeemed unless all outstanding shares of Series A Preferred Stock are simultaneously
redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Series A Preferred Stock (except
by exchanging it for our capital stock ranking junior to the Series A Preferred Stock as to dividends and upon liquidation); provided,
however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Series A Preferred Stock pursuant
to a purchase or exchange offer made on the same terms to holders of all outstanding Series A Depositary Shares representing interests
in the Series A Preferred Stock.
Conversion Rights
Upon the occurrence
of a Delisting Event or a Change of Control, as applicable, each holder of Series A Depositary Shares representing interests in
the Series A Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Right or Change of Control Conversion
Date, as applicable, we have provided or provide notice of our election to redeem the Series A Depositary Shares or the Series
A Preferred Stock as described above under “— Optional Redemption” or “— Special Optional Redemption”)
to direct the depositary, on such holder’s behalf, to convert some or all of the shares of Series A Preferred Stock underlying
the Series A Depositary Shares held by such holder (the “Delisting Event Conversion Right” or “Change of Control
Conversion Right,” as applicable) on the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable,
into a number of shares of our common stock (or equivalent value of alternative consideration) per depositary share, or the “Common
Stock Conversion Consideration,” equal to the lesser of:
|
●
|
the quotient obtained
by dividing (1) the sum of the $25.00 per depositary share liquidation preference plus the amount of any accumulated and unpaid
dividends to, but not including, the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable (unless
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, is after a record date for a Series
A Preferred Stock dividend payment and prior to the corresponding Series A Preferred Stock dividend payment date, in which
case no additional amount for such accumulated and then remaining unpaid dividend will be included in this sum) by (2) the
Common Stock Price (such quotient, the “Conversion Rate”); and
|
|
●
|
2.176 (i.e., the
Share Cap), subject to certain adjustments described below.
|
The Share Cap is subject
to pro rata adjustments for any share splits (including those effected pursuant to a distribution of shares of our common stock
to existing holders of common stock), subdivisions or combinations (in each case, a “Share Split”) with respect to
our common stock as follows: the adjusted Share Cap as the result of a Share Split will be the number of shares of our common
stock that is equivalent to the product obtained by multiplying (1) the Share Cap in effect immediately prior to such Share Split
by (2) a fraction, the numerator of which is the number of shares of our common stock outstanding after giving effect to such
Share Split and the denominator of which is the number of shares of our common stock outstanding immediately prior to such Share
Split.
In the case of a Delisting
Event or Change of Control pursuant to, or in connection with, which our common stock will be converted into cash, securities
or other property or assets (including any combination thereof) (the “Alternative Form Consideration”), a holder of
Series A Depositary Shares representing interests in Series A Preferred Stock will receive upon conversion of such Series A Preferred
Stock the kind and amount of Alternative Form Consideration which such holder would have owned or been entitled to receive upon
the Delisting Event or Change of Control, as applicable, had such holder held a number of shares of our common stock equal to
the Common Stock Conversion Consideration immediately prior to the effective time of the Delisting Event or Change of Control,
as applicable (the “Alternative Conversion Consideration,” and the Common Stock Conversion Consideration or the Alternative
Conversion Consideration, as may be applicable to a Delisting Event or Change of Control, as applicable, is referred to as the
“Conversion Consideration”).
If the holders of
our common stock have the opportunity to elect the form of consideration to be received in the Delisting Event or Change of Control,
the Conversion Consideration that the holders of the Series A Depositary Shares representing interests in the Series A Preferred
Stock will receive will be the form and proportion of the aggregate consideration elected by the holders of our common stock who
participate in the determination (based on the weighted average of elections) and will be subject to any limitations to which
all holders of our common stock are subject, including, without limitation, pro rata reductions applicable to any portion of the
consideration payable in, or in connection with, the Delisting Event or Change of Control, as applicable.
We will not issue
fractional shares of common stock upon the conversion of the Series A Preferred Stock. Because each depositary share represents
a 1/1000th interest in a share of the Series A Preferred Stock, the number of shares of common stock ultimately received
for each depositary share will be equal to the number of shares of common stock received upon conversion of each share of Series
A Preferred Stock divided by 1000. In the event that the conversion would result in the issuance of fractional shares of common
stock, we will pay the holder of Series A Depositary Shares the cash value of such fractional shares in lieu of such fractional
shares.
Within 15 days following
the occurrence of a Delisting Event or Change of Control, as applicable, we will provide to holders of the Series A Depositary
Shares representing interests in the Series A Preferred Stock a notice of occurrence of the Delisting Event or Change of Control,
as applicable, that describes the resulting Delisting Event Conversion Right or Change of Control Conversion Right, as applicable.
This notice will state the following:
|
●
|
the events constituting
the Delisting Event or Change of Control, as applicable;
|
|
●
|
the date of the
Delisting Event or Change of Control, as applicable;
|
|
●
|
the last date on
which the holders of the Series A Depositary Shares representing interests in the Series A Preferred Stock may exercise their
Delisting Event Conversion Right or Change of Control Conversion Right, as applicable;
|
|
●
|
the method and period
for calculating the Common Stock Price;
|
|
●
|
the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable;
|
|
●
|
that if, prior to
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, we have provided or provide notice
of our election to redeem all or any portion of the Series A Depositary Shares representing interests in the Series A Preferred
Stock, holders will not be able to convert the Series A Depositary Shares representing interests in the Series A Preferred
Stock and such shares will be redeemed on the related redemption date, even if such shares have already been tendered for
conversion pursuant to the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable;
|
|
●
|
if applicable, the
type and amount of Conversion Consideration entitled to be received per share of Series A Preferred Stock;
|
|
●
|
the name and address
of the paying agent and the conversion agent;
|
|
●
|
the procedures that
the holders of the Series A Depositary Shares representing interests in the Series A Preferred Stock must follow to exercise
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable; and
|
|
●
|
the last date on
which holders of the Series A Depositary Shares representing interests in the Series A Preferred Stock may withdraw shares
surrendered for conversion and the procedures that such holders must follow to effect such a withdrawal.
|
We will issue a press
release for publication on the Dow Jones & Company, Inc., Business Wire, PR Newswire or Bloomberg Business News (or, if these
organizations are not in existence at the time of issuance of the press release, such other news or press organization as is reasonably
calculated to broadly disseminate the relevant information to the public), or post notice on our website, in any event prior to
the opening of business on the first business day following any date on which we provide the notice described above to the holders
of the Series A Depositary Shares representing interests in the Series A Preferred Stock.
To exercise the Delisting
Event Conversion Right or Change of Control Conversion Right, as applicable, each holder of Series A Depositary Shares representing
interests in the Series A Preferred Stock will be required to deliver, on or before the close of business on the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable, the depositary receipts or certificates, if any, evidencing
the interests in Series A Preferred Stock to be converted, duly endorsed for transfer, together with a written conversion notice
completed, to the depositary. The conversion notice must state:
|
●
|
the “Delisting
Event Conversion Date” or “Change of Control Conversion Date”, as applicable, which will be a business day
fixed by our board of directors that is not fewer than 20 days nor more than 35 days after the date on which we provide the
notice described above to the holders of the Series A Depositary Shares representing interests in the Series A Preferred Stock;
|
|
●
|
the number of Series
A Depositary Shares representing interests in the shares of Series A Preferred Stock to be converted; and
|
|
●
|
that the Series
A Depositary Shares are to be converted pursuant to the applicable provisions of the Series A Preferred Stock.
|
The “Common
Stock Price” for any Change of Control will be: (1) if the consideration to be received in the Change of Control by the
holders of our common stock is solely cash, the amount of cash consideration per share of common stock; and (2) if the consideration
to be received in the Change of Control by holders of our common stock is other than solely cash (x) the average of the closing
prices for our common stock on the principal U.S. securities exchange on which our common stock is then traded (or, if no closing
sale price is reported, the average of the closing bid and ask prices per share or, if more than one in either case, the average
of the average closing bid and the average closing ask prices per share) for the ten consecutive trading days immediately preceding,
but not including, the date on which such Change of Control occurred as reported on the principal U.S. securities exchange on
which our common stock is then traded, or (y) the average of the last quoted bid prices for our common stock in the over-the-counter
market as reported by OTC Markets Group Inc. or similar organization for the ten consecutive trading days immediately preceding,
but not including, the date on which such Change of Control occurred, if our common stock is not then listed for trading on a
U.S. securities exchange.
The “Common
Stock Price” for any Delisting Event will be the average of the closing price per share of our common stock on the 10 consecutive
trading days immediately preceding, but not including, the effective date of the Delisting Event.
Holders of the Series
A Depositary Shares representing interests in the Series A Preferred Stock may withdraw any notice of exercise of a Delisting
Event Conversion Date or Change of Control Conversion Date, as applicable (in whole or in part), by a written notice of withdrawal
delivered to the depositary prior to the close of business on the business day prior to the Delisting Event Conversion Date or
Change of Control Conversion Date, as applicable. The notice of withdrawal must state:
|
●
|
the number of withdrawn
Series A Depositary Shares;
|
|
●
|
if certificated
Series A Depositary Shares have been issued, the receipt or certificate numbers of the withdrawn Series A Depositary Shares;
and
|
|
●
|
the number of Series
A Depositary Shares, if any, which remain subject to the conversion notice.
|
Notwithstanding the
foregoing, if the Series A Preferred Stock is held in global form, the conversion notice and/or the notice of withdrawal, as applicable,
must comply with applicable procedures of The Depository Trust Company or a similar depositary, and the conversion notice and/or
the notice of withdrawal, as applicable, must comply with applicable procedures, if any, of the applicable depositary.
Shares of Series A
Preferred Stock as to which the Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, has been
properly exercised and for which the conversion notice has not been properly withdrawn will be converted into the applicable Conversion
Consideration in accordance with the Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, on
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, unless prior to the Delisting Event Conversion
Date or Change of Control Conversion Date, as applicable, we have provided or provide notice of our election to redeem such shares
of Series A Preferred Stock, whether pursuant to our optional redemption right or our special optional redemption right. If we
elect to redeem shares of Series A Preferred Stock that would otherwise be converted into the applicable Conversion Consideration
on a Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, such shares of Series A Preferred Stock
will not be so converted and the holders of such shares will be entitled to receive on the applicable redemption date $25,000.00
per share (or $25.00 per depositary share), plus any accumulated and unpaid dividends thereon to, but not including, the redemption
date. See “— Optional Redemption” and “— Special Optional Redemption.”
We will deliver the
applicable Conversion Consideration no later than the third business day following the Delisting Event Conversion Date or Change
of Control Conversion Date, as applicable.
In connection with
the exercise of any Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, we will comply with
all applicable federal and state securities laws and stock exchange rules in connection with any conversion of Series A Preferred
Stock into our common stock.
The Delisting Event
Conversion Right or Change of Control Conversion Right, as applicable, may make it more difficult for a third party to acquire
us or discourage a party from acquiring us.
Neither the Series
A Preferred Stock nor the Series A Depositary Shares are convertible into or exchangeable for any other securities or property,
except as provided above.
Limited Voting Rights
Except as described
below, holders of Series A Depositary Shares will generally have no voting rights. In any matter in which the Series A Preferred
Stock may vote (as expressly provided herein, or as may be required by law), each share of Series A Preferred Stock shall be entitled
to one vote. As a result, each depositary share will be entitled to 1/1000th of a vote.
If dividends on the
Series A Preferred Stock are in arrears, whether or not declared, for six or more quarterly periods, whether or not these quarterly
periods are consecutive, holders of Series A Preferred Stock (voting separately as a class with all other outstanding series of
preferred stock upon which like voting rights have been conferred and are exercisable) will be entitled to vote, at a special
meeting called by the holders of record of at least 10% of any series of preferred stock as to which dividends are so in arrears
or at the next annual meeting of shareholders, for the election of two additional directors to serve on our Board of Directors
until all dividend arrearages have been paid. If and when all accumulated dividends on the Series A Preferred Stock for all past
dividend periods shall have been paid in full, holders of shares of Series A Preferred Stock shall be divested of the voting rights
set forth above (subject to re-vesting in the event of each and every preferred dividend default) and, unless outstanding shares
of parity preferred stock remain entitled to vote in the election of preferred stock directors, the term of office of such preferred
stock directors so elected will terminate and the number of directors will be reduced accordingly.
Any amendment, alteration,
repeal or other change to any provision of our articles of incorporation, including the certificate of designation establishing
the Series A Preferred Stock, whether by merger, consolidation or otherwise, in any manner that would materially and adversely
affect the rights, preferences, powers or privileges of the Series A Preferred Stock cannot be made without the affirmative vote
of holders of at least 66 2/3% of the outstanding shares of Series A Preferred Stock, voting separately
as a class.
In addition, the creation,
issuance or increase in the authorized number of shares of any class or series of stock having a preference as to dividends or
distributions, whether upon liquidation, dissolution, or otherwise, that is senior to the shares of Series A Preferred Stock requires
the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series A Preferred Stock,
voting separately as a class.
The following actions
are not deemed to materially and adversely affect the rights, preferences, powers or privileges of the Series A Preferred Stock:
|
●
|
any increase in
the amount of our authorized common stock or preferred stock or the creation or issuance of equity securities of any class
or series ranking, as to dividends or liquidation preference, on a parity with, or junior to, the Series A Preferred Stock;
or
|
|
●
|
the amendment, alteration
or repeal or change of any provision of our articles of incorporation, including the certificate of designation establishing
the Series A Preferred Stock, as a result of a merger, consolidation, reorganization or other business combination, if the
Series A Preferred Stock (or shares into which the Series A Preferred Stock have been converted in any successor entity to
us) remain outstanding with the terms thereof materially unchanged.
|
No Maturity, Sinking Fund or Mandatory Redemption
The Series A Preferred
Stock has no maturity date and we are not required to redeem the Series A Preferred Stock at any time. Accordingly, the Series
A Preferred Stock will remain outstanding indefinitely, unless we decide, at our option, to exercise our redemption right or,
under circumstances where the holders of the Series A Depositary Shares representing interests in the Series A Preferred Stock
have a conversion right, such holders convert the Series A Preferred Stock into our common stock. The Series A Preferred Stock
is not subject to any sinking fund.
Surrender of Series A Depositary Shares for Shares of Series
A Preferred Stock
Under certain circumstances,
holders may be required to surrender depositary receipts to the depositary or us. In the event of such a surrender of Series A
Depositary Shares, the holder will be entitled to receive the number of whole or fractional shares of Series A Preferred Stock
represented by the Series A Depositary Shares. See “Description of Depositary Shares — Withdrawal of Stock”
and “— Amendment and Termination of the Deposit Agreement” in the accompanying prospectus.
Series A Depositary Share Listing
The Series A Depositary
Shares are listed on NASDAQ under the symbol “RILYP.” The Series A Preferred Stock underlying the Series A Depositary
Shares will not be listed, and we do not expect any trading market will develop for the Series A Preferred Stock except as represented
by the Series A Depositary Shares.
Depositary
The depositary for
the Series A Preferred Stock is Continental Stock Transfer & Trust Company.
DESCRIPTION OF SERIES B PREFERRED STOCK
AND THE SERIES B DEPOSITARY SHARES
The following is a summary of the material
terms and provisions of the Series B Preferred Stock and the Depositary Shares. The statements below describing our Series B Preferred
Stock are in all respects subject to and qualified in their entirety by reference to the applicable provisions of our articles
of incorporation, including the certificate of designation establishing the Series B Preferred Stock, and our bylaws, each of
which is available from us as described in the “Where You Can Find More Information” section of this prospectus supplement
and is incorporated by reference in this prospectus supplement. See also “Description of Depositary Shares” in the
accompanying prospectus. This description of the particular terms of the Series B Preferred Stock and the Series B Depositary
Shares supplements the description of the general terms and provisions of our preferred stock set forth in the accompanying prospectus
under “Description of Preferred Stock” and under “Description of Depositary Shares.” For a description
of the common stock into which the Series B Preferred Stock is convertible, see “Description of Capital Stock — Common
Stock” in the accompanying prospectus.
General
Our Amended and Restated
Certificate of Incorporation, provides that we are authorized to issue 101,000,000 shares of capital stock. Our authorized capital
stock is comprised of 100,000,000 shares of common stock, $0.0001 par value per share, and 1,000,000 shares of preferred stock,
par value $0.0001 per share.
Shares of preferred
stock and related depositary shares may be offered and sold from time to time, in one or more series, as authorized by our Board
of Directors. Our Board of Directors is authorized to set for each series of preferred stock and related depositary shares the
terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to distributions, qualifications and
terms or conditions of redemption. The Series B Preferred Stock is being issued pursuant to the certificate of designation that
sets forth the terms of a series of preferred stock consisting of up to 10,000 shares, designated 7.375% Series B Cumulative Perpetual
Preferred Stock.
The depositary for
the Series B Preferred Stock is Continental Stock Transfer & Trust Company.
Each depositary share
represents a 1/1000th fractional interest in a share of Series B Preferred Stock. The Series B Preferred Stock underlying
the Series B Depositary Shares will be deposited with Continental Stock Transfer & Trust Company, as depositary, under a deposit
agreement among us, the depositary and the holders from time to time of the depositary receipts issued by the depositary under
the deposit agreement. The Series B Depositary Shares will be evidenced by depositary receipts issued pursuant to the deposit
agreement. Subject to the terms of the deposit agreement, each record holder of depositary receipts evidencing Series B Depositary
Shares will be entitled, proportionately, to all the rights and preferences of, and subject to all of the limitations of, the
interest in the Series B Preferred Stock underlying the Series B Depositary Shares (including dividend, voting, redemption and
liquidation rights and preferences).
Ranking
The Series B Preferred
Stock represented by the Series B Depositary Shares will, as to dividend rights and rights upon our liquidation, dissolution or
winding-up, rank:
|
(1)
|
Senior to all classes or series of our common stock and
to all other equity securities issued by us expressly designated as ranking junior to the Series B Preferred Stock;
|
|
|
|
|
(2)
|
On parity with our Series A Preferred Stock, and with
any future class or series of our equity securities expressly designated as ranking on parity with the Series B Preferred Stock;
|
|
|
|
|
(3)
|
Junior to all equity securities issued by us with terms
specifically providing that those equity securities rank senior to the Series B Preferred Stock with respect to the payment of
dividends and the distribution of assets upon our liquidation, dissolution or winding up, none of which exists on the date hereof;
and
|
|
|
|
|
(4)
|
Effectively junior to all our existing and future indebtedness
(including indebtedness convertible into our common stock or preferred stock) and to the indebtedness and other liabilities of
(as well as any preferred equity interests held by others in) our existing or future subsidiaries.
|
Dividends
Holders of Series
B Depositary Shares representing interests in the Series B Preferred Stock will be entitled to receive, when and as declared by
our Board of Directors, out of funds legally available for the payment of dividends, cumulative cash dividends at the rate of
7.375% of the $25,000.00 liquidation preference ($25.00 per depositary share) per year (equivalent to $1,843.75 per year or $1.84375
per year per depositary share). Dividends on the Series B Preferred Stock will accumulate and be cumulative from, and including,
the date of original issue by us of the Series B Preferred Stock. Dividends will be payable quarterly in arrears on or about the
last day of January, April, July and October; provided that if any dividend payment date is not a business day, as defined in
the certificate of designation, then the dividend which would otherwise have been payable on that dividend payment date may be
paid on the next succeeding business day and no interest, additional dividends or other sums will accumulate on the amounts so
payable for the period from and after that dividend payment date to that next succeeding business day. Whenever we pay dividends
on the Series B Preferred Stock held by the depositary, the depositary will pay dividends on the same date on the Series B Depositary
Shares. We refer to each such date as a Dividend Payment Date.
Any dividend, including
any dividend payable on the Series B Preferred Stock for any partial dividend period, will be computed on the basis of a 360-day
year consisting of twelve 30-day months. Dividends are payable to holders of record of Series B Depositary Shares as they appear
in the depositary’s records at the close of business on the applicable record date, which will be the date that our Board
of Directors designates for the payment of a dividend that is not more than 30 nor less than 10 days prior to the Dividend Payment
Date, which we refer to as a Dividend Payment Record Date.
Our Board of Directors
will not authorize, pay or set apart for payment by us any dividend on the Series B Preferred Stock at any time that:
|
●
|
the terms and provisions
of any of our agreements, including any agreement relating to our indebtedness, prohibits such authorization, payment or setting
apart for payment;
|
|
●
|
the terms and provisions
of any of our agreements, including any agreement relating to our indebtedness, provides that such authorization, payment
or setting apart for payment thereof would constitute a breach of, or a default under, such agreement; or
|
|
●
|
the law restricts
or prohibits the authorization or payment.
|
Notwithstanding the
foregoing, dividends on the Series B Preferred Stock will accumulate whether or not:
|
●
|
the terms and provisions
of any of our agreements relating to our indebtedness prohibit such authorization, payment or setting apart for payment;
|
|
●
|
there are funds
legally available for the payment of the dividends; and
|
|
●
|
the dividends are
authorized.
|
No interest, or sums
in lieu of interest, will be payable in respect of any dividend payment or payments on the Series B Preferred Stock, which may
be in arrears, and holders of the Series B Preferred Stock will not be entitled to any dividends in excess of the full cumulative
dividends described above. Any dividend payment made on the Series B Preferred Stock shall first be credited against the earliest
accumulated but unpaid dividends due with respect to those shares.
If, for any taxable
year, we elect to designate as “capital gain dividends” (as defined in Section 857 of the Internal Revenue Code of
1986, as amended, which we refer to as the Code) a portion, which we refer to as the Capital Gains Amount, of the dividends not
in excess of our earning and profits that are paid or made available for the year to the holders of all classes of shares, or
the Total Dividends, then the portion of the Capital Gains Amount that will be allocable to the holders of Series B Depositary
Shares will be the Capital Gains Amount multiplied by a fraction, the numerator of which will be the total dividends (within the
meaning of the Code) paid or made available to the holders of Series B Depositary Shares for the year and the denominator of which
will be the Total Dividends.
We will not pay or
declare and set apart for payment any dividends (other than a dividend paid in common stock or other stock ranking junior to the
Series B Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution
or winding up) or declare or make any distribution of cash or other property on common stock or other stock that ranks junior
to or on parity with the Series B Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary
liquidation, dissolution or winding up or redeem or otherwise acquire common stock or other stock that ranks junior to or on parity
with the Series B Preferred Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution
or winding up (except (i) by conversion into or exchange for common stock or other stock ranking junior to the Series B Preferred
Stock with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution or winding up, (ii)
for the redemption of shares of our stock pursuant to the provisions of our charter relating to the restrictions upon ownership
and transfer of our stock and (iii) for a purchase or exchange offer made on the same terms to holders of all outstanding shares
of Series B Preferred Stock and any other stock that ranks on parity with the Series B Preferred Stock with respect to dividend
rights and rights upon our voluntary or involuntary liquidation, dissolution or winding up), unless we also have either paid or
declared and set apart for payment full cumulative dividends on the Series B Preferred Stock for all past dividend periods.
Notwithstanding the
foregoing, if we do not either pay or declare and set apart for payment full cumulative dividends on the Series B Preferred Stock
and all stock that ranks on parity with the Series B Preferred Stock with respect to dividends, the amount which we have declared
will be allocated pro rata to the holders of Series B Preferred Stock and to each equally ranked class or series of stock, so
that the amount declared for each share of Series B Preferred Stock and for each share of each equally ranked class or series
of stock is proportionate to the accrued and unpaid dividends on those shares. Any dividend payment made on the Series B Preferred
Stock will first be credited against the earliest accrued and unpaid dividend.
Liquidation Preference
In the event of any
voluntary or involuntary liquidation, dissolution or winding up of our affairs, the holders of shares of Series B Preferred Stock
are entitled to be paid out of our assets legally available for distribution to our shareholders a liquidation preference of $25,000.00
per share (or $25.00 per depositary share), plus an amount equal to any accumulated and unpaid dividends to the date of payment
(whether or not declared), before any distribution or payment may be made to holders of shares of common stock or any other class
or series of our equity stock ranking, as to liquidation rights, junior to the Series B Preferred Stock.
If, upon our voluntary
or involuntary liquidation, dissolution or winding up, our available assets are insufficient to pay the full amount of the liquidating
distributions on all outstanding shares of Series B Preferred Stock and the corresponding amounts payable on all shares of each
other class or series of capital stock ranking, as to liquidation rights, on a parity with the Series B Preferred Stock, then
the holders of the Series B Preferred Stock and each such other class or series of capital stock ranking, as to liquidation rights,
on a parity with the Series B Preferred Stock will share ratably in any distribution of assets in proportion to the full liquidating
distributions to which they would otherwise be respectively entitled. Holders of Series B Preferred Stock will be entitled to
written notice of any liquidation no fewer than 30 days and no more than 60 days prior to the payment date. After payment of the
full amount of the liquidating distributions to which they are entitled, the holders of Series B Preferred Stock and Series B
Depositary Shares will have no right or claim to any of our remaining assets.
Our consolidation
or merger with or into any other entity or the sale, lease, transfer or conveyance of all or substantially all of our property
or business will not be deemed to constitute our liquidation, dissolution or winding up. The Series B Preferred Stock will rank
senior to the common stock as to priority for receiving liquidating distributions and on a parity with any existing and future
equity securities which, by their terms, rank on a parity with the Series B Preferred Stock.
Optional Redemption
The Series B Preferred
Stock is not redeemable prior to September 4, 2025, except under the circumstances described below. On or after September 4, 2025,
the Series B Preferred Stock may be redeemed at our option, in whole or in part, from time to time, at a redemption price of $25,000.00
per share ($25.00 per depositary share), plus all dividends accumulated and unpaid (whether or not declared) on the Series B Preferred
Stock up to, but not including, the date of such redemption, upon the giving of notice, as provided below. Whenever we redeem
shares of our Series B Preferred Stock held by the depositary, the depositary will redeem as of the same redemption date a number
of Series B Depositary Shares representing the shares so redeemed and the depositary receipts evidencing such Series B Depositary
Shares.
If fewer than all
of the outstanding shares of Series B Preferred Stock are to be redeemed, the shares to be redeemed will be determined pro rata
or by lot.
We shall give the
depositary not less than 30 nor more than 60 days prior written notice of redemption of the deposited Series B Preferred Stock.
A similar notice of redemption will be mailed by the depositary not less than 30 nor more than 60 days prior to the date fixed
for redemption to each holder of record of Series B Depositary Shares that is to be redeemed. The notice will notify the holder
of the election to redeem the shares and will state at least the following:
|
●
|
the date fixed for
redemption thereof, which we refer to as the Redemption Date;
|
|
●
|
the number of shares
of Series B Preferred Stock and Series B Depositary Shares to be redeemed (and, if fewer than all the shares are to be redeemed,
the number of shares to be redeemed from such holder);
|
|
●
|
the place(s) where
the depositary receipts evidencing the Series B Depositary Shares are to be surrendered for payment; and
|
|
●
|
that dividends on
the Series B Depositary Shares will cease to accumulate on the date prior to the Redemption Date.
|
On or after the Redemption
Date, each holder of Series B Depositary Shares to be redeemed must present and surrender the depositary receipts evidencing the
Series B Depositary Shares to the depositary at the place designated in the notice of redemption. The redemption price of the
shares will then be paid to or on the order of the person whose name appears on such depositary receipts as the owner thereof.
Each surrendered depositary receipt will be canceled. In the event that fewer than all the depositary receipts are to be redeemed,
a new depositary receipt will be issued representing the unredeemed Series B Depositary Shares.
From and after the
Redemption Date (unless we default in payment of the redemption price):
|
●
|
all dividends on
the shares designated for redemption in the notice will cease to accumulate;
|
|
●
|
all rights of the
holders of the shares, except the right to receive the redemption price thereof (including all accumulated and unpaid dividends
up to the date prior to the Redemption Date), will cease and terminate;
|
|
●
|
the shares will
not thereafter be transferred (except with our consent) on the depositary’s books; and
|
|
●
|
the shares will
not be deemed to be outstanding for any purpose whatsoever.
|
Unless full cumulative
dividends on all shares of Series B Preferred Stock shall have been or contemporaneously are declared and paid or declared and
a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods,
no shares of Series B Preferred Stock shall be redeemed unless all outstanding shares of Series B Preferred Stock are simultaneously
redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Series B Preferred Stock (except
by exchanging it for our capital stock ranking junior to the Series B Preferred Stock as to dividends and upon liquidation); provided,
however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Series B Preferred Stock pursuant
to a purchase or exchange offer made on the same terms to holders of all outstanding Series B Depositary Shares representing interests
in the Series B Preferred Stock.
Special Optional Redemption
During any period
of time (whether before or after September 4, 2025) that both (i) the Series B Preferred Stock (or the Series B Depositary Shares)
are no longer listed on the NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor
to the NYSE, the NYSE AMER or NASDAQ, and (ii) we are not subject to the reporting requirements of the Exchange Act, but any Series
B Preferred Stock is still outstanding (which we refer to collectively as a “Delisting Event”), we may, at our option,
redeem the Series B Preferred Stock, in whole or in part and within 90 days after the date of the Delisting Event, by paying $25,000.00
per share (equivalent to $25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date
of redemption.
In addition, upon
the occurrence of a Change of Control (defined below), we may, at our option, redeem the Series B Preferred Stock, in whole or
in part and within 120 days after the first date on which such Change of Control occurred, by paying $25,000.00 per share (equivalent
to $25.00 per depositary share), plus any accumulated and unpaid dividends to, but not including, the date of redemption (other
than any dividend with a record date before the applicable redemption date and a payment date after the applicable redemption
date, which will be paid on the payment date notwithstanding prior redemption of such shares).
If, prior to the Delisting
Event Conversion Date or Change of Control Conversion Date (each as defined below), as applicable, we have provided or provide
notice of redemption with respect to the Series B Preferred Stock (whether pursuant to our optional redemption right described
above or our special optional redemption), the holders of Series B Depositary Shares representing interests in the Series B Preferred
Stock will not be permitted to exercise the conversion right described below under “— Conversion Rights” in
respect of their shares called for redemption.
The depositary will
mail to you, if you are a record holder of the Series B Depositary Shares representing interests in the Series B Preferred Stock,
a notice of redemption, furnished by us, no fewer than 30 days nor more than 60 days before the redemption date. The depositary
will send the notice to your address shown on the records of the depositary. No failure to give the notice or any defect in the
notice or in the mailing of the notice will affect the validity of the proceedings for the redemption of any Series B Depositary
Shares or shares of our Series B Preferred Stock except as to a holder to whom notice was defective or not given. Each notice
will state the following:
|
●
|
the number of Series
B Depositary Shares representing interests in the Series B Preferred Stock to be redeemed;
|
|
●
|
the place(s) where
the depositary receipts (or Series B Preferred Stock certificates, if no longer held in depositary form) are to be surrendered
for payment;
|
|
●
|
that the Series
B Preferred Stock is being redeemed pursuant to our special optional redemption right in connection with the occurrence of
a Delisting Event or Change of Control, as applicable, and a brief description of the transaction or transactions or circumstances
constituting such Delisting Event or Change of Control, as applicable;
|
|
●
|
that the holders
of Series B Depositary Shares representing interests in the Series B Preferred Stock to which the notice relates will not
be able to convert such shares of Series B Preferred Stock in connection with the Delisting Event or Change of Control, as
applicable, and each share of Series B Preferred Stock tendered for conversion that is selected, prior to the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable, for redemption will be redeemed on the related date of
redemption instead of converted on the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable;
and
|
|
●
|
that dividends on
the Series B Preferred Stock to be redeemed will cease to accumulate on the date prior to the redemption date.
|
A “Change of
Control” is when, after the original issuance of the Series B Preferred Stock, the following have occurred and are continuing:
|
●
|
the acquisition
by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange
Act of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series
of purchases, mergers or other acquisition transactions of shares of our company entitling that person to exercise more than
50% of the total voting power of all shares of our company entitled to vote generally in elections of directors (except that
such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire, whether
such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
|
|
●
|
following the closing
of any transaction referred to in the bullet point above, neither we nor any acquiring or surviving entity (or if, in connection
with such transaction shares of our common stock are converted into or exchanged for (in whole or in part) common equity securities
of another entity, such other entity) has a class of common securities (or ADRs representing such securities) listed on the
NYSE, the NYSE AMER or NASDAQ, or listed or quoted on an exchange or quotation system that is a successor to the NYSE, the
NYSE AMER or NASDAQ.
|
If we redeem fewer
than all of the outstanding shares of Series B Preferred Stock, the notice of redemption mailed to each record holder of Series
B Depositary Shares will also specify the number of shares of Series B Preferred Stock that we will redeem from such record holder.
In this case, we will determine the number of shares of Series B Preferred Stock to be redeemed on a pro rata basis or by lot.
If we have given a
notice of redemption and have irrevocably set aside sufficient funds for the redemption for the benefit of the holders of the
Series B Depositary Shares representing interests in the Series B Preferred Stock called for redemption, then from and after the
redemption date, those Series B Depositary Shares will be treated as no longer being outstanding, no further dividends will accumulate
on the underlying Series B Preferred Stock and all other rights of the holders of those Series B Depositary Shares will terminate.
If any redemption date is not a business day, then the redemption price and accumulated and unpaid dividends, if any, payable
upon redemption may be paid on the next business day and no interest, additional dividends or other sums will accumulate on the
amount payable for the period from and after that redemption date to that next business day. The holders of those Series B Depositary
Shares will retain their right to receive the redemption price for their underlying shares of Series B Preferred Stock (including
any accumulated and unpaid dividends to but excluding the redemption date).
The holders of Series
B Depositary Shares representing interests in the Series B Preferred Stock at the close of business on a dividend record date
will be entitled to receive the dividend payable with respect to the Series B Preferred Stock on the corresponding payment date
notwithstanding the redemption of the Series B Preferred Stock between such record date and the corresponding payment date or
our default in the payment of the dividend due. Except as provided above, we will make no payment or allowance for unpaid dividends,
whether or not in arrears, on Series B Preferred Stock to be redeemed.
Unless full cumulative
dividends on all shares of Series B Preferred Stock shall have been or contemporaneously are declared and paid or declared and
a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods,
no shares of Series B Preferred Stock shall be redeemed unless all outstanding shares of Series B Preferred Stock are simultaneously
redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Series B Preferred Stock (except
by exchanging it for our capital stock ranking junior to the Series B Preferred Stock as to dividends and upon liquidation); provided,
however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Series B Preferred Stock pursuant
to a purchase or exchange offer made on the same terms to holders of all outstanding Series B Depositary Shares representing interests
in the Series B Preferred Stock.
Conversion Rights
Upon the occurrence
of a Delisting Event or a Change of Control, as applicable, each holder of Series B Depositary Shares representing interests in
the Series B Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Right or Change of Control Conversion
Date, as applicable, we have provided or provide notice of our election to redeem the Series B Depositary Shares or the Series
B Preferred Stock) to direct the depositary, on such holder’s behalf, to convert some or all of the shares of Series B Preferred
Stock underlying the Series B Depositary Shares held by such holder (the “Delisting Event Conversion Right” or “Change
of Control Conversion Right,” as applicable) on the Delisting Event Conversion Date or Change of Control Conversion Date,
as applicable, into a number of shares of our common stock (or equivalent value of alternative consideration) per depositary share,
or the “Common Stock Conversion Consideration,” equal to the lesser of:
|
●
|
the quotient obtained
by dividing (1) the sum of the $25.00 per depositary share liquidation preference plus the amount of any accumulated and unpaid
dividends to, but not including, the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable (unless
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, is after a record date for a Series
B Preferred Stock dividend payment and prior to the corresponding Series B Preferred Stock dividend payment date, in which
case no additional amount for such accumulated and then remaining unpaid dividend will be included in this sum) by (2) the
Common Stock Price (such quotient, the “Conversion Rate”); and
|
|
●
|
1.8671 (i.e., the
Share Cap), subject to certain adjustments described below.
|
The Share Cap is subject
to pro rata adjustments for any share splits (including those effected pursuant to a distribution of shares of our common stock
to existing holders of common stock), subdivisions or combinations (in each case, a “Share Split”) with respect to
our common stock as follows: the adjusted Share Cap as the result of a Share Split will be the number of shares of our common
stock that is equivalent to the product obtained by multiplying (1) the Share Cap in effect immediately prior to such Share Split
by (2) a fraction, the numerator of which is the number of shares of our common stock outstanding after giving effect to such
Share Split and the denominator of which is the number of shares of our common stock outstanding immediately prior to such Share
Split.
In the case of a Delisting
Event or Change of Control pursuant to, or in connection with, which our common stock will be converted into cash, securities
or other property or assets (including any combination thereof) (the “Alternative Form Consideration”), a holder of
Series B Depositary Shares representing interests in Series B Preferred Stock will receive upon conversion of such Series B Preferred
Stock the kind and amount of Alternative Form Consideration which such holder would have owned or been entitled to receive upon
the Delisting Event or Change of Control, as applicable, had such holder held a number of shares of our common stock equal to
the Common Stock Conversion Consideration immediately prior to the effective time of the Delisting Event or Change of Control,
as applicable (the “Alternative Conversion Consideration,” and the Common Stock Conversion Consideration or the Alternative
Conversion Consideration, as may be applicable to a Delisting Event or Change of Control, as applicable, is referred to as the
“Conversion Consideration”).
If the holders of
our common stock have the opportunity to elect the form of consideration to be received in the Delisting Event or Change of Control,
the Conversion Consideration that the holders of the Series B Depositary Shares representing interests in the Series B Preferred
Stock will receive will be the form and proportion of the aggregate consideration elected by the holders of our common stock who
participate in the determination (based on the weighted average of elections) and will be subject to any limitations to which
all holders of our common stock are subject, including, without limitation, pro rata reductions applicable to any portion of the
consideration payable in, or in connection with, the Delisting Event or Change of Control, as applicable.
We will not issue
fractional shares of common stock upon the conversion of the Series B Preferred Stock. Because each depositary share represents
a 1/1000th interest in a share of the Series B Preferred Stock, the number of shares of common stock ultimately received
for each depositary share will be equal to the number of shares of common stock received upon conversion of each share of Series
B Preferred Stock divided by 1000. In the event that the conversion would result in the issuance of fractional shares of common
stock, we will pay the holder of Series B Depositary Shares the cash value of such fractional shares in lieu of such fractional
shares.
Within 15 days following
the occurrence of a Delisting Event or Change of Control, as applicable, we will provide to holders of the Series B Depositary
Shares representing interests in the Series B Preferred Stock a notice of occurrence of the Delisting Event or Change of Control,
as applicable, that describes the resulting Delisting Event Conversion Right or Change of Control Conversion Right, as applicable.
This notice will state the following:
|
●
|
the events constituting
the Delisting Event or Change of Control, as applicable;
|
|
●
|
the date of the
Delisting Event or Change of Control, as applicable;
|
|
●
|
the last date on
which the holders of the Series B Depositary Shares representing interests in the Series B Preferred Stock may exercise their
Delisting Event Conversion Right or Change of Control Conversion Right, as applicable;
|
|
●
|
the method and period
for calculating the Common Stock Price;
|
|
●
|
the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable;
|
|
●
|
that if, prior to
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, we have provided or provide notice
of our election to redeem all or any portion of the Series B Depositary Shares representing interests in the Series B Preferred
Stock, holders will not be able to convert the Series B Depositary Shares representing interests in the Series B Preferred
Stock and such shares will be redeemed on the related redemption date, even if such shares have already been tendered for
conversion pursuant to the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable;
|
|
●
|
if applicable, the
type and amount of Conversion Consideration entitled to be received per share of Series B Preferred Stock;
|
|
●
|
the name and address
of the paying agent and the conversion agent;
|
|
●
|
the procedures that
the holders of the Series B Depositary Shares representing interests in the Series B Preferred Stock must follow to exercise
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable; and
|
|
●
|
the last date on
which holders of the Series B Depositary Shares representing interests in the Series B Preferred Stock may withdraw shares
surrendered for conversion and the procedures that such holders must follow to effect such a withdrawal.
|
We will issue a press
release for publication on the Dow Jones & Company, Inc., Business Wire, PR Newswire or Bloomberg Business News (or, if these
organizations are not in existence at the time of issuance of the press release, such other news or press organization as is reasonably
calculated to broadly disseminate the relevant information to the public), or post notice on our website, in any event prior to
the opening of business on the first business day following any date on which we provide the notice described above to the holders
of the Series B Depositary Shares representing interests in the Series B Preferred Stock.
To exercise the Delisting
Event Conversion Right or Change of Control Conversion Right, as applicable, each holder of Series B Depositary Shares representing
interests in the Series B Preferred Stock will be required to deliver, on or before the close of business on the Delisting Event
Conversion Date or Change of Control Conversion Date, as applicable, the depositary receipts or certificates, if any, evidencing
the interests in Series B Preferred Stock to be converted, duly endorsed for transfer, together with a written conversion notice
completed, to the depositary. The conversion notice must state:
|
●
|
the “Delisting
Event Conversion Date” or “Change of Control Conversion Date”, as applicable, which will be a business day
fixed by our board of directors that is not fewer than 20 days nor more than 35 days after the date on which we provide the
notice described above to the holders of the Series B Depositary Shares representing interests in the Series B Preferred Stock;
|
|
●
|
the number of Series
B Depositary Shares representing interests in the shares of Series B Preferred Stock to be converted; and
|
|
●
|
that the Series
B Depositary Shares are to be converted pursuant to the applicable provisions of the Series B Preferred Stock.
|
The “Common
Stock Price” for any Change of Control will be: (1) if the consideration to be received in the Change of Control by the
holders of our common stock is solely cash, the amount of cash consideration per share of common stock; and (2) if the consideration
to be received in the Change of Control by holders of our common stock is other than solely cash (x) the average of the closing
prices for our common stock on the principal U.S. securities exchange on which our common stock is then traded (or, if no closing
sale price is reported, the average of the closing bid and ask prices per share or, if more than one in either case, the average
of the average closing bid and the average closing ask prices per share) for the ten consecutive trading days immediately preceding,
but not including, the date on which such Change of Control occurred as reported on the principal U.S. securities exchange on
which our common stock is then traded, or (y) the average of the last quoted bid prices for our common stock in the over-the-counter
market as reported by OTC Markets Group Inc. or similar organization for the ten consecutive trading days immediately preceding,
but not including, the date on which such Change of Control occurred, if our common stock is not then listed for trading on a
U.S. securities exchange.
The “Common
Stock Price” for any Delisting Event will be the average of the closing price per share of our common stock on the 10 consecutive
trading days immediately preceding, but not including, the effective date of the Delisting Event.
Holders of the Series
B Depositary Shares representing interests in the Series B Preferred Stock may withdraw any notice of exercise of a Delisting
Event Conversion Date or Change of Control Conversion Date, as applicable (in whole or in part), by a written notice of withdrawal
delivered to the depositary prior to the close of business on the business day prior to the Delisting Event Conversion Date or
Change of Control Conversion Date, as applicable. The notice of withdrawal must state:
|
●
|
the number of withdrawn
Series B Depositary Shares;
|
|
●
|
if certificated
Series B Depositary Shares have been issued, the receipt or certificate numbers of the withdrawn Series B Depositary Shares;
and
|
|
●
|
the number of Series
B Depositary Shares, if any, which remain subject to the conversion notice.
|
Notwithstanding the
foregoing, if the Series B Preferred Stock is held in global form, the conversion notice and/or the notice of withdrawal, as applicable,
must comply with applicable procedures of The Depository Trust Company or a similar depositary, and the conversion notice and/or
the notice of withdrawal, as applicable, must comply with applicable procedures, if any, of the applicable depositary.
Shares of Series B
Preferred Stock as to which the Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, has been
properly exercised and for which the conversion notice has not been properly withdrawn will be converted into the applicable Conversion
Consideration in accordance with the Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, on
the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, unless prior to the Delisting Event Conversion
Date or Change of Control Conversion Date, as applicable, we have provided or provide notice of our election to redeem such shares
of Series B Preferred Stock, whether pursuant to our optional redemption right or our special optional redemption right. If we
elect to redeem shares of Series B Preferred Stock that would otherwise be converted into the applicable Conversion Consideration
on a Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, such shares of Series B Preferred Stock
will not be so converted and the holders of such shares will be entitled to receive on the applicable redemption date $25,000.00
per share (or $25.00 per depositary share), plus any accumulated and unpaid dividends thereon to, but not including, the redemption
date. See “— Optional Redemption” and “— Special Optional Redemption.”
We will deliver the
applicable Conversion Consideration no later than the third business day following the Delisting Event Conversion Date or Change
of Control Conversion Date, as applicable.
In connection with
the exercise of any Delisting Event Conversion Right or Change of Control Conversion Right, as applicable, we will comply with
all applicable federal and state securities laws and stock exchange rules in connection with any conversion of Series B Preferred
Stock into our common stock.
The Delisting Event
Conversion Right or Change of Control Conversion Right, as applicable, may make it more difficult for a third party to acquire
us or discourage a party from acquiring us.
Neither the Series
B Preferred Stock nor the Series B Depositary Shares are convertible into or exchangeable for any other securities or property,
except as provided above.
Limited Voting Rights
Except as described
below, holders of Series B Depositary Shares will generally have no voting rights. In any matter in which the Series B Preferred
Stock may vote (as expressly provided herein, or as may be required by law), each share of Series B Preferred Stock shall be entitled
to one vote. As a result, each depositary share will be entitled to 1/1000th of a vote.
If dividends on the
Series B Preferred Stock are in arrears, whether or not declared, for six or more quarterly periods, whether or not these quarterly
periods are consecutive, holders of Series B Preferred Stock (voting separately as a class with all other outstanding series of
preferred stock upon which like voting rights have been conferred and are exercisable) will be entitled to vote, at a special
meeting called by the holders of record of at least 10% of any series of preferred stock as to which dividends are so in arrears
or at the next annual meeting of shareholders, for the election of two additional directors to serve on our Board of Directors
until all dividend arrearages have been paid. If and when all accumulated dividends on the Series B Preferred Stock for all past
dividend periods shall have been paid in full, holders of shares of Series B Preferred Stock shall be divested of the voting rights
set forth above (subject to re-vesting in the event of each and every preferred dividend default) and, unless outstanding shares
of parity preferred stock remain entitled to vote in the election of preferred stock directors, the term of office of such preferred
stock directors so elected will terminate and the number of directors will be reduced accordingly.
Any amendment, alteration,
repeal or other change to any provision of our articles of incorporation, including the certificate of designation establishing
the Series B Preferred Stock, whether by merger, consolidation or otherwise, in any manner that would materially and adversely
affect the rights, preferences, powers or privileges of the Series B Preferred Stock cannot be made without the affirmative vote
of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock, voting separately
as a class.
In addition, the creation,
issuance or increase in the authorized number of shares of any class or series of stock having a preference as to dividends or
distributions, whether upon liquidation, dissolution, or otherwise, that is senior to the shares of Series B Preferred Stock requires
the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock,
voting separately as a class.
The following actions
are not deemed to materially and adversely affect the rights, preferences, powers or privileges of the Series B Preferred Stock:
|
●
|
any increase in
the amount of our authorized common stock or preferred stock or the creation or issuance of equity securities of any class
or series ranking, as to dividends or liquidation preference, on a parity with, or junior to, the Series B Preferred Stock;
or
|
|
●
|
the amendment, alteration
or repeal or change of any provision of our articles of incorporation, including the certificate of designation establishing
the Series B Preferred Stock, as a result of a merger, consolidation, reorganization or other business combination, if the
Series B Preferred Stock (or shares into which the Series B Preferred Stock have been converted in any successor entity to
us) remain outstanding with the terms thereof materially unchanged.
|
No Maturity, Sinking Fund or Mandatory Redemption
The Series B Preferred
Stock has no maturity date and we are not required to redeem the Series B Preferred Stock at any time. Accordingly, the Series
B Preferred Stock will remain outstanding indefinitely, unless we decide, at our option, to exercise our redemption right or,
under circumstances where the holders of the Series B Depositary Shares representing interests in the Series B Preferred Stock
have a conversion right, such holders convert the Series B Preferred Stock into our common stock. The Series B Preferred Stock
is not subject to any sinking fund.
Surrender of Series B Depositary Shares for Shares of Series
B Preferred Stock
Under certain circumstances,
holders may be required to surrender depositary receipts to the depositary or us. In the event of such a surrender of Series B
Depositary Shares, the holder will be entitled to receive the number of whole or fractional shares of Series B Preferred Stock
represented by the Series B Depositary Shares. See “Description of Depositary Shares — Withdrawal of Stock”
and “— Amendment and Termination of the Deposit Agreement” in the accompanying prospectus.
Depositary Share Listing
The Series B Depositary
Shares are listed on NASDAQ under the symbol “RILYL.” The Series B Preferred Stock underlying the Series B Depositary
Shares will not be listed, and we do not expect any trading market will develop for the Series B Preferred Stock except as represented
by the Series B Depositary Shares.
Depositary
The depositary for
the Series B Preferred Stock is Continental Stock Transfer & Trust Company.
Book-Entry, Delivery and Form for Depositary Shares
The depositary shares
will be issued in fully registered form in the name of Cede & Co., as nominee of The Depository Trust Company (“DTC”).
One or more fully registered global depositary receipts will be issued representing in the aggregate the total number of the depositary
shares. Such global depositary receipt will be deposited with or on behalf of DTC and may not be transferred except as a whole
by DTC to a nominee of DTC or by a nominee of DTC to DTC or another nominee of DTC or by DTC or any nominee to a successor of
DTC or a nominee of such successor.
So long as DTC, or
its nominee, is the registered owner of a global depositary receipt, DTC or such nominee, as the case may be, will be considered
the sole owner or holder of the depositary shares represented by such global depositary receipts for all purposes under the Deposit
Agreement. Except as set forth in the accompanying prospectus, owners of beneficial interests in a global depositary receipt will
not be entitled to have the depositary shares represented by such global receipt registered in their names, will not receive or
be entitled to receive physical delivery of such depositary shares in definitive form and will not be considered the owners or
holders thereof. Accordingly, each person owning a beneficial interest in a global note must rely on the procedures of DTC for
such global receipt and, if such person is not a participant in DTC (as described below), on the procedures of the participant
through which such person owns its interest, to exercise any rights of a holder.
As long as the depositary
shares are represented by the global depositary receipts, we will pay dividends, if any, on the Series A Preferred Stock or Series
B Preferred Stock, respectively, represented by the depositary shares to or as directed by DTC as the registered holder of the
global depositary receipts. Payments to DTC will be in immediately available funds by wire transfer. DTC will credit the relevant
accounts of their participants on the applicable date. Neither we nor Continental Stock Transfer & Trust Company will be responsible
for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of
participants and their customers, and each person owning a beneficial interest will have to rely on the procedures of the depositary
and its participants.
DTC has advised us
that it is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within
the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the
meaning of the New York Uniform Commercial Code, and a “clearing agency” registered pursuant to the provisions of
Section 17A of the Securities Exchange Act of 1934, as amended. DTC holds securities deposited with it by its participants and
facilitates the settlement of transactions among its participants in such securities through electronic computerized book-entry
changes in accounts of the participants, thereby eliminating the need for physical movement of securities certificates. DTC’s
participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations,
some of whom (and/or their representatives) own DTC. Access to DTC’s book-entry system is also available to others, such
as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either
directly or indirectly. According to DTC, the foregoing information with respect to DTC has been provided to the financial community
for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.
Settlement
Investors in the depositary
shares will be required to make their initial payment for the depositary shares in immediately available funds. Secondary market
trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately
available funds.
The information in
this section concerning DTC and DTC’s book-entry system has been obtained from sources that we believe to be reliable (including
DTC), but we take no responsibility for the accuracy thereof.
Neither us, the Depositary
nor the underwriters will have any responsibility or obligation to participants, or the persons for whom they act as nominees,
with respect to the accuracy of the records of DTC, its nominee or any participant with respect to any ownership interest in the
depositary shares or payments to, or the providing of notice to participants or beneficial owners.
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
FOR NOTES
The following is a
summary of the material U.S. federal income tax consequences of the acquisition, ownership, and disposition of the Notes that
we are offering. The following discussion is not exhaustive of all possible tax considerations. This summary is based upon the
Code, regulations promulgated under the Code by the U.S. Treasury Department (including proposed and temporary regulations), rulings,
current administrative interpretations and official pronouncements of the Internal Revenue Service (the “IRS”),
and judicial decisions, all as currently in effect and all of which are subject to differing interpretations or to change, possibly
with retroactive effect. Such change could materially and adversely affect the tax consequences described below. No assurance
can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax consequences
described below.
This summary is for
general information only, and does not address all aspects of U.S. federal income taxation that may be important to a particular
holder in light of its investment or tax circumstances or to holders subject to special tax rules, such as partnerships (including
entities and arrangements classified as partnerships for U.S. federal income tax purposes), subchapter S corporations or other
pass-through entities, banks, financial institutions, tax-exempt entities, insurance companies, regulated investment companies,
real estate investment trusts, trusts and estates, dealers in stocks, securities or currencies, traders in securities that have
elected to use the mark-to-market method of accounting for their securities, persons holding the Notes as part of an integrated
transaction, including a “straddle,” “hedge,” “constructive sale,” or “conversion transaction,”
U.S. Holders (as defined below) whose functional currency for tax purposes (as defined in Section 985 of the Code) is not the
U.S. dollar, holders subject to Section 451(b) of the Code, and individuals subject to the alternative minimum tax provisions
of the Code. This summary does not include any description of the tax laws of any state or local governments, or of any foreign
government, that may be applicable to a particular holder.
This summary is directed
solely to holders that, except as otherwise specifically noted, will purchase the Notes offered in this prospectus supplement
upon original issuance for the “issue price” (i.e., the first price at which a substantial amount of the Notes
is sold for money to persons, other than to bond houses, brokers or similar persons or organizations acting in the capacity of
the underwriters, placement agents or wholesalers) for cash and will hold such securities as capital assets within the meaning
of Section 1221 of the Code, which generally means as property held for investment.
This summary is
not a comprehensive description of all of the U.S. federal tax consequences that may be relevant with respect to the acquisition,
ownership and disposition of the Notes. We urge you to consult your own tax advisor regarding your particular circumstances and
the U.S. federal income and estate tax consequences to you of acquiring, owning and disposing of these securities, as well as
any tax consequences arising under the laws of any state, local, foreign, or other tax jurisdiction and the possible effects of
changes in U.S. federal or other tax laws.
As used in this prospectus
supplement, the term “U.S. Holder” means a beneficial owner of Notes that is for U.S. federal income tax purposes:
|
●
|
an individual who
is a citizen or resident of the United States;
|
|
●
|
a corporation (including
an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the
United States or of any state of the United States or the District of Columbia;
|
|
●
|
an estate the income
of which is subject to U.S. federal income taxation regardless of its source;
|
|
●
|
a trust if a court
within the United States is able to exercise primary supervision over the administration of the trust and one or more “United
States persons” have the authority to control all substantial decisions of the trust; or
|
|
●
|
a trust in existence
on August 20, 1996 that has a valid election in effect under applicable Treasury regulations to be treated as a United States
person.
|
As used in this prospectus
supplement, the term “Non-U.S. Holder” is a beneficial owner of the Notes (other than a partnership or other entity
taxable as a partnership) that is not a U.S. Holder.
If an entity or arrangement
treated as a partnership for U.S. federal income tax purposes holds the Notes offered in this prospectus supplement, the U.S.
federal income tax treatment of a partner generally will depend upon the status of the partner and the activities of the partnership
and accordingly, this summary does not apply to partnerships. A partner of a partnership holding the Notes should consult its
own tax advisor regarding the U.S. federal income tax consequences to the partner of the acquisition, ownership and disposition
of the Notes by the partnership.
Consequences to U.S. Holders
The following is a
summary of the material U.S. federal income tax consequences that will apply to U.S. Holders of the Notes.
Payment of Interest.
It is expected, and this discussion assumes, that the Notes will be issued with less than a de minimis amount of “original
issue discount” for U.S. federal income tax purposes. Accordingly, interest on a Note generally will be included in the
income of a U.S. Holder as ordinary interest income at the time it is accrued or is received in accordance with the U.S. Holder’s
regular method of accounting for U.S. federal income tax purposes and will be ordinary income.
Qualified Reopening.
We will not issue any additional 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25% 2027 Notes or
7.50% 2027 Notes unless such additional notes would constitute a “qualified reopening” of the Initial 7.375% 2023
Notes, Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and
Initial 7.50% 2027 Notes, respectively for U.S. federal income tax purposes. For U.S. federal income tax purposes, debt instruments
issued in a qualified reopening are deemed to be part of the same issue as the original debt instruments. Under the treatment
described in this paragraph, the additional 7.375% 2023 Notes, additional 6.875% 2023 Notes, additional 2024 Notes, additional
2025 Notes, additional 2026 Notes, additional 7.25% 2027 Notes and additional 7.50% 2027 Notes will have the same issue date,
the same issue price and the same adjusted issue price as the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial 2024
Notes, Initial 2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes and Initial 7.50% 2027 Notes, respectively, for U.S. federal
income tax purposes. The remainder of this discussion assumes the correctness of the treatment described in this paragraph.
Pre-issuance Accrued
Interest. The aggregate purchase price of the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes, 2026 Notes, 7.25%
2027 Notes or 7.50% 2027 Notes issued pursuant to this offering may include interest that accrued prior to the date the notes
are purchased, which is referred to herein as “pre-issuance accrued interest.” Pre-issuance accrued interest will
be included in the accrued interest to be paid on the Notes on the first interest payment date after the issuance of the Notes
offered hereby. We intend to take the position that a portion of the interest payment following the issuance of any Notes pursuant
to this offering equal to the pre-issuance accrued interest for such Notes will be treated as a return of the pre-issuance accrued
interest and not as an amount payable on the Notes. If this position is respected, our payment of such pre-issuance accrued interest
will not be treated as taxable interest income to U.S. Holders of the Notes and the amount of the pre-issuance accrued interest
will reduce such U.S. Holder’s adjusted tax basis in the Notes. Prospective purchasers of the Notes are urged to consult
their tax advisors with respect to the tax treatment of pre-issuance accrued interest.
Bond Premium.
In general, if a U.S. Holder purchases a Note for an amount (excluding any amount attributable to any pre-issuance accrued interest)
in excess of the stated principal amount of the Note, the U.S. Holder will be treated as purchasing the Note with bond premium
in an amount equal to such excess. A U.S. Holder may elect to amortize such bond premium over the remaining term of the Note on
a constant yield method as an offset to interest when includible in income under the U.S. Holder’s regular method of tax
accounting. In such case, the U.S. Holder’s tax basis in the Note will be reduced by the amortized bond premium. Any election
to amortize bond premium shall apply to all debt instruments (other than debt instruments the interest on which is excludable
from gross income for U.S. federal income tax purposes) held by the U.S. Holder at the beginning of the first taxable year to
which the election applies or thereafter acquired by the U.S. Holder, and is irrevocable without the consent of the IRS. If a
U.S. Holder does not elect to amortize the bond premium, the bond premium will decrease the gain or increase the loss that would
otherwise be recognized on a disposition of the Note. U.S. Holders should consult their tax advisors about the decision to amortize
the bond premium and the effects of such an election, including the effect on other debt instruments held by the U.S. Holder.
Sale, Exchange,
or Retirement of Notes. Upon the sale, exchange, retirement, or other disposition of a Note, a U.S. Holder will recognize
gain or loss equal to the difference between the amount realized upon the sale, exchange, retirement or other disposition and
the U.S. Holder’s adjusted tax basis in the Note. The amount realized by the U.S. Holder will include the amount of any
cash and the fair market value of any other property received for the Note, but will exclude amounts attributable to accrued but
unpaid interest which will be treated as described above under “Payments of Interest.” A U.S. Holder’s adjusted
tax basis in a Note will generally be the cost of the Note to such U.S. Holder (excluding any amounts paid for pre-issuance accrued
interest that is not taxable when received), decreased by any amortized bond premium.
Gain or loss realized
on the sale, exchange, retirement, or other disposition of a Note generally will be capital gain or loss, and will be long-term
capital gain or loss if the Note has been held for more than one year. Net long-term capital gain recognized by an individual
U.S. Holder is generally taxed at preferential rates. The ability of U.S. Holders to deduct capital losses is subject to limitations
under the Code. Prospective investors should consult with their own tax advisors concerning these tax law provisions.
Additional Medicare
Tax on Unearned Income. Certain U.S. Holders, including individuals, estates and trusts, are subject to an additional
3.8% Medicare tax on unearned income. For individual U.S. Holders, the additional Medicare tax applies to the lesser of (i) “net
investment income” or (ii) the excess of “modified adjusted gross income” over $200,000 ($250,000 if married
and filing jointly or $125,000 if married and filing separately). “Net investment income” generally equals the taxpayer’s
gross investment income reduced by the deductions that are allocable to such income. Investment income generally includes passive
income such as interest and capital gains. U.S. Holders are urged to consult their own tax advisors regarding the implications
of the additional Medicare tax resulting from an investment in the Notes.
Taxation of Non-U.S. Holders
The following is a
summary of the material U.S. federal income tax consequences that will apply to Non-U.S. Holders of a Note.
Payments of Interest.
Except as discussed below, principal and interest payments that are received from us or our agent and that are not effectively
connected with the conduct by the Non-U.S. Holder of a trade or business within the United States, or a permanent establishment
maintained in the United States if certain tax treaties apply, generally will not be subject to U.S. federal income or withholding
tax, except as provided below.
Interest may be subject
to a 30% withholding tax (or less under an applicable treaty, if any) if:
|
●
|
a Non-U.S. Holder
actually or constructively owns 10% or more of the total combined voting power of all classes of our stock entitled to vote;
|
|
●
|
a Non-U.S. Holder
is a “controlled foreign corporation” for U.S. federal income tax purposes that is related to us (directly or
indirectly) through stock ownership;
|
|
●
|
a Non-U.S. Holder
is a bank extending credit pursuant to a loan agreement entered into in the ordinary course of its trade or business (as described
in Section 881(c)(3)(A) of the Code); or
|
|
●
|
the Non-U.S. Holder does not satisfy the certification
requirements described below.
|
In the case of the
Notes, a Non-U.S. Holder generally will satisfy the certification requirements if either: (a) the Non-U.S. Holder certifies to
us or our agent, under penalties of perjury, that it is not a “United States person” (within the meaning of the Code)
and provides its name and address (which certification may generally be made on an IRS Form W-8BEN, IRS Form W-8BEN-E or other
applicable U.S. nonresident withholding tax certification form), or (b) a securities clearing organization, bank, or other financial
institution that holds customer securities in the ordinary course of its trade or business (a “financial institution”)
and holds the Note certifies to us under penalties of perjury that either it or another financial institution has received the
required statement from the Non-U.S. Holder certifying that it is not a United States person and furnishes us with a copy of the
statement.
Except as discussed
below, payments not meeting the requirements set forth above and thus subject to withholding of U.S. federal income tax may nevertheless
be exempt from withholding (or subject to withholding at a reduced rate) if the Non-U.S. Holder provides us with a properly executed
IRS Form W-8BEN, Form W-8BEN-E, or other applicable U.S. nonresident withholding tax certification form, claiming an exemption
from, or reduction in, withholding under the benefit of a tax treaty, or IRS Form W-8ECI (or other applicable form) stating that
interest paid on the Notes is not subject to withholding tax because it is effectively connected with the conduct of a trade or
business within the United States as discussed below. These forms may be required to be updated periodically. To claim benefits
under an income tax treaty, a Non-U.S. Holder must obtain a taxpayer identification number and certify as to its eligibility under
the appropriate treaty’s limitations on benefits article. In addition, special rules may apply to claims for treaty benefits
made by Non-U.S. Holders that are entities rather than individuals. A Non-U.S. Holder that is eligible for a reduced rate of U.S.
federal withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an
appropriate claim for refund with the IRS.
Sale, Exchange,
or Retirement of Note. Except as discussed below, a Non-U.S. Holder generally will not be subject to U.S. federal income or
withholding tax on any capital gain or market discount realized on the sale, exchange, retirement or other disposition of Notes,
provided that: (a) the gain is not effectively connected with the conduct of a trade or business within the United States, or
a permanent establishment maintained in the United States if certain tax treaties apply, and (b) in the case of a Non-U.S. Holder
that is an individual, the Non-U.S. Holder is not present in the United States for 183 days or more in the taxable year of the
sale, exchange or other disposition of the Note. An individual Non-U.S. Holder who is present in the United States for 183 days
or more in the taxable year of sale, exchange or other disposition of a Note, and if certain other conditions are met, will be
subject to U.S. federal income tax at a rate of 30% on the gain realized on the sale, exchange or other disposition of such Note.
Income Effectively
Connected with a Trade or Business within the United States. If a Non-U.S. Holder of a Note is engaged in the conduct
of a trade or business within the United States and if interest on the Note, or gain realized on the sale, exchange or other disposition
of the Note, is effectively connected with the conduct of such trade or business (and, if certain tax treaties apply, is attributable
to a permanent establishment maintained by the Non-U.S. Holder in the United States), the Non-U.S. Holder, although exempt from
U.S. federal withholding tax (provided that the certification requirements discussed above are satisfied), will generally be subject
to U.S. federal income tax on such interest or gain on a net income basis in the same manner as if it were a U.S. Holder. Non-U.S.
Holders should read the material under the heading “Consequences to U.S. Holders,” for a description of the U.S. federal
income tax consequences of acquiring, owning, and disposing of a Note. In addition, if such Non-U.S. Holder is a foreign corporation,
it may also be subject to a branch profits tax equal to 30% (or such lower rate provided by an applicable U.S. income tax treaty)
of all or a portion of its earnings and profits for the taxable year that are effectively connected with its conduct of a trade
or business in the United States, subject to certain adjustments.
Backup Withholding and Information
Reporting
In general, in the
case of a U.S. Holder, other than certain exempt recipients (including a corporation and certain other persons who, when required,
demonstrate their exempt status), we and other payors are required to report to the IRS all payments of principal and interest
on the Notes. In addition, we and other payors generally are required to report to the IRS any payment of proceeds from the sale
of a Note before maturity. Additionally, backup withholding generally will apply to any payments if a U.S. Holder fails to provide
an accurate taxpayer identification number and certify that the taxpayer identification number is correct, the U.S. Holder is
notified by the IRS that it is subject to backup withholding, or the U.S. Holder does not certify that it is not subject to backup
withholding. If applicable, backup withholding will be imposed at a rate of 24%.
In the case of a Non-U.S.
Holder, backup withholding and information reporting will not apply to payments made if the Non-U.S. Holder provides the required
certification to the applicable withholding agent under penalties of perjury that it is not a United States person, or the Non-U.S.
Holder otherwise establishes an exemption, provided that the payor does not have actual knowledge that the holder is a United
States person, or that the conditions of any exemption are not satisfied.
In addition, payments
of the proceeds from the sale of a Note to or through a foreign office of a broker or the foreign office of a custodian, nominee,
or other dealer acting on behalf of a holder generally will not be subject to information reporting or backup withholding. However,
if the broker, custodian, nominee, or other dealer is a United States person, the government of the United States or the government
of any state or political subdivision of any state, or any agency or instrumentality of any of these governmental units, a controlled
foreign corporation for U.S. federal income tax purposes, a foreign partnership that is either engaged in a trade or business
within the United States or whose United States partners in the aggregate hold more than 50% of the income or capital interest
in the partnership, a foreign person 50% or more of whose gross income for a certain period is effectively connected with a trade
or business within the United States, or a United States branch of a foreign bank or insurance company, information reporting
(but not backup withholding) generally will be required with respect to payments made to a holder unless the broker, custodian,
nominee, or other dealer has documentation of the holder’s foreign status and the broker, custodian, nominee, or other dealer
has no actual knowledge or reason to know to the contrary.
Payment of the proceeds
from a sale of a Note to or through the U.S. office of a broker is subject to information reporting and backup withholding, unless
the holder certifies as to its non-United States person status or otherwise establishes an exemption from information reporting
and backup withholding.
Any amounts withheld
under the backup withholding rules will be allowed as a refund or a credit against a holder’s U.S. federal income tax liability
provided the required information is timely furnished to the IRS.
Foreign Account Tax Compliance Act
Certain provisions
of the Code, known as the Foreign Account Tax Compliance Act (“FATCA”), impose a 30% U.S. withholding tax on
certain U.S. source payments, including interest (and OID), dividends, other fixed or determinable annual or periodical gain,
profits, and income, and on the gross proceeds from a disposition of property of a type which can produce U.S. source interest
or dividends (“Withholdable Payments”), if paid to a foreign financial institution (including amounts paid
to a “foreign financial institution” on behalf of a holder), unless such institution enters into an agreement with
the Treasury to collect and provide to the Treasury certain information (that is in addition to and significantly more onerous
than, the requirement to deliver an applicable U.S. nonresident withholding tax certification form (e.g., IRS Form W-8BEN),
as discussed above) regarding U.S. financial account holders, including certain account holders that are foreign entities with
U.S. owners, with such institution or otherwise complies with FATCA. FATCA also generally imposes a withholding tax of 30% on
Withholdable Payments made to a non-financial foreign entity unless such entity provides the withholding agent with a certification
that it does not have any substantial U.S. owners or a certification identifying the direct and indirect substantial U.S. owners
of the entity. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.
These withholding
and reporting requirements generally apply to U.S. source periodic payments (such as interest payments on the Notes) and, after
December 31, 2018, to payments of gross proceeds from a sale, exchange, retirement or other disposition. If we determine withholding
is appropriate with respect to the Notes, we will withhold tax at the applicable statutory rate, and we will not pay any additional
amounts in respect of such withholding. Foreign financial institutions and non-financial foreign entities located in jurisdictions
that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. We will not
be required to pay any additional amounts in respect of any payments to which FATCA withholding applies. Holders are urged to
consult with their own tax advisors regarding the possible implications of FATCA on their investment in the Notes.
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
FOR DEPOSITARY SHARES
This section describes
the material U.S. federal income tax consequences of owning the depositary shares. It applies to you only if you acquire depositary
shares upon their original issuance at their original offering price and you hold your depositary shares as capital assets for
tax purposes. This section does not describe other U.S. federal tax consequences, nor does it describe any tax consequences arising
under the laws of any state, local or foreign jurisdiction.
This section is based
on the Internal Revenue Code of 1986, as amended (the “Code”), existing and proposed regulations under the Code, and
published rulings and court decisions currently in effect, all of which are subject to change. Any such change may be applied
retroactively and may adversely affect the U.S. federal income tax consequences described herein.
This section does
not describe all of the consequences that may be relevant to you if you are a member of a class of holders subject to special
rules, including, but not limited to, tax-exempt organizations, insurance companies, banks or other financial institutions, partnerships
or other entities classified as partnerships for U.S. federal income tax purposes, dealers in securities or currencies, regulated
investment companies, real estate investment trusts, U.S. persons whose functional currency is not the U.S. dollar, U.S. expatriates,
persons subject to the alternative minimum tax, non-U.S. holders (as defined below) subject to the Medicare contribution tax,
traders in securities that elect to use a mark-to-market method of accounting for their securities holdings, and persons that
will hold the depositary shares as a position in a hedging transaction, “straddle,” “conversion transaction”
or other risk reduction transaction.
If a partnership (or
any other entity treated as a partnership for U.S. federal income tax purposes) holds Depositary Shares, the U.S. federal income
tax treatment of a partner of that partnership generally will depend upon the status of the partner and the activities of the
partnership. If you are a partnership or a partner of a partnership holding Depositary Shares, you should consult your tax advisors
as to the particular U.S. federal income tax consequences of holding and disposing of Depositary Shares.
This discussion applies
only to purchasers who purchase and hold the Depositary Shares as a capital asset within the meaning of Section 1221 of the Code
(generally property held for investment).
In general, and assuming
that each obligation in the Deposit Agreement and any related agreement will be performed in accordance with its terms, for United
States federal income tax purposes, if you hold depositary shares, you will be treated as the owner of the underlying Series A
Preferred Stock represented by those depositary shares. Accordingly, the following discussion addresses the tax consequences of
owning share of Series A Preferred Stock as if you owned such shares directly rather than through the ownership interests represented
by the depositary shares which are being sold in this offering.
Tax consequences
may vary depending upon the particular status of an investor. Potential investors should consult with their own tax advisers in
determining the specific tax consequences and risks to them of purchasing, holding and disposing of depositary shares, including
the application to their particular situation of the U.S. federal income tax considerations discussed below, as well as the application
of state, local, foreign or other tax laws.
U.S. Holders
For purposes of this
discussion, a U.S. holder means a beneficial owner of depositary shares that is, for U.S. federal income tax purposes, (1) an
individual citizen or resident of the United States, (2) a corporation (or other entity treated as a corporation for U.S. federal
tax purposes) created or organized in or under the laws of the United States or of any state thereof or the District of Columbia,
(3) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (4) a trust if (i) a
court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have
the authority to control all of its substantial decisions or (ii) it has a valid election in effect under applicable U.S. Treasury
regulations to be treated as a U.S. person.
Dividends. Distributions
with respect to the Series A Preferred Stock or Series B Preferred Stock, respectively, will be taxable as dividend income when
paid to the extent of our current or accumulated earnings and profits as determined for U.S. federal income tax purposes. To the
extent that the amount of a distribution with respect to the shares of Series A Preferred Stock or Series B Preferred Stock, respectively,
exceeds our current and accumulated earnings and profits, such distribution will be treated first as a tax-free return of capital
to the extent of the U.S. holder’s adjusted tax basis in such Series A Preferred Stock and thereafter as gain from the disposition
of the Series A Preferred Stock or Series B Preferred Stock, respectively, as described under “U.S. Holders — Dispositions.”
Although we presently
have accumulated earnings and profits, we may not have sufficient current or accumulated earnings and profits during future years
for distributions with respect to the Series A Preferred Stock or Series B Preferred Stock, respectively, to be treated as dividend
income.
Distributions constituting
dividend income received by an individual U.S. holder in respect of Series A Preferred Stock or Series B Preferred Stock, respectively,
will be “qualified dividend income” if the Series A Preferred Stock has been held for more than 90 days during the
181-day period beginning 90 days before the ex-dividend date. Qualified dividend income is generally taxed at favorable rates
applicable to long-term capital gains. In addition, if a dividend received by an individual holder that qualifies for the “qualified
dividend income” rate is an “extraordinary dividend” within the meaning of Section 1059 of the Code, any loss
recognized by such individual holder on a subsequent disposition of the stock will be treated as long-term capital loss to the
extent of such “extraordinary dividend,” irrespective of such holder’s holding period for the stock.
Distributions with
respect to the Series A Preferred Stock or Series B Preferred Stock, constituting dividend income paid to holders that are U.S.
corporations or entities taxed as corporations will generally qualify for the dividends-received deduction if the applicable holding
period is met. Corporate holders of Series A Preferred Stock or Series B Preferred Stock, should also consider the effect of Section
246A of the Code, which reduces the dividends-received deduction allowed to a corporate shareholder that has incurred indebtedness
that is “directly attributable” to an investment in portfolio stock such as preferred stock. Also, if a corporate
holder of Series A Preferred Stock or Series B Preferred Stock, receives a dividend on the Series A Preferred Stock or Series
B Preferred Stock, that is an “extraordinary dividend” within the meaning of Section 1059 of the Code, such holder
in certain instances must reduce its tax basis in the Series A Preferred Stock or Series B Preferred Stock, by the amount of the
“nontaxed portion” of such “extraordinary dividend” that results from the application of the dividends-received
deduction. If the “nontaxed portion” of such “extraordinary dividend” exceeds such corporate holder’s
basis, any excess will be taxed as gain as if such holder had disposed of its Series A Preferred Stock or Series B Preferred Stock,
in the year the “extraordinary dividend” is paid. Each domestic corporate holder of Series A Preferred Stock or Series
B Preferred Stock, is urged to consult with its tax advisors with respect to the eligibility for and amount of any dividends received
deduction and the application of Sections 246A and 1059 of the Code to any dividends it receives.
The availability of
the reduced dividend tax rate for individuals and the dividends-received deduction for U.S. corporations are subject to certain
exceptions for short-term and hedged positions and other applicable limitations. You should consult your own tax adviser regarding
the availability of the reduced dividend tax rate and the dividends-received deduction in light of your particular circumstances.
Holder’s
Conversion Option in connection with a Change of Control. In the event of a U.S. holder’s conversion
of Series A Preferred Stock or Series B Preferred Stock, respectively, in connection with a Change of Control, the tax consequences
of such conversion will depend, in part, upon the facts underlying the transaction in which the Change of Control occurs. A
U.S. holder should consult the holder’s tax advisor regarding the tax consequences to the U.S. holder of the conversion
of Series A Preferred Stock or Series B Preferred Stock, under a Change of Control transaction.
Dispositions. A
U.S. holder will generally recognize capital gain or loss on a sale or exchange of the Series A Preferred Stock or Series B Preferred
Stock, equal to the difference between the amount realized (which does not include any declared but unpaid distributions, which
will be treated in the manner described above) upon the sale or exchange and such U.S. holder’s adjusted tax basis in the
securities sold or exchanged. A U.S. holder’s initial tax basis in the Series A Preferred Stock or Series B Preferred Stock,
will equal its cost. Such capital gain or loss will be long-term capital gain or loss if the U.S. holder’s holding period
for the securities sold or exchanged is more than one year. Long-term capital gains of non-corporate taxpayers are generally taxed
at the same lower maximum tax rates applicable to qualified dividend income summarized above. Net capital gains of a U.S. holder
other than long-term capital gains are taxed at the rates applicable to ordinary income. The deductibility of net capital losses
is subject to limitations.
Although a U.S. holder
receiving cash in a redemption of the Series A Preferred Stock or Series B Preferred Stock, is generally expected to be taxed
in the same manner described for any other disposition, that treatment is subject to certain exceptions, particularly in the case
of a holder actually or constructively owning other shares of our stock. A U.S. holder should consult its own tax adviser regarding
the application of these rules in light of its particular circumstances.
Medicare Tax. In
addition, a U.S. holder that is an individual or estate, or a trust that does not fall into a special class of trusts that is
exempt from such tax, will be subject to a 3.8% Medicare tax on all or a portion of its “net investment income”, which
will generally include its dividend income and its net gains from the disposition of Series A Preferred Stock, unless such dividend
income or net gains are derived in the ordinary course of the conduct of a trade or business (other than a trade or business that
consists of certain passive or trading activities). If you are a U.S. holder that is an individual, estate, or trust, you are
urged to consult your tax adviser regarding the applicability of the Medicare tax to your income and gains in respect of your
investment in the Series A Preferred Stock or Series B Preferred Stock.
Backup withholding
on U.S. holders. U.S. holders may be subject to backup withholding with respect to the payment of dividends on the Series
A Preferred Stock or Series B Preferred Stock, and to payments of proceeds on the disposition of the Series A Preferred Stock
or Series B Preferred Stock, unless such U.S. holders provide proof of an applicable exemption or a correct taxpayer identification
number, and otherwise comply with applicable requirements of the backup withholding rules.
Any amount withheld
under the backup withholding rules from a payment to a U.S. holder is allowable as a credit against such holder’s U.S. federal
income tax, which may entitle the U.S. holder to a refund, provided that the U.S. holder provides the required information to
the Internal Revenue Service (the “IRS”) in a timely manner. Moreover, certain penalties may be imposed by the IRS
on a U.S. holder who is required to furnish information, but does not do so in the proper manner.
Information reporting.
Information returns will generally be filed with the IRS in connection with the payment of dividends on the Series A Preferred
Stock or Series B Preferred Stock, to non-corporate U.S. holders and certain payments of proceeds to non-corporate U.S. holders
on the disposition of the Series A Preferred Stock or Series B Preferred Stock.
Non-U.S. holders
The discussion in
this section is addressed to non-U.S. holders of the Series A Preferred Stock or Series B Preferred Stock. For this purpose, a
non-U.S. holder is a beneficial owner of Series A Preferred Stock or Series B Preferred Stock, other than a U.S. holder or partnership.
Dividends. Generally,
dividends paid to a non-U.S. holder with respect to the Series A Preferred Stock or Series B Preferred Stock, will be subject
to withholding of U.S. federal income tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty,
provided the non-U.S. holder furnishes the payor with a properly completed IRS Form W-8BEN or W-8BEN-E (or other applicable form)
certifying under penalty of perjury that such holder is eligible for treaty benefits. The 30% withholding does not apply if the
dividends are effectively connected with a trade or business carried on by the non-U.S. holder within the United States and, if
a tax treaty applies, are attributable to a U.S. permanent establishment maintained by the non-U.S. holder and the non-U.S. holder
provides the payor with a properly completed IRS Form W-8ECI. In such case, the dividends will generally be subject to U.S. federal
income tax on a net basis at applicable individual or corporate rates and, in the case of a non-U.S. holder that is a corporation,
may be subject to a “branch profits tax” at a 30% rate or such lower rate as may be specified by an applicable income
tax treaty.
Dispositions. A
non-U.S. holder generally will not be subject to U.S. federal income tax on gain realized on the sale or exchange of the Series
A Preferred Stock or Series B Preferred Stock, unless: (1) the gain is effectively connected with a U.S. trade or business of
the non-U.S. holder (and if a tax treaty applies, the gain is attributable to a U.S. permanent establishment maintained by such
non-U.S. holder); (2) in the case of an individual, such non-U.S. holder is present in the United States for 183 or more days
in the taxable year of the sale or disposition and certain other conditions exist; or (3) we have been a “U.S. real property
holding corporation” for U.S. federal income tax purposes at any time during the five-year period ending on the date of
disposition of the Series A Preferred Stock or Series B Preferred Stock, and certain other conditions are met. We believe that
we are not currently, and we do not anticipate becoming, a U.S. real property holding corporation.
Cash received by a
non-U.S. holder in a disposition that is in respect of dividends in arrears on the Series A Preferred Stock or Series B Preferred
Stock, should generally be treated as provided under “Non-U.S. holders — Dividends.”
Although a non-U.S.
holder receiving cash in a redemption of the Series A Preferred Stock or Series B Preferred Stock, is generally expected to be
taxed in the same manner described for any other disposition, that treatment is subject to certain exceptions, particularly in
the case of a non-U.S. holder actually or constructively owning other shares of our stock. A non-U.S. holder should consult its
own tax adviser regarding the application of these rules in light of its particular circumstances.
Information reporting
and backup withholding on non-U.S. holders. Payment of dividends and the tax withheld with respect thereto are subject to
information reporting requirements. These information reporting requirements apply regardless of whether withholding was reduced
or eliminated by an applicable income tax treaty, or withholding was not required because the dividends were effectively connected
with a trade or business in the United States conducted by the non-U.S. holder. Copies of the information returns reporting such
dividends and withholding may also be made available by the IRS under the provisions of an applicable income tax treaty or agreement
to the tax authorities in the country in which the non-U.S. holder resides. U.S. backup withholding will generally apply on payment
of dividends to non-U.S. holders unless such non-U.S. holders furnish to the payor an IRS Form W-8BEN or W-8BEN-E (or other applicable
form) certifying, under penalty of perjury, that the person is a non-U.S. person, or such non-U.S. holders otherwise establish
an exemption.
Payment by a U.S.
office of a broker of the proceeds of a sale of the Series A Preferred Stock or Series B Preferred Stock, is subject to both backup
withholding and information reporting unless the non-U.S. holder, or beneficial owner thereof, as applicable, certifies that it
is a non-U.S. holder on IRS Form W-8BEN or W-8BEN-E (or other applicable form), or otherwise establishes an exemption. Subject
to certain exceptions, backup withholding and information reporting generally will not apply to a payment of proceeds from the
sale of the Series A Preferred Stock or Series B Preferred Stock, if such sale is effected through a foreign office of a broker
without certain specified U.S. connections.).
FATCA withholding
Pursuant to sections
1471 through 1474 of the Code, commonly known as FATCA, a 30% withholding tax (“FATCA withholding”) may be
imposed on certain payments to a holder or to certain foreign financial institutions, investment funds and other non-U.S. persons
receiving payments on the holder’s behalf if the holder or such persons fail to comply with certain information reporting
requirements. Such payments will include U.S.-source dividends. Payments of dividends received in respect of the Series A Preferred
Stock or Series B Preferred Stock, could be affected by this withholding if a holder is subject to the FATCA information reporting
requirements and fails to comply with them or holds the Series A Preferred Stock or Series B Preferred Stock, through a non-U.S.
person (e.g., a foreign bank or broker) that fails to comply with them (even if payments to the holder would not otherwise have
been subject to FATCA withholding). Holders should consult their own tax advisors regarding the relevant U.S. law and other official
guidance on FATCA withholding, including the possible application of an intergovernmental agreement that alters the general FATCA
requirements.
If any amount of,
or in respect of, U.S. withholding tax were to be deducted or withheld from payments on the Series A Preferred Stock or Series
B Preferred Stock, as a result of a failure by a holder (or by an institution through which a holder holds the Series A Preferred
Stock or Series B Preferred Stock) to comply with FATCA, neither us nor any paying agent nor any other person would, pursuant
to the terms of the Series A Preferred Stock or Series B Preferred Stock, be required to pay additional amounts with respect to
any Series A Preferred Stock or Series B Preferred Stock as a result of the deduction or withholding of such tax. Depending on
your circumstances, you may be entitled to a refund or credit in respect of some or all of this withholding. However, even if
a holder is entitled to have such withholding refunded, the required procedures could be cumbersome and significantly delay the
holder’s receipt of any amounts withheld.
This summary is
for general information only and is not intended to constitute a complete description of all tax consequences for non-U.S. holders
relating to the purchase, ownership and disposition of the Series A Preferred Stock or Series B Preferred Stock. You are urged
to consult your tax advisors regarding the U.S. federal, state, local, and foreign income and other tax consequences of the purchase,
ownership and disposition of the Series A Preferred Stock or Series B Preferred Stock.
PLAN OF DISTRIBUTION (Conflict of Interest)
The Agent is acting
as our sales agent in connection with the offer and sale of the Offered Securities pursuant to this prospectus supplement. Upon
written instructions from us, the Agent will use its commercially reasonable efforts consistent with its normal sales and trading
practices to sell, as our sales agent, the Offered Securities under the terms and subject to the conditions set forth in the Sales
Agreement. We will instruct the Agent as to the series and amount of the Notes or shares of Depositary Shares to be sold by it.
We may instruct the Agent not to sell the Offered Securities if the sales cannot be effected at or above the price designated
by us in any instruction. We will instruct the Agent not to sell the 7.375% 2023 Notes, 6.875% 2023 Notes, 2024 Notes, 2025 Notes,
2026 Notes, 7.25% 2027 Notes or 7.50% 2027 Notes if the sales cannot be effected at or above prices that will allow the Notes
to be treated as “fungible” with the Initial 7.375% 2023 Notes, Initial 6.875% 2023 Notes, Initial 2024 Notes, Initial
2025 Notes, Initial 2026 Notes, Initial 7.25% 2027 Notes or Initial 7.50% 2027 Notes, as applicable, for U.S. federal income tax
purposes. We or the Agent may suspend the offering of Offered Securities upon proper notice and subject to other conditions.
Sales of the Offered
Securities, if any, under this prospectus supplement may be made in transactions that are deemed to be “at the market,”
as defined in Rule 415 under the Securities Act. If any of the Notes are sold at prices above par, the effective yield on such
Notes to the purchasers may be less than 7.375%, 6.875%, 6.75%, 6.375%, 6.50%, 7.25%, or 7.50%, as applicable.
The Agent will provide
written confirmation of a sale to us no later than the opening of the trading day on the NASDAQ following each trading day in
which the Offered Securities are sold under the Sales Agreement. Each confirmation will include the series and principal amount
of Notes sold or number of depositary shares in the case of Depositary Shares on the preceding day, the sales price of Offered
Securities sold, the aggregate gross sales proceeds of such Offered Securities, the net proceeds to us and the compensation payable
by us to the Agent in connection with the sales.
The Agent will receive a commission from us up to 2.0% of the
gross sales price of any Offered Securities sold through the Agent under the Sales Agreement. We estimate that the total expenses
for the offering, excluding compensation payable to the Agent under the terms of the Sales Agreement, will be approximately $65,000.
This estimate includes the reimbursement by the Company of the reasonable fees and expenses of the Agent in connection with the
transactions contemplated by the Sales Agreement.
Settlement for sales
of the Offered Securities will occur on the second trading day following the date on which such sales are made, or on some other
date that is agreed upon by us and the Agent in connection with a particular transaction, in return for payment of the net proceeds
to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.
We will report at
least quarterly the series and principal amount of Notes or number of Depositary Shares sold through the Agent under the Sales
Agreement, the net proceeds to us and the compensation paid by us to the Agent, if any.
In connection with
the sale of the Offered Securities on our behalf, the Agent will be deemed to be an “underwriter” within the meaning
of the Securities Act, and the compensation of the Agent will be deemed to be underwriting commissions or discounts. We have agreed
to provide indemnification and contribution to the Agent against certain civil liabilities, including liabilities under the Securities
Act.
The offering of the
Offered Securities pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of the dollar amount of Offered
Securities subject to the Sales Agreement or (ii) the termination of the Sales Agreement as permitted therein.
Other Relationships
The Agent and certain
of its affiliates are full service financial institutions engaged in various activities, which may include securities trading,
commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging,
financing and brokerage activities. The Agent and certain of its affiliates have, from time to time, performed, and may in the
future perform, various commercial and investment banking and financial advisory services for the Company and our affiliates,
for which they received or may in the future receive customary fees and expenses.
In the ordinary course
of its various business activities, the Agent and certain of its affiliates actively trade debt and equity securities (or related
derivative securities) and financial instruments for their own account and for the accounts of their customers, and such investment
and securities activities may involve securities and/or instruments of the Company or our affiliates. The Agent and certain of
its affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express
independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that
they acquire, long and/or short positions in such securities and instruments.
The principal business
address of the Agent is 299 Park Avenue, 21st Floor, New York, New York 10171.
Conflict of Interest
B. Riley Securities
is an affiliate of B. Riley Financial, Inc. and, as such, will have a “conflict of interest” in this offering of Offered
Securities within the meaning of FINRA Rule 5121. Consequently, this offering of Notes and Depositary Shares will be conducted
in compliance with the provisions of FINRA Rule 5121. B. Riley Securities will not be permitted to sell Notes or Depositary Shares
in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the
account holder.
EXPERTS
Marcum LLP, an independent
registered public accounting firm, has audited our consolidated financial statements as of December 31, 2018 and 2017 and for
each of the three years in the period ended December 31, 2018, as well as the effectiveness of our internal controls over financial
reporting as of December 31, 2018, as stated in its report incorporated by reference into this prospectus supplement, and such
audited consolidated financial statements have been incorporated by reference into this prospectus supplement in reliance upon
the report of such firm given upon its authority as experts in accounting and auditing.
The combined financial
statements of BR Brand Group as of December 31, 2018 and 2017 and for each of the two years in the period ended December 31, 2018
incorporated by reference in this prospectus supplement have been so incorporated in reliance on the reports of Mayer Hoffman
McCann CPAs, The New York Practice of Mayer Hoffman McCann P.C., independent auditor of BR Brand Group, incorporated herein by
reference, given on the authority of said firm as experts in auditing and accounting.
LEGAL MATTERS
Certain legal matters
will be passed upon for us by The NBD Group, Inc., Los Angeles, California, and for the Agent by Duane Morris LLP, New York, New
York.
INCORPORATION OF CERTAIN DOCUMENTS BY
REFERENCE
This prospectus supplement
and the accompanying prospectus are part of a registration statement that we have filed with the SEC. The SEC allows us to “incorporate
by reference” the information that we file with it, which means that we can disclose important information to you by referring
you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement and the
accompanying prospectus from the date we file that document. Any documents filed by us under Sections 13(a), 13(c), 14 or 15(d)
of the Exchange Act with the SEC after the date of this prospectus supplement and before the date that the offering of Offered
Securities by means of this prospectus is terminated will automatically update and, where applicable, supersede any information
contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. We incorporate by reference
into this prospectus supplement and the accompanying prospectus the following documents or information filed with the SEC (other
than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules):
|
●
|
Our quarterly report on Form 10-Q for the quarterly periods ended March 31, 2020 and June 30, 2020, filed with the SEC on May 11, 2020 and August 3, 2020, respectively;
|
|
|
|
|
●
|
Our annual report on Form 10-K for the
year ended December
31, 2019, filed with the SEC on March
10, 2020 and Form 10-K/A filed with the SEC on April
23, 2020;
|
|
|
|
|
●
|
Our current reports on Form 8-K filed with the SEC on January 9, 2020, February 10, 2020, February 12, 2020, February 21, 2020, April 13, 2020, May 6, 2020, May 15, 2020, June 24, 2020, September 1, 2020, September 4, 2020 and September 14, 2020;
|
|
|
|
|
●
|
The description of our Series A Preferred Stock included in our registration statement on Form 8-A filed with the SEC on October 7, 2019; and
|
|
|
|
|
●
|
The description of our Series B Preferred Stock included in our registration statement on Form 8-A filed with the SEC on September 4, 2020.
|
We will provide without
charge to each person, including any beneficial owner, to whom this prospectus supplement and the accompanying prospectus are
delivered, upon his or her written or oral request, a copy of any or all documents referred to above that have been or may be
incorporated by reference into this prospectus supplement and the accompanying prospectus, excluding exhibits to those documents
unless they are specifically incorporated by reference into those documents. You may request those documents from us by contacting
us at: B. Riley Financial, Inc., 11100 Santa Monica Blvd., Suite 800, Los Angeles, California 90025, Attention: Investor Relations,
telephone (818) 884-3737.
PROSPECTUS
B.
RILEY FINANCIAL, INC.
$350,000,000
COMMON STOCK
PREFERRED STOCK
WARRANTS
DEBT SECURITIES
DEPOSITARY
SHARES
UNITS
We
may offer and sell from time to time the above securities in one or more classes, in one or more transactions, separately or together
in any combination and as separate series, and in amounts, at prices and on terms that we will determine at the times of the offerings.
We may also offer any of these securities that may be issuable upon the conversion, exercise or exchange of debt securities, preferred
stock or warrants. The aggregate initial offering price of the securities that we may offer through this prospectus will be up
to $350,000,000.
We
will provide specific terms of any offering in supplements to this prospectus, which we will deliver together with the prospectus
at the time of sale. The supplements may add, update or change information contained in this prospectus. You should read this
prospectus and any prospectus supplement carefully before you invest. This prospectus may not be used to offer and sell securities
unless accompanied by a prospectus supplement.
We
may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters,
dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents
are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount
arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus
supplement. See the sections of this prospectus entitled “About this Prospectus” and “Plan of Distribution”
for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing
the method and terms of the offering of such securities.
Our common stock is
traded on the Nasdaq Global Market (“NASDAQ”) under the symbol “RILY”. On February 13, 2020, the
last reported sales price of our common stock as quoted on NASDAQ was $26.88 per share.
On February 13, 2020,
the aggregate market value of our outstanding common stock held by non-affiliates was $521.6 million.
Investing
in our securities involves risks. Risks associated with an investment in our securities will be described in the applicable prospectus
supplement and certain of our filings with the Securities and Exchange Commission, as described under the caption “Risk
Factors” on page 3 of this prospectus.
NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR
DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is February 24, 2020.
TABLE
OF CONTENTS
ABOUT
THIS PROSPECTUS
This
prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or SEC, using a
“shelf” registration process. Under this shelf registration process, we may, from time to time, sell the securities
or combinations of the securities described in this prospectus in one or more offerings in amounts that we will determine from
time to time. For further information about our business and the securities, you should refer to the registration statement containing
this prospectus and its exhibits. The exhibits to our registration statement contain the full text of certain contracts and other
important documents we have summarized in this prospectus. Since these summaries may not contain all the information that you
may find important in deciding whether to purchase the securities we offer, you should review the full text of these documents.
We have filed and plan to continue to file other documents with the SEC that contain information about us and our business. Also,
we will file legal documents that control the terms of the securities offered by this prospectus as exhibits to the reports we
file by the SEC. The registration statement and other reports can be obtained from the SEC as indicated under the heading “Where
You Can Find More Information.”
This
prospectus provides you with a general description of the securities that we may offer. Each time we offer securities pursuant
to this prospectus, we will provide a prospectus supplement and/or other offering material that will contain specific information
about the terms of that offering. When we refer to a “prospectus supplement,” we are also referring to any free writing
prospectus or other offering material authorized by us. The prospectus supplement may also add, update or change information contained
in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement,
you should rely on the information in the prospectus supplement or incorporated information having a later date. You should read
this prospectus and any prospectus supplement together with additional information described under the heading “Where You
Can Find More Information.”
You
should rely only on the information provided in this prospectus, in any prospectus supplement, or any other offering material
that we authorize, including the information incorporated by reference. We have not authorized anyone to provide you with different
information. You should not assume that the information in this prospectus, any supplement to this prospectus, or any other offering
material that we authorize, is accurate at any date other than the date indicated on the cover page of these documents or the
date of the statement contained in any incorporated documents, respectively. This prospectus is not an offer to sell or a solicitation
of an offer to buy any securities other than the securities referred to in the prospectus supplement. This prospectus is not an
offer to sell or a solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is
unlawful. You should not interpret the delivery of this prospectus, or any sale of securities, as an indication that there has
been no change in our affairs since the date of this prospectus. You should also be aware that information in this prospectus
may change after this date. The information contained in this prospectus or a prospectus supplement or amendment, or incorporated
herein or therein by reference, is accurate only as of the date of this prospectus or prospectus supplement or amendment, as applicable,
regardless of the time of delivery of this prospectus or prospectus supplement or amendment, as applicable, or of any sale of
the shares.
As
used in this prospectus, unless the context indicates or otherwise requires, “the Company,” “B. Riley,”
“we,” “us,” or “our” refer to the combined business of B. Riley Financial, Inc. and all of
its subsidiaries.
ABOUT
B. RILEY FINANCIAL, INC.
Our
Business
B.
Riley Financial, Inc. (NASDAQ: RILY) and its subsidiaries provide collaborative financial services and solutions through several
operating subsidiaries including:
|
●
|
B.
Riley FBR, Inc. (“B. Riley FBR”) is a leading, full service investment
bank providing financial advisory, corporate finance, research, securities lending and
sales and trading services to corporate, institutional and high net worth individual
clients.
|
|
●
|
B.
Riley Wealth Management, Inc. provides comprehensive wealth management and brokerage
services to individuals and families, corporations and non-profit organizations, including
qualified retirement plans, trusts, foundations and endowments.
|
|
●
|
B.
Riley Capital Management, LLC, a Securities and Exchange Commission (“SEC”)
registered investment advisor, which includes:
|
|
●
|
B. Riley Asset Management, an advisor to certain private funds, including BRC Partners Opportunity Fund, LP..
|
|
●
|
Great
American Capital Partners, LLC (“GACP”), the general partner of two
private funds, GACP I, L.P. and GACP II, L.P., both direct lending funds that provide
senior secured loans and second lien secured loan facilities to middle market public
and private U.S. companies.
|
|
●
|
GlassRatner
Advisory & Capital Group LLC (“GlassRatner”), a specialty financial
advisory services firm that provides consulting services to shareholders, creditors and
companies, including due diligence, fraud investigations, corporate litigation support,
crisis management and bankruptcy services. We acquired GlassRatner on August 1, 2018.
GlassRatner strengthens B. Riley’s diverse platform and complements the restructuring
services provided by B. Riley FBR.
|
|
●
|
Great
American Group, LLC, a leading provider of asset disposition and auction solutions to
a wide range of retail and industrial clients.
|
|
●
|
Great
American Group Advisory and Valuation Services, LLC, a leading provider of appraisal
and valuation services for asset based lenders, private equity firms and corporate clients.
|
We
also pursue a strategy of investing in or acquiring companies which we believe have attractive investment return characteristics.
As part of this strategy, we have completed the following acquisitions or investments.
|
●
|
UOL
is a communications company that offers consumer subscription services and products,
consisting of Internet access services and devices under the NetZero and Juno brands
primarily sold in the United States.
|
|
●
|
magicJack
is a Voice over IP (“VoIP”) cloud-based technology and services communications
provider.
|
|
●
|
BR
Brand Holdings LLC, in which we acquired a majority investment interest on October 28, 2019, is a brand investment portfolio.
|
We
are headquartered in Los Angeles with offices in major cities throughout the United States including New York, Chicago, Boston,
Dallas, Memphis, Metro Washington D.C. and West Palm Beach.
For financial reporting
purposes we classify our businesses into five operating segments: (i) Capital Markets, (ii) Auction and Liquidation, (iii)
Valuation and Appraisal, (iv) Principal Investments – United Online and magicJack and (v) Brands segment as a result of
acquiring a majority investment interest in BR Brands Holdings LLC on October 28, 2019.
Capital
Markets Segment. Our Capital Markets segment provides a full
array of investment banking, corporate finance, consulting, financial advisory, research,
securities lending, wealth management and sales and trading services to corporate, institutional
and high net worth clients. Our corporate finance and investment banking services include
merger and acquisitions as well as restructuring advisory services to public and private
companies, initial and secondary public offerings, and institutional private placements.
In addition, we trade equity securities as a principal for our account, including investments
in funds managed by our subsidiaries. Our Capital Markets segment also includes our asset
management businesses that manage various private and public funds for institutional
and individual investors.
Auction
and Liquidation Segment. Our Auction and Liquidation segment utilizes our significant industry experience,
a scalable network of independent contractors and industry-specific advisors to tailor our services to the specific needs of a
multitude of clients, logistical challenges and distressed circumstances. Furthermore, our scale and pool of resources allow us
to offer our services across North American as well as parts of Europe, Asia and Australia. Our Auction and Liquidation segment
operates through two main divisions, retail store liquidations and wholesale and industrial assets dispositions. Our wholesale
and industrial assets dispositions division operates through limited liability companies that are controlled by us.
Valuation
and Appraisal Segment. Our Valuation and Appraisal segment provides valuation and appraisal services
to financial institutions, lenders, private equity firms and other providers of capital. These services primarily include the
valuation of assets (i) for purposes of determining and monitoring the value of collateral securing financial transactions and
loan arrangements and (ii) in connection with potential business combinations. Our Valuation and Appraisal segment operates through
limited liability companies that are majority owned by us.
Principal Investments
– United Online and magicJack Segment. Our Principal Investments – United Online and magicJack
segment consists of businesses which have been acquired primarily for attractive investment return characteristics. Currently,
this segment includes UOL, through which we provide consumer Internet access, magicJack, through which we provide VoIP communication
and related product and subscription services.
Brands
Segment. Our Brands segment consists of a brand investment
portfolio that is focused on generating revenue through the licensing of trademarks held by BR Brand Holdings LLC, which we
own a majority of the equity interests. We license intellectual property of six brands: Catherine Malandrino, English Laundry, Joan
Vass, Kensie Girl, Limited Too and Nanette Lepore.
Our
Corporate Information
We
are a Delaware corporation. Our executive offices are located at 21255 Burbank Blvd, Suite 400, Woodland Hills, California 91367,
and the telephone number at our principal executive office is (818) 884-3737. Our website addresses are http://www.brileyfin.com,
https://brileyfbr.com, http://www.greatamerican.com, https://www.glassratner.com, http://www.unitedonline.net, http://www.magicjack.com
and http://www.vocaltec.com. We have not incorporated by reference into this prospectus the information on our website,
and you should not consider it to be a part of this document.
RISK
FACTORS
Investing
in our securities involves risk. Before making an investment decision, you should carefully consider the risks described under
the heading “Risk Factors” contained in the applicable prospectus supplement and any related free writing prospectus
and in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, together with all of the
other information appearing in, or incorporated by reference into, this prospectus and any applicable prospectus supplement, as
updated by our subsequent filings under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
These risks could materially and adversely affect our business, results of operations and financial condition and could result
in a partial or complete loss of your investment. Additional risks not presently known to us or that we currently believe are
immaterial may also significantly impair our business operations and financial condition. See “Where You Can Find More Information.”
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements
in this prospectus that are not descriptions of historical facts are forward-looking statements that are based on management’s
current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or
such assumptions prove incorrect, our business, operating results, financial condition and stock price could be materially negatively
affected. In some cases, you can identify forward-looking statements by terminology including “anticipates,” “believes,”
“can,” “continue,” “could,” “estimates,” “expects,” “intends,”
“may,” “plans,” “potential,” “predicts,” “should,” “will,”
“would” or the negative of these terms or other comparable terminology. Factors that could cause actual results to
differ materially from those currently anticipated include those set forth in the section titled “Risk Factors.”
We operate in a very competitive
and rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to
predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination
of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make.
In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus
may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking
statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of
activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover,
neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. The
forward-looking statements included in this prospectus speak only as of the date hereof, and except as required by law, we undertake
no obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these
statements to actual results or to changes in our expectations.
DETERMINATION
OF OFFERING PRICE
The
terms of any particular offering by us, the initial offering price and the net proceeds to us will be contained in the applicable
prospectus supplement, information incorporated by reference or free writing prospectus, relating to such offering.
USE
OF PROCEEDS
Unless
we inform you otherwise in the applicable prospectus supplement, we expect to use the net proceeds from the sale of the securities
for general corporate purposes, which may include funding future acquisitions and investments, repaying indebtedness, making capital
expenditures and funding working capital. Pending any specific application, we may initially invest the net proceeds in short-term
marketable securities.
We
have not determined the amounts we plan to spend on the areas listed above or the timing of these expenditures. As a result, our
management will have broad discretion to allocate the net proceeds of any offering.
SECURITIES
WE MAY OFFER
We
may issue from time to time, in one or more offerings the following securities:
|
●
|
shares
of common stock;
|
|
●
|
shares
of preferred stock;
|
|
●
|
warrants
exercisable for debt securities, common stock or preferred stock;
|
|
●
|
debt
securities;
|
|
|
|
|
●
|
depositary
shares; and
|
|
●
|
units
of common stock, preferred stock, warrants, debt securities or depositary shares, in any combination.
|
This
prospectus contains a summary of the material general terms of the various securities that we may offer. The specific terms of
the securities will be described in a prospectus supplement, information incorporated by reference, or free writing prospectus,
which may be in addition to or different from the general terms summarized in this prospectus. Where applicable, the prospectus
supplement, information incorporated by reference or free writing prospectus will also describe any material United States federal
income tax considerations relating to the securities offered and indicate whether the securities offered are or will be listed
on any securities exchange. The summaries contained in this prospectus and in any prospectus supplements, information incorporated
by reference or free writing prospectus may not contain all of the information that you would find useful. Accordingly, you should
read the actual documents relating to any securities sold pursuant to this prospectus. See “Where You Can Find Additional
Information” and “Incorporation of Certain Information by Reference” for information about how to obtain copies
of those documents.
The
terms of any particular offering, the initial offering price and the net proceeds to us will be contained in the prospectus supplement,
information incorporated by reference or free writing prospectus, relating to such offering.
DESCRIPTION
OF CAPITAL STOCK
Our
Amended and Restated Certificate of Incorporation, provides that we are authorized to issue 101,000,000 shares of capital stock.
Our authorized capital stock is comprised of 100,000,000 shares of common stock, $0.0001 par value per share, and 1,000,000 shares
of preferred stock, par value $0.0001 per share.
The
following description is a summary of the material terms of our capital stock and certain provisions of our Amended and Restated
Certificate of Incorporation, and Amended and Restated Bylaws, as amended. This description does not purport to be complete. For
information on how you can obtain our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, as amended,
see “Where You Can Find Additional Information.”
Common
Stock
We
are authorized to issue up to 100,000,000 shares of our common stock, par value $0.0001 per share.
The
holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders.
Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the
shares voting are able to elect all of our directors. Subject to preferences that may apply to any then outstanding shares of
preferred stock, the holders of outstanding shares of our common stock are entitled to receive dividends out of assets legally
available for distribution at the times and in the amounts, if any, that our Board of Directors may determine from time to time.
In the event of our liquidation, dissolution or winding up, subject to the rights of each series of our preferred stock, which
may, from time to time come into existence, holders of our common stock are entitled to share ratably in all of our assets remaining
after we pay our liabilities. Holders of our common stock have no preemptive or other subscription or conversion rights. Our common
stock is not redeemable and there are no sinking fund provisions applicable to our common stock.
Preferred
Stock
Our
Board of Directors is authorized, subject to limitations imposed by Delaware law, to issue up to 1,000,000 shares of preferred
stock, par value $0.0001 per share, in one or more series, without stockholder approval. Our Board of Directors is authorized
to fix the number of shares of preferred stock and to determine or (so long as no shares of such series are then outstanding)
alter for each such series, such voting powers, full or limited, or no voting powers, and such designations, preferences, and
relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be
stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such shares
and as may be permitted by Delaware General Corporation Law. The rights, privileges, preferences and restrictions of any such
additional series may be subordinated to, pari passu with, or senior to any of those of any present or future class or
series of our capital stock. Our Board of Directors is also authorized to decrease the number of shares of any series, prior or
subsequent to the issue of that series, but not below the number of shares of such series then outstanding. In case the number
of shares of any series shall be so decreased, the shares constituting any decrease shall resume the status which they had prior
to the adoption of the resolution originally fixing the number of shares of such series.
This
section describes the general terms and provisions of our preferred stock. The applicable prospectus supplement will describe
the specific terms of any shares of preferred stock offered through that prospectus supplement, as well as any general terms described
in this section that will not apply to those shares of preferred stock. We will file a copy of the certificate of designation
that contains the terms of each new series of preferred stock with the SEC each time we issue a new series of preferred stock.
Each certificate of designation will establish the number of shares included in a designated series and fix the designation, powers,
privileges, preferences and rights of the shares of each series as well as any applicable qualifications, limitations or restrictions.
You should refer to the applicable certificate of designation as well as our Amended and Restated Certificate of Incorporation
before deciding to buy shares of our preferred stock as described in the applicable prospectus supplement.
Anti-Takeover
Provisions of Delaware Law and Charter Provisions
Interested
Stockholder Transactions
We
are subject to Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from
engaging in any “business combination” with any “interested stockholder” for a period of three years after
the date that such stockholder became an interested stockholder, with the following exceptions:
|
●
|
before
such date, the board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested holder;
|
|
●
|
upon
consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding, for purposes
of determining the number of shares outstanding, those shares owned by persons who are directors and also officers and by
employee stock plans in which employee participants do not have the right to determine confidentially whether shares held
subject to the plan will be tendered in a tender or exchange offer; or
|
|
●
|
on
or after such date, the business combination is approved by the board of directors and authorized at an annual or special
meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting
stock that is not owned by the interested stockholder.
|
Section
203 defines “business combination” to include the following:
|
●
|
any
merger or consolidation involving the corporation and the interested stockholder;
|
|
●
|
any
sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the assets of the corporation involving
the interested stockholder;
|
|
●
|
subject
to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
to the interested stockholder;
|
|
●
|
any
transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class
or series of the corporation beneficially owned by the interested stockholder; or
|
|
●
|
the
receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits
by or through the corporation.
|
In
general, Section 203 defines “interested stockholder” as an entity or person beneficially owning 15% or more of the
outstanding voting stock of the corporation or any entity or person affiliated with or controlling or controlled by such entity
or person.
Amended
and Restated Certificate of Incorporation and Bylaws
Provisions
in our Amended and Restated Certificate of Incorporation, and Amended and Restated Bylaws, as amended, may have the effect of
discouraging certain transactions that may result in a change in control of our company. Some of these provisions provide that
stockholders cannot act by written consent and impose advance notice requirements and procedures with respect to stockholder proposals
and the nomination of candidates for election as directors. Our Amended and Restated Certificate of Incorporation allows us to
issue shares of preferred stock (see “Blank Check Preferred Stock”) or common stock without any action by stockholders.
Our directors and our officers are indemnified by us to the fullest extent permitted by applicable law pursuant to our Amended
and Restated Certificate of Incorporation. Our Board of Directors is expressly authorized to make, alter or repeal our Amended
and Restated Bylaws. These provisions may make it more difficult for stockholders to take specific corporate actions and may make
it more difficult or discourage an attempt to obtain control of the Company by means of a proxy contest, tender offer, merger
or otherwise.
Blank
Check Preferred Stock
Our
Amended and Restated Certificate of Incorporation, authorizes our Board of Directors to approve the issuance of up to 1,000,000
shares of preferred stock, without further approval of the stockholders, and to determine the rights and preferences of any series
of preferred stock. The Board of Directors could issue one or more series of preferred stock with voting, conversion, dividend,
liquidation or other rights that would adversely affect the voting power and ownership interest of holders of our common stock.
This authority may have the effect of deterring hostile takeovers, delaying or preventing a change in control and discouraging
bids for our common stock at a premium over the market price.
DESCRIPTION
OF WARRANTS
We
may issue warrants to purchase common stock, preferred stock or other securities described in this prospectus. We may issue warrants
independently or as part of a unit with other securities. Warrants sold with other securities as a unit may be attached to or
separate from the other securities. The prospectus supplement relating to any warrants we are offering will describe specific
terms relating to the offering, including a description of any other securities sold together with the warrants. These terms will
include some or all of the following:
|
●
|
the
title of the warrants;
|
|
●
|
the
aggregate number of warrants offered;
|
|
●
|
the
price or prices at which the warrants will be issued;
|
|
●
|
the
designation, number and terms of any common stock, preferred stock or other securities purchasable upon exercise of the warrants
and procedures by which those numbers may be adjusted;
|
|
●
|
the
exercise price of the warrants, including any provisions for changes or adjustments to the exercise price, and terms relating
to the currency in which such price is payable;
|
|
●
|
the
dates or periods during which the warrants are exercisable;
|
|
●
|
the
designation and terms of any securities with which the warrants are issued as a unit;
|
|
●
|
if
the warrants are issued as a unit with another security, the date on or after which the warrants and the other security will
be separately transferable;
|
|
●
|
any
minimum or maximum amount of warrants that may be exercised at any one time;
|
|
●
|
any
terms relating to the modification of the warrants;
|
|
●
|
a
discussion of material federal income tax considerations, if applicable; and
|
|
●
|
any
other terms of the warrants and any other securities sold together with the warrants, including, but not limited to, the terms,
procedures and limitations relating to the transferability, exchange, exercise or redemption of the warrants.
|
The
applicable prospectus supplement will describe the specific terms of any warrant units.
The
descriptions of the warrants in this prospectus and in any prospectus supplement are summaries of the material provisions of the
applicable warrant agreements. These descriptions do not restate those agreements in their entirety and do not contain all of
the information that you may find useful. We urge you to read the applicable agreements because they, and not the summaries, define
many of your rights as holders of the warrants or any warrant units. For more information, please review the form of the relevant
agreements, which will be filed with the SEC promptly after the offering of warrants or warrant units and will be available as
described under the heading “Where You Can Find Additional Information.”
DESCRIPTION
OF DEBT SECURITIES
We
may issue debt securities, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible
debt. The senior debt securities will rank equally with any other unsubordinated debt that we may have and may be secured or unsecured.
The subordinated debt securities will be subordinate and junior in right of payment, to the extent and in the manner described
in the instrument governing the debt, to all or some portion of our senior indebtedness. Any convertible debt securities that
we may issue will be convertible into or exchangeable for common stock, preferred stock or other securities of ours or of a third
party. Conversion may be mandatory or at your option and would be at prescribed conversion rates.
The
debt securities will be issued either (i) pursuant to our existing indenture, dated as of November 2, 2016, as supplemented, between
us and U.S. Bank National Association, as trustee (our “2016 Indenture”), (ii) pursuant to our existing indenture,
dated as of May 7, 2019, as supplemented, between us and The Bank of New York Mellon Trust Company, N.A., as trustee (our “2019
Indenture” and together with the 2016 Indenture, the “existing indentures”), or (iii) pursuant to
a subordinated debt indenture that we will enter into with The Bank of New York Mellon Trust Company, N.A., as trustee (“new
subordinated debt indenture”). While the terms we have summarized below will apply generally to any debt securities
that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more
detail in a prospectus supplement (and any free writing prospectus).
We
have incorporated by reference our existing indentures and filed forms of our new subordinated debt indenture as exhibits to the
registration statement of which this prospectus is a part. We use the term “indentures” to refer collectively to our
existing indentures and our new subordinated debt indenture.
The
indentures, to the extent not already qualified, will be qualified under the Trust Indenture Act of 1939, as amended (the “Trust
Indenture Act”).
The
following summaries of the material provisions of the senior debt securities, the subordinated debt securities and the indentures,
together with the additional information we may include in any applicable prospectus supplements, does not purport to be complete
and is subject to, and qualified in its entirety by reference to, all of the provisions of the form of our new subordinated debt
indenture filed as exhibits to the registration statement of which this prospectus is part, as it may be supplemented, amended
or modified from time to time, as well as our existing indentures that are incorporated by reference as exhibits to the registration
statement of which this prospectus is part. You should read the applicable prospectus supplement (and any free writing prospectus
that we may authorize to be provided to you) related to the series of debt securities being offered, as well as the complete indentures
that contain the terms of the debt securities.
The
following are some of the terms relating to our existing indentures and our new subordinated debt indenture of debt securities
that could be described in a prospectus supplement:
|
●
|
principal
amount being offered, and, if a series, the total amount authorized and the total amount outstanding;
|
|
●
|
any
limit on the amount that may be issued;
|
|
●
|
whether
we will issue the series of debt securities in global form and, if so, the terms and who the depositary will be;
|
|
●
|
principal
amount due at maturity, and whether the debt securities will be issued with any original issue discount;
|
|
●
|
whether
and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a
United States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts;
|
|
●
|
annual
interest rate, which may be fixed or variable, or the method for determining the rate, the date interest will begin to accrue,
the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such
dates;
|
|
●
|
whether
the debt securities will be secured or unsecured, and the terms of any secured debt;
|
|
●
|
terms
of the subordination of any series of subordinated debt;
|
|
●
|
place
where payments will be payable;
|
|
●
|
restrictions
on transfer, sale or other assignment, if any;
|
|
●
|
our
right, if any, to defer payment of interest and the maximum length of any such deferral period;
|
|
●
|
date,
if any, after which, the conditions upon which, and the price at which we may, at our option, redeem the series of debt securities
pursuant to any optional or provisional redemption provisions, and any other applicable terms of those redemption provisions;
|
|
●
|
provisions
for a sinking fund, purchase or other analogous fund, if any;
|
|
●
|
date,
if any, on which, and the price at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions
or otherwise, to redeem, or at the holder’s option to purchase, the series of debt securities;
|
|
●
|
whether
the indenture will restrict our ability or the ability of our subsidiaries to:
|
|
○
|
incur
additional indebtedness;
|
|
○
|
issue
additional securities;
|
|
|
|
|
○
|
create
liens;
|
|
○
|
pay
dividends or make distributions in respect of our capital stock or the capital stock of our subsidiaries;
|
|
○
|
place
restrictions on our subsidiaries’ ability to pay dividends, make distributions or transfer assets;
|
|
○
|
make
investments or other restricted payments;
|
|
○
|
sell
or otherwise dispose of assets;
|
|
|
|
|
○
|
enter
into sale-leaseback transactions;
|
|
○
|
engage
in transactions with shareholders or affiliates;
|
|
○
|
issue
or sell stock of our subsidiaries; or
|
|
○
|
effect
a consolidation or merger;
|
|
●
|
whether
the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial
ratios;
|
|
●
|
a
discussion of any material or special United States federal income tax considerations applicable to the debt securities;
|
|
●
|
information
describing any book-entry features;
|
|
●
|
procedures
for any auction or remarketing, if any;
|
|
●
|
whether
the debt securities are to be offered at a price such that they will be deemed to be offered at an “original issue discount”
as defined in paragraph (a) of Section 1273 of the Internal Revenue Code of 1986, as amended;
|
|
●
|
denominations
in which we will issue the series of debt securities, if other than denominations of $2,000 and any integral multiple of $1,000
in excess thereof;
|
|
●
|
if
other than dollars, the currency in which the series of debt securities will be denominated; and
|
|
●
|
any
other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any events
of default that are in addition to those described in this prospectus or any covenants provided with respect to the debt securities
that are in addition to those described above, and any terms that may be required by us or advisable under applicable laws
or regulations or advisable in connection with the marketing of the debt securities.
|
Conversion
or Exchange Rights
We
will set forth in the applicable prospectus supplement or free writing prospectus the terms on which a series of debt securities
may be convertible into or exchangeable for common stock, preferred stock or other securities of ours, including the conversion
or exchange rate, as applicable, or how it will be calculated, and the applicable conversion or exchange period. We will include
provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions
pursuant to which the number of our securities that the holders of the series of debt securities receive upon conversion or exchange
would, under the circumstances described in those provisions, be subject to adjustment, or pursuant to which those holders would,
under those circumstances, receive other property upon conversion or exchange, for example in the event of our merger or consolidation
with another entity.
Consolidation,
Merger or Sale
The
terms of any securities that we may offer pursuant to this prospectus may limit our ability to merge or consolidate or otherwise
sell, convey, transfer or otherwise dispose of all or substantially all of our assets, which terms would be set forth in the applicable
prospectus supplement and supplemental indenture. Any successor of ours or acquiror of such assets would have to assume all of
our obligations under the indentures and the debt securities, as appropriate.
If
the debt securities are convertible for our other securities, the person with whom we consolidate or merge or to whom we sell
all of our property would have to make provisions for the conversion of the debt securities into securities that the holders of
the debt securities would have received if they had converted the debt securities before the consolidation, merger or sale.
Events
of Default Under the Indenture
Unless
otherwise indicated in the applicable prospectus supplement, the following are events of default under the indentures with respect
to any series of debt securities that we may issue:
|
●
|
if
we fail to pay interest when due and payable and our failure continues for 30 days and the time for payment has not been extended
or deferred;
|
|
|
|
|
●
|
if
we fail to pay the principal or premium, if any, when due and payable and the time for payment has not been extended or deferred;
|
|
|
|
|
●
|
if
we fail to deposit any sinking fund payment, to the extent applicable, when and as due;
|
|
●
|
if
we fail to observe or perform any other covenant contained in the debt securities or the indentures, and our failure continues
for 60 days after we receive notice from the trustee or holders of at least 25% in aggregate principal amount of the outstanding
debt securities of the applicable series; and
|
|
●
|
if
specified events of bankruptcy, insolvency or reorganization occur.
|
If
an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified
in the last bullet point above, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt
securities of that series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the
unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default specified
in the last bullet point above occurs with respect to us, the principal amount of and accrued interest, if any, of each issue
of debt securities then outstanding would be due and payable without any notice or other action on the part of the trustee or
any holder.
The
holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event
of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal,
premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver
shall cure the default or event of default.
Subject
to the terms of the indentures, if an event of default under an indenture occurs and continues, the trustee would be under no
obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the
applicable series of debt securities, unless such holders have offered the trustee indemnity satisfactory to the trustee. The
holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time,
method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred
on the trustee, with respect to the debt securities of that series, provided that:
|
●
|
the
direction so given by the holder is not in conflict with any law or the applicable indenture, nor subject the trustee to a
risk of personal liability in respect of which the trustee has not received indemnification satisfactory to it in its sole
discretion against all losses, liabilities and expenses caused by taking or not taking such action; and
|
|
●
|
the
trustee may take any other action deemed proper by the trustee which is not inconsistent with such direction.
|
A
holder of the debt securities of any series will have the right to institute a proceeding under the indentures or to appoint a
receiver or trustee, or to seek other remedies only if:
|
●
|
the
holder has given written notice to the trustee of a continuing event of default with respect to that series;
|
|
●
|
the
holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written
request, and such holders have offered indemnity satisfactory to the trustee to institute the proceeding as trustee; and
|
|
●
|
the
trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount
of the outstanding debt securities of that series other conflicting directions within 60 days after the notice, request and
offer.
|
These
limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium,
if any, or interest on, the debt securities.
We
will periodically file statements with the trustee regarding our compliance with specified covenants in the indentures.
Supplemental
Indentures
We
and the trustee may from time to time and at any time enter into an indenture or supplemental indenture without the consent of
any holders for one or more of the following purposes:
|
●
|
to
evidence the succession of another corporation, and the assumption by the successor corporation of our covenants, agreements
and obligations under the indenture and debt securities;
|
|
●
|
to
add to our covenants such new covenants, restrictions, conditions or provisions for the protection of the holders, and to
make the occurrence, or the occurrence and continuance, of a default in any of such additional covenants, restrictions, conditions
or provisions an event of default;
|
|
●
|
to
modify, eliminate or add to any of the provisions of the indenture to such extent as necessary to effect the qualification
of the indenture under the Trust Indenture Act, and to add to the indenture such other provisions as may be expressly permitted
by the Trust Indenture Act, excluding however, the provisions referred to in Section 316(a)(2) of the Trust Indenture Act;
|
|
●
|
to
cure any ambiguity or to correct or supplement any provision contained in the indenture or in any supplemental indenture which
may be defective or inconsistent with other provisions;
|
|
●
|
to
make provisions in regard to matters or questions arising under the indenture, so long such other provisions to do not adversely
affect the interest of any other holder of debt securities in any material respect;
|
|
●
|
to
secure any series of security;
|
|
●
|
to
evidence and provide for the acceptance and appointment of a successor trustee and to add or change any provisions of the
indenture as necessary to provide for or facilitate the administration of the trust by more than one trustee; and
|
|
●
|
to
establish the form or terms of securities of any series as permitted under the indenture, including any subordination provisions.
|
In
addition, we and the trustee, with the consent of the holders of not less than a majority in aggregate principal of the outstanding
debt securities of each series that is affected, may from time to time and at any time enter into an indenture or supplemental
indenture for the purpose of adding any provisions to or changing in any manner the rights of the holders of the securities of
such series and any related coupons of the indenture, provided that no such supplemental indenture shall:
|
●
|
extend
the fixed maturity of any securities, or reduce the principal amount thereof or premium, if any, or reduce the rate or extend
the time of payment of interest, without the extent of the holder so affected;
|
|
●
|
reduce
the aforesaid percentage of securities, the consent of the holders of which is required for any such supplemental indenture,
without the consent of all holders of outstanding series of debt securities; or
|
|
●
|
modify
any of the above provisions.
|
Discharge
Each
indenture will provide that we can elect to be discharged from our obligations with respect to one or more series of debt securities,
except for specified obligations, including obligations to:
|
●
|
register
the transfer or exchange of debt securities of the series;
|
|
|
|
|
●
|
replace
stolen, lost or mutilated debt securities of the series;
|
|
●
|
maintain
paying agencies; and
|
|
●
|
hold
monies for payment in trust.
|
In
order to exercise our rights to be discharged, we must deposit with the trustee money or government obligations, or a combination
thereof, sufficient to pay all the principal of, any premium and interest on, the debt securities of the series on the dates payments
are due.
Form,
Exchange and Transfer
We
will issue the debt securities of each series only in fully registered form without coupons and, unless we otherwise specify in
the applicable prospectus supplement or free writing prospectus, in denominations of $2,000 and any integral multiple of $1,000
in excess thereof. The indentures will provide that we may issue debt securities of a series in temporary or permanent global
form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company or another depositary
named by us and identified in a prospectus supplement or free writing prospectus with respect to that series.
At
the option of the holder, subject to the terms of the indentures and the limitations applicable to global securities described
in the applicable prospectus supplement or free writing prospectus, the holder of the debt securities of any series can exchange
the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate
principal amount.
Subject
to the terms of the indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement
or free writing prospectus, holders of the debt securities may present the debt securities for exchange or for registration of
transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar,
at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise
provided in the debt securities that the holder presents for transfer or exchange, we will make no service charge for any registration
of transfer or exchange, but we may require payment of any taxes or other governmental charges.
We
will name in the applicable prospectus supplement or free writing prospectus the security registrar, and any transfer agent in
addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional
transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer
agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each
series.
If
we elect to redeem the debt securities of any series, we will not be required to:
|
●
|
issue,
register the transfer of, or exchange any debt securities of any series being redeemed in part during a period beginning at
the opening of business 15 days before the day of sending of a notice of redemption of any debt securities that may be selected
for redemption and ending at the close of business on the day of such transmission; or
|
|
●
|
register
the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion
of any debt securities we are redeeming in part.
|
Information
Concerning the Trustee
The
trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only
those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the trustee
must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to
this provision, the trustee is under no obligation to exercise any of the powers given it by an indenture at the request of any
holder of debt securities unless it is offered security and indemnity against the costs, expenses and liabilities that it might
incur.
Payment
and Paying Agents
Unless
we otherwise indicate in the applicable prospectus supplement or free writing prospectus, we will make payment of the interest
on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor
securities, are registered at the close of business on the regular record date for the interest.
We
will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents
designated by us, except that, unless we otherwise indicate in the applicable prospectus supplement or free writing prospectus,
we may make interest payments by check which we will mail to the holder or by wire transfer to certain holders. Unless we otherwise
indicate in a prospectus supplement or free writing prospectus, we will designate an office or agency of the trustee in the contiguous
United States as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable
prospectus supplement or free writing prospectus any other paying agents that we initially designate for the debt securities of
a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.
All
money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities
which remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid
to us, and the holder of the debt security thereafter may look only to us for payment thereof.
Governing
Law
The
indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except
to the extent that the Trust Indenture Act is applicable.
Subordination
of Subordinated Debt Securities
The
subordinated debt securities will be subordinate and junior in priority of payment to certain of our other indebtedness to the
extent described in a prospectus supplement or free writing prospectus. Our new subordinated debt indenture in the form initially
filed as exhibits to the registration statement of which this prospectus is a part, and our existing indentures, do not limit
the amount of indebtedness which we may incur, including senior indebtedness or subordinated indebtedness, and do not limit us
from issuing any other debt, including secured debt or unsecured debt.
DESCRIPTION
OF DEPOSITARY SHARES
General
We
may, at our option, elect to offer fractional interests in shares of preferred stock, which we call depositary shares, rather
than full shares of preferred stock. If we do, we will issue to the public receipts, called depositary receipts, for depositary
shares, each of which will represent a fraction, to be described in the applicable prospectus supplement, of a share of a particular
series of preferred stock. Unless otherwise provided in the prospectus supplement, each owner of a depositary share will be entitled,
in proportion to the applicable fractional interest in a share of preferred stock represented by the depositary share, to all
the rights and preferences of the preferred stock represented by the depositary share. Those rights include dividend, voting,
redemption, conversion and liquidation rights.
The
shares of preferred stock underlying the depositary shares will be deposited with a bank or trust company selected by us to act
as depositary under a deposit agreement between us, the depositary and the holders of the depositary receipts. The depositary
will be the transfer agent, registrar and dividend disbursing agent for the depositary shares.
The
depositary shares will be evidenced by depositary receipts issued pursuant to the deposit agreement. Holders of depositary receipts
agree to be bound by the deposit agreement, which requires holders to take certain actions such as filing proof of residence and
paying certain charges.
The
summary of terms of the depositary shares contained in this prospectus is not complete. You should refer to the form of the deposit
agreement and the certificate of designation for the applicable series of preferred stock that are, or will be, filed with the
SEC.
Dividends
and Other Distributions
The
depositary will distribute all cash dividends or other cash distributions, if any, received in respect of the preferred stock
underlying the depositary shares to the record holders of depositary shares in proportion to the numbers of depositary shares
owned by those holders on the relevant record date. The relevant record date for depositary shares will be the same date as the
record date for, or otherwise in accordance with the terms of, the underlying preferred stock. The depositary will not distribute
amounts less than one cent. The depositary will distribute any balance with the next sum received for distribution to record holders
of depositary shares.
If
there is a distribution other than in cash, the depositary will distribute property received by it to the record holders of depositary
shares, unless the depositary determines that it is not feasible to make the distribution. If this occurs, the depositary may,
with our approval, adopt another method for the distribution, including selling the property and distributing the net proceeds
from the sale to the holders.
Liquidation
Preference
If
a series of preferred stock underlying the depositary shares has a liquidation preference, in the event of the voluntary or involuntary
liquidation, dissolution or winding up of the Corporation, holders of depositary shares will be entitled to receive the fraction
of the liquidation preference accorded each share of the applicable series of preferred stock, as set forth in the applicable
prospectus supplement.
Withdrawal
of Stock
Unless
the related depositary shares have been previously called for redemption, upon surrender of the depositary receipts at the office
of the depositary, the holder of the depositary shares will be entitled to delivery, at the office of the depositary to or upon
his or her order, of the number of whole shares of the preferred stock and any money or
other property represented by the depositary shares. If the depositary receipts delivered by the holder evidence a number of depositary
shares in excess of the number of depositary shares representing the number of whole shares of preferred stock to be withdrawn,
the depositary will deliver to the holder at the same time a new depositary receipt evidencing the excess number of depositary
shares. In no event will the depositary deliver fractional shares of preferred stock upon surrender of depositary receipts.
Redemption
of Depositary Shares
Whenever
we redeem shares of preferred stock held by the depositary, the depositary will redeem, as of the same redemption date, the number
of depositary shares representing the preferred stock redeemed, so long as we have set aside all funds necessary for the redemption,
including the redemption price for such shares and all dividends declared but not paid as of the date fixed for redemption. The
redemption price per depositary share will bear the same relationship to the redemption price per share of preferred stock that
the depositary share bears to the underlying preferred stock. If less than all the depositary shares are to be redeemed, the depositary
shares to be redeemed will be selected pro rata, by lot or by any other equitable method.
After
the date fixed for redemption, the depositary shares called for redemption will no longer be outstanding. When the depositary
shares are no longer outstanding, all rights of the holders will cease, except the right to receive money or other property that
the holders of the depositary shares were entitled to receive upon the redemption. Payments will be made when holders surrender
their depositary receipts to the depositary.
Voting
the Preferred Stock
Upon
receipt of notice of any meeting at which the holders of the preferred stock are entitled to vote, the depositary will forward
the information contained in the notice of meeting to the record holders of the depositary receipts relating to that preferred
stock. The relevant record date for depositary shares will be the same date as the record date for, or otherwise in accordance
with the terms of, the underlying preferred stock. Each record holder of the depositary shares on the record date will be entitled
to instruct the depositary as to the exercise of the voting rights pertaining to the number of shares of preferred stock represented
by that holder’s depositary shares. The depositary will endeavor, insofar as reasonably practicable, to vote the number
of shares of preferred stock represented by the depositary shares in accordance with those instructions, and we will agree to
take all reasonable action requested by and deemed necessary by the depositary in order to enable the depositary to do so. In
the absence of any specific instructions from a holder of depositary shares, the depositary will, subject to any applicable restrictions,
cast votes pertaining to the number of whole shares of preferred stock represented by such depositary shares proportionately with
instructions actually received.
Charges
of Depositary
We
will pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements.
We will pay associated charges of the depositary in connection with the initial deposit of the preferred stock and any redemption
of the preferred stock. Holders of depositary receipts will pay transfer, income and other taxes and governmental charges and
such other charges as are expressly provided in the deposit agreement to be for their accounts. If these charges have not been
paid by the holders of depositary receipts, the depositary may refuse to transfer depositary shares, withhold dividends and distributions
and sell the depositary shares evidenced by the depositary receipt.
Amendment
and Termination of the Deposit Agreement
The
form of depositary receipt evidencing the depositary shares and any provision of the deposit agreement may be amended by agreement
between us and the depositary. However, any amendment that materially and adversely alters the rights of the holders of depositary
shares will not be effective unless the amendment has been approved by at least a majority (or, in the case of such amendments
relating to or affecting rights to receive dividends or distributions or voting or redemption rights, holders of at least two-thirds)
of the outstanding depositary shares. The deposit agreement may be terminated by the depositary or us only if:
|
●
|
all
outstanding depositary shares have been redeemed; or
|
|
●
|
there
has been a final distribution of the preferred stock in connection with our liquidation,
dissolution or winding up and such distribution has been made to all the holders of depositary
shares.
|
Resignation
and Removal of Depositary
The
depositary may resign at any time by delivering to us notice of its election to do so, and we may remove the depositary at any
time. Any resignation or removal of the depositary will take effect upon our appointment of a successor depositary and its acceptance
of such appointment. The successor depositary must be appointed within 60 days after delivery of the notice of resignation or
removal and must be a bank or trust company having its principal office in the United States and having the requisite combined
capital and surplus as set forth in the applicable agreement.
Notices
The
depositary will forward to holders of depositary receipts all notices, reports and other communications, including proxy solicitation
materials received from us, that are delivered to the depositary and that we are required to furnish to the holders of the preferred
stock. In addition, the depositary will make available for inspection by holders of depositary receipts at the principal office
of the depositary, and at such other places as it may from time to time deem advisable, any reports and communications we deliver
to the depositary as the holder of preferred stock.
Limitation
of Liability
Neither
we nor the depositary will be liable if either of us is prevented or delayed by law or any circumstance beyond its control in
performing its obligations under the deposit agreement. Our obligations and those of the depositary under the deposit agreement
will be limited to performance in good faith of our and their obligations thereunder. We and the depositary will not be obligated
to prosecute or defend any legal proceeding in respect of any depositary shares or preferred stock unless satisfactory indemnity
is furnished. We and the depositary may rely upon advice of counsel or accountants, on information provided by persons presenting
preferred stock for deposit, holders of depositary receipts or other persons believed to be competent to give such information
and on documents believed to be genuine and to have been signed or presented by the proper party or parties.
DESCRIPTION
OF UNITS
As
specified in the applicable prospectus supplement, we may issue units comprised of one or more of the other securities described
in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security
included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The
prospectus supplement will describe:
|
●
|
the
designation and terms of the units and of the securities comprising the units, including whether and under what circumstances
the securities comprising the units may be held or transferred separately;
|
|
●
|
the
terms of any unit agreement governing the units;
|
|
●
|
the
provisions for the payment, settlement, transfer or exchange of the units;
|
|
●
|
material
federal income tax considerations, if applicable; and
|
|
●
|
whether
the units will be issued in fully registered or global form.
|
The
descriptions of the units and any applicable underlying security or pledge arrangements in this prospectus and in any prospectus
supplement are summaries of the material provisions of the applicable agreements. These descriptions do not restate those agreements
in their entirety and may not contain all the information that you may find useful. We urge you to read the applicable agreements
because they, and not the summaries, define many of your rights as holders of the units. For more information, please review the
form of the relevant agreements, which will be filed with the SEC promptly after the offering of units and will be available as
described under the heading “Where You Can Find Additional Information.”
PLAN
OF DISTRIBUTION
Securities
Offered by Us
We
may sell the securities from time to time pursuant to underwritten public offerings, negotiated transactions, block trades, “at
the market offerings” as defined in Rule 415 promulgated under the Securities Act or a combination of these methods. We
may sell the securities to or through underwriters or dealers, through agents, or directly to one or more purchasers.
We
may distribute securities from time to time in one or more transactions:
|
●
|
at
a fixed price or prices, which may be changed;
|
|
●
|
at
market prices prevailing at the time of sale;
|
|
●
|
at
prices related to such prevailing market prices; or
|
Unless
stated otherwise in the applicable prospectus supplement, the obligations of any underwriter to purchase securities will be subject
to certain conditions, and an underwriter will be obligated to purchase all of the applicable securities if any are purchased.
If a dealer is used in a sale, we may sell the securities to the dealer as principal. The dealer may then resell the securities
to the public at varying prices to be determined by the dealer at the time of resale.
We
or our agents may solicit offers to purchase securities from time to time. Unless stated otherwise in the applicable prospectus
supplement, any agent will be acting on a best efforts basis for the period of its appointment.
In
connection with the sale of securities, underwriters or agents may receive compensation (in the form of discounts, concessions
or commissions) from us or from purchasers of securities for whom they may act as agents. Underwriters may sell securities to
or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the
distribution of securities may be deemed to be underwriters, as that term is defined in the Securities Act of 1933, as amended
(the “Securities Act”), and any discounts or commissions received by them from us and any profits on the resale
of the securities by them may be deemed to be underwriting discounts and commissions under the Securities Act. We will identify
any such underwriter or agent, and we will describe any compensation paid to them, in the related prospectus supplement.
Underwriters,
dealers and agents may be entitled under agreements with us to indemnification against and contribution toward certain civil liabilities,
including liabilities under the Securities Act.
If
stated in the applicable prospectus supplement, we will authorize agents and underwriters to solicit offers by certain specified
institutions or other persons to purchase securities at the public offering price set forth in the prospectus supplement under
delayed delivery contracts providing for payment and delivery on a specified date in the future. Institutions with which these
contracts may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational
and charitable institutions, and other institutions, but shall in all cases be subject to our approval. These contracts will be
subject only to those conditions set forth in the applicable prospectus supplement and the applicable prospectus supplement will
set forth the commission payable for solicitation of these contracts. The obligations of any purchaser under any such contract
will be subject to the condition that the purchase of the securities shall not be prohibited at the time of delivery under the
laws of the jurisdiction to which the purchaser is subject. The underwriters and other agents will not have any responsibility
in respect of the validity or performance of these contracts.
There is no established
trading market for any security other than our common stock, which is listed on the NASDAQ Global Market (“NASDAQ”)
under the symbol “RILY”, our Depositary Shares, listed on NASDAQ under the symbol “RILYP,” our 7.50% Senior
Notes due 2027, listed on NASDAQ under the symbol “RILYZ”, our 7.375% Senior Notes due 2023, listed on NASDAQ under
the symbol “RILYH”, our 7.25% Senior Notes due 2027, listed on NASDAQ under the symbol “RILYG”, our 6.875%
Senior Notes due 2023, listed on NASDAQ under the symbol “RILYI”, our 6.75% Senior Notes due 2024, listed on NASDAQ
under the symbol “RILYO”, and our 6.50% Senior Notes due 2026, listed on NASDAQ under the symbol “RILYN”
and our 6.375% Senior Notes due 2025, listed on NASDAQ under the symbol “RILYM.” The securities issued under this
registration statement may or may not be listed on a national securities exchange or traded in the over-the-counter market, as
set forth in the applicable prospectus supplement. No assurance can be given as to the liquidity of the trading market for any
of our securities. Any underwriter may make a market in these securities. However, no underwriter will be obligated to do so,
and any underwriter may discontinue any market making at any time, without prior notice.
If
underwriters or dealers are used in the sale, until the distribution of the securities is completed, SEC rules may limit the ability
of any underwriters and selling group members to bid for and purchase the securities. As an exception to these rules, representatives
of any underwriters are permitted to engage in certain transactions that stabilize the price of the securities. These transactions
may consist of bids or purchases for the purpose of pegging, fixing or maintaining the price of the securities. If the underwriters
create a short position in the applicable securities in connection with any offering (in other words, if they sell more securities
than are set forth on the cover page of the applicable prospectus supplement) the representatives of the underwriters may reduce
that short position by purchasing securities in the open market. The representatives of the underwriters may also elect to reduce
any short position by exercising all or part of any over-allotment option we may grant to the underwriters, as described in the
prospectus supplement. The representatives of the underwriters may also impose a penalty bid on certain underwriters and selling
group members. This means that if the representatives purchase securities in the open market to reduce the underwriters’
short position or to stabilize the price of the securities, they may reclaim the amount of the selling concession from the underwriters
and selling group members who sold those shares as part of the offering.
In
general, purchases of a security for the purpose of stabilization or to reduce a short position could cause the price of the security
to be higher than it might be in the absence of those purchases. The imposition of a penalty bid might also have an effect on
the price of the securities to the extent that it discourages resales of the securities. The transactions described above may
have the effect of causing the price of the securities to be higher than it would otherwise be. If commenced, the representatives
of the underwriters may discontinue any of the transactions at any time. In addition, the representatives of any underwriters
may determine not to engage in those transactions or that those transactions, once commenced, may be discontinued without notice.
Certain
of the underwriters or agents and their associates may engage in transactions with and perform services for us or our affiliates
in the ordinary course of their respective businesses.
In
no event will the commission or discount received by any Financial Industry Regulatory Authority (“FINRA”)
member or independent broker-dealer participating in a distribution of securities exceed eight percent of the aggregate principal
amount of the offering of securities in which that FINRA member or independent broker-dealer participates.
LEGAL
MATTERS
The
NBD Group, Inc., Los Angeles, California, has passed upon the validity of the securities to be offered pursuant to this prospectus.
EXPERTS
Marcum
LLP, an independent registered public accounting firm, has audited our consolidated financial statements as of December 31, 2018
and 2017 and for each of the three years in the period ended December 31, 2018, as well as the effectiveness of our internal controls
over financial reporting as of December 31, 2018, as stated in its report incorporated by reference into this prospectus, and
such audited consolidated financial statements have been incorporated by reference into this prospectus in reliance upon the report
of such firm given upon its authority as experts in accounting and auditing.
The
consolidated financial statements of FBR & Co. and its subsidiaries as of December 31, 2016 and 2015 and for each of the three
years in the period ended December 31, 2016 incorporated by reference in this prospectus have been so incorporated in reliance
on the reports of BDO USA, LLP, an independent registered public accounting firm, incorporated herein by reference, given on the
authority of said firm as experts in auditing and accounting.
The
consolidated financial statements of magicJack VocalTec Ltd. as of December 31, 2017
and 2016 and for each of the three years in the period ended December 31, 2017 and management’s assessment of the effectiveness
of internal control over financial reporting as of December 31, 2017 incorporated by reference in this prospectus have been so
incorporated in reliance on the reports of BDO USA, LLP, an independent registered public accounting firm, incorporated herein
by reference, given on the authority of said firm as experts in auditing and accounting.
The
combined financial statements of BR Brand Group as of December 31, 2018 and 2017 and for each of the two years in the period ended
December 31, 2018 incorporated by reference in this prospectus have been so incorporated in reliance on the reports of Mayer Hoffman
McCann CPAs, The New York Practice of Mayer Hoffman McCann P.C., independent auditor of BR Brand Group, incorporated herein by
reference, given on the authority of said firm as experts in auditing and accounting.
WHERE
YOU CAN FIND MORE INFORMATION
We
file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any document
that we file at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549, on official business days
during the hours of 10:00 am and 3:00 pm. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference
Room. All filings we make with the SEC are also available on the SEC’s web site at http://www.sec.gov. Our website addresses
are http://www.greatamerican.com, http://www.brileyfin.com, http://www.unitedonline.net, http://www.magicjack.com and http://www.vocaltec.com.
We have not incorporated by reference into this prospectus the information on our websites, and you should not consider it to
be a part of this document.
We
have filed with the SEC a registration statement on Form S-3 under the Securities Act with respect to the securities being offered
by this prospectus. This prospectus is part of that registration statement. This prospectus does not contain all of the information
set forth in the registration statement or the exhibits to the registration statement. For further information with respect to
us and the securities we are offering pursuant to this prospectus, you should refer to the complete registration statement, its
exhibits and the information incorporated by reference in the registration statement. Statements contained in this prospectus
as to the contents of any contract, agreement or other document referred to are not necessarily complete, and you should refer
to the copy of that contract or other documents filed as an exhibit to the registration statement. You may read or obtain a copy
of the registration statement at the SEC’s public reference room and website referred to above.
INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE
For
purposes of this prospectus, the SEC allows us to “incorporate by reference” certain information we have filed with
the SEC, which means that we are disclosing important information to you by referring you to other information we have filed with
the SEC. The information we incorporate by reference is considered part of this prospectus. We specifically are incorporating
by reference the following documents filed with the SEC (excluding those portions of any Current Report on Form 8-K that are not
deemed “filed” pursuant to the General Instructions of Form 8-K):
|
●
|
Our
quarterly report on Form 10-Q for the quarterly periods ended March
31, 2019, June
30, 2019 and September
30, 2019, filed with the SEC on May 1, 2019, August 9, 2019 and November 1, 2019, respectively;
|
|
|
|
|
●
|
Our
annual report on Form 10-K
for the year ended December 31, 2018, filed with the SEC on March 6, 2019 (including any portions of our Definitive Proxy
Statement on Schedule 14A
filed on April 15, 2019 that are incorporated by reference into such Annual Report on Form 10-K);
|
|
|
|
|
●
|
Our
current reports on Form 8-K/A filed with the SEC on June
28, 2017, March 21, 2018, December
10, 2018, and November
26, 2019, and our current reports on Form 8-K filed with the SEC on November
21, 2017, March 20, 2018,
April 25, 2018, May
11, 2018, August 13, 2018,
November 20, 2018, January
4, 2019, February 7, 2019,
April 9, 2019, April
22, 2019, May 7, 2019,
July 18, 2019, September
23, 2019, October
7, 2019, October
11, 2019, October
15, 2019, October
18, 2019, November
1, 2019, December
5, 2019, January
9, 2020 and February
12, 2020; and
|
|
●
|
Description
of our common stock contained in our Registration Statement on Form 8-A filed on July
15, 2015.
|
|
●
|
Certificate
of Designation designating the 6.875% Series A Cumulative Perpetual Preferred Stock filed on October
4, 2019.
|
All
documents we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, except as to any portion of
any report or documents that is not deemed filed under such provisions, (1) on or after the date of filing of the registration
statement containing this prospectus and prior to the effectiveness of the registration statement and (2) on or after the date
of this prospectus until the earlier of the date on which all of the securities registered hereunder have been sold or the registration
statement of which this prospectus is a part has been withdrawn, shall be deemed incorporated by reference in this prospectus
and to be a part of this prospectus from the date of filing of those documents.
These
reports and documents can be accessed free of charge on our website http://www.brileyfin.com by clicking on “Investor Relations”
and then clicking on “SEC Filings.” We will provide without charge to each person, including any beneficial owner,
to whom this prospectus is delivered, upon written or oral request, a copy of any or all documents that are incorporated by reference
into this prospectus, but not delivered with the prospectus, other than exhibits to such documents unless such exhibits are specifically
incorporated by reference into the documents that this prospectus incorporates. Please send written requests to:
21255
Burbank Boulevard, Suite 400
Woodland
Hills, California 91367
Attn.:
Chief Financial Officer
You
should rely only on the information incorporated by reference or provided in this prospectus or any prospectus supplement. We
have not authorized anyone else to provide you with different information. You should not assume that the information in this
prospectus or any prospectus supplement is accurate as of any date other than the date on the front page of those documents.
Up to $150,000,000
7.375% Senior Notes due 2023
6.875% Senior Notes due 2023
6.75% Senior Notes due 2024
6.375% Senior Notes due 2025
6.50% Senior Notes due 2026
7.25% Senior Notes due 2027
7.50% Senior Notes due 2027
Depositary Shares Each Representing
1/1000th of a Share of 6.875% Series A Cumulative Perpetual Preferred Stock (Liquidation Preference Equivalent to $25.00
Per Depositary Share)
Depositary Shares Each Representing
1/1000th of a Share of 7.375% Series B Cumulative Perpetual Preferred Stock (Liquidation Preference Equivalent to $25.00
Per Depositary Share)
PROSPECTUS SUPPLEMENT
B. Riley Securities
October 9, 2020
B Riley Financial (NASDAQ:RILY)
Historical Stock Chart
From Mar 2024 to Apr 2024
B Riley Financial (NASDAQ:RILY)
Historical Stock Chart
From Apr 2023 to Apr 2024